<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="3baa9142-fe9a-4787-bdf0-964ed073cc39" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><meta name="pbContext" content=";product:product:elsevier\:product\:cell;issue:issue:pii\:S0092867420X00067;website:website:cell-site;ctype:string:Journal Content;article:article:pii\:S0092867421000659;journal:journal:cell;pageGroup:string:Article View;page:string:Show Full Text;requestedJournal:journal:cell;wgroup:string:Default Website Group;subPage:string:Full Text">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="Inhibitory CD161 receptor identified in glioma-infiltrating T&nbsp;cells by single-cell analysis">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(21)00065-9">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/asset/859e801e-5f80-44f6-8e16-27fb0d48de46/fx1.jpg">
    


        <meta property="og:description" content="Single-cell analysis of tumor-infiltrating T cells in glioma patients identifies a
T cell population co-expressing a cytotoxicity program and NK cell receptors. Mathewson
et al.&nbsp;reveal&nbsp;the functional significance of NK cell receptors such as CD161 in inhibiting
the anti-tumor function of T cells, highlighting their potential as targets for immunotherapy.">
    











        <meta name="twitter:title" content="Inhibitory CD161 receptor identified in glioma-infiltrating T&nbsp;cells by single-cell analysis">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/asset/859e801e-5f80-44f6-8e16-27fb0d48de46/fx1.jpg">
    


        <meta name="twitter:description" content="Single-cell analysis of tumor-infiltrating T cells in glioma patients identifies a
T cell population co-expressing a cytotoxicity program and NK cell receptors. Mathewson
et al.&nbsp;reveal&nbsp;the functional significance of NK cell receptors such as CD161 in inhibiting
the anti-tumor function of T cells, highlighting their potential as targets for immunotherapy.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(21)00065-9">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>Inhibitory CD161 receptor identified in glioma-infiltrating T&nbsp;cells by single-cell analysis: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="Inhibitory CD161 receptor identified in glioma-infiltrating T&nbsp;cells by single-cell analysis"> <meta name="citation_date" content="2021/03/04"> <meta name="citation_online_date" content="2021/02/15"> <meta name="citation_volume" content="184"> <meta name="citation_issue" content="5"> <meta name="citation_firstpage" content="1281"> <meta name="citation_lastpage" content="1298.e26"> <meta name="citation_pmid" content="33592174"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S0092867421000659"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S0092867421000659"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S0092867421000659"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2021.01.022"> <meta name="citation_pmid" content="33592174"> <meta name="citation_author" content="Nathan D. Mathewson"><meta name="citation_author_orcid" content="0000-0002-8895-2609"><meta name="citation_author_institution" content="Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA"><meta name="citation_author_institution" content="Department of Immunology, Harvard Medical School, Boston, MA, USA"><meta name="citation_author_institution" content="Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author" content="Orr Ashenberg"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author_institution" content="Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA"><meta name="citation_author" content="Itay Tirosh"><meta name="citation_author_institution" content="Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 761001, Israel"><meta name="citation_author" content="Simon Gritsch"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author_institution" content="Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA"><meta name="citation_author_institution" content="Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA"><meta name="citation_author" content="Elizabeth M. Perez"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author_institution" content="Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA"><meta name="citation_author_institution" content="Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA"><meta name="citation_author_institution" content="Department of Systems Biology, Harvard Medical School, Boston, MA, USA"><meta name="citation_author" content="Sascha Marx"><meta name="citation_author_orcid" content="0000-0002-6451-5404"><meta name="citation_author_institution" content="Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA"><meta name="citation_author_institution" content="Department of Immunology, Harvard Medical School, Boston, MA, USA"><meta name="citation_author" content="Livnat Jerby-Arnon"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author_institution" content="Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA"><meta name="citation_author_institution" content="Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA"><meta name="citation_author_institution" content="Chan Zuckerberg Biohub, San Francisco, CA 94158, USA"><meta name="citation_author" content="Rony Chanoch-Myers"><meta name="citation_author_orcid" content="0000-0002-8197-5795"><meta name="citation_author_institution" content="Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 761001, Israel"><meta name="citation_author" content="Toshiro Hara"><meta name="citation_author_orcid" content="0000-0002-4389-3393"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author_institution" content="Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA"><meta name="citation_author_institution" content="Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA"><meta name="citation_author" content="Alyssa R. Richman"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author_institution" content="Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA"><meta name="citation_author_institution" content="Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA"><meta name="citation_author" content="Yoshinaga Ito"><meta name="citation_author_institution" content="Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA"><meta name="citation_author_institution" content="Department of Immunology, Harvard Medical School, Boston, MA, USA"><meta name="citation_author" content="Jason Pyrdol"><meta name="citation_author_institution" content="Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA"><meta name="citation_author" content="Mirco Friedrich"><meta name="citation_author_institution" content="Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA"><meta name="citation_author" content="Kathrin Schumann"><meta name="citation_author_orcid" content="0000-0002-0993-3910"><meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA"><meta name="citation_author_institution" content="Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany"><meta name="citation_author" content="Michael J. Poitras"><meta name="citation_author_institution" content="Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA"><meta name="citation_author" content="Prafulla C. Gokhale"><meta name="citation_author_institution" content="Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA"><meta name="citation_author" content="L. Nicolas Gonzalez Castro"><meta name="citation_author_institution" content="Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author_institution" content="Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA"><meta name="citation_author_institution" content="Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA"><meta name="citation_author_institution" content="Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"><meta name="citation_author" content="Marni E. Shore"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author_institution" content="Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA"><meta name="citation_author_institution" content="Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA"><meta name="citation_author" content="Christine M. Hebert"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author_institution" content="Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA"><meta name="citation_author_institution" content="Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA"><meta name="citation_author" content="Brian Shaw"><meta name="citation_author_institution" content="Departments of Neurology and Radiation Oncology, Divisions of Hematology/Oncology and Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA"><meta name="citation_author" content="Heather L. Cahill"><meta name="citation_author_orcid" content="0000-0003-0829-9580"><meta name="citation_author_institution" content="Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA"><meta name="citation_author" content="Matthew Drummond"><meta name="citation_author_orcid" content="0000-0001-9669-4489"><meta name="citation_author_institution" content="Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA"><meta name="citation_author" content="Wubing Zhang"><meta name="citation_author_orcid" content="0000-0003-2233-299X"><meta name="citation_author_institution" content="Department of Data Science, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA, USA"><meta name="citation_author" content="Olamide Olawoyin"><meta name="citation_author_institution" content="Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA"><meta name="citation_author" content="Hiroaki Wakimoto"><meta name="citation_author_institution" content="Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 USA"><meta name="citation_author" content="Orit Rozenblatt-Rosen"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author_institution" content="Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA"><meta name="citation_author_institution" content="Genentech, South San Francisco, CA, USA"><meta name="citation_author" content="Priscilla K. Brastianos"><meta name="citation_author_institution" content="Departments of Neurology and Radiation Oncology, Divisions of Hematology/Oncology and Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA"><meta name="citation_author" content="X. Shirley Liu"><meta name="citation_author_institution" content="Department of Data Science, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA, USA"><meta name="citation_author" content="Pamela S. Jones"><meta name="citation_author_orcid" content="0000-0002-4573-3641"><meta name="citation_author_institution" content="Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 USA"><meta name="citation_author" content="Daniel P. Cahill"><meta name="citation_author_institution" content="Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 USA"><meta name="citation_author" content="Matthew P. Frosch"><meta name="citation_author_institution" content="Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA"><meta name="citation_author" content="David N. Louis"><meta name="citation_author_institution" content="Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA"><meta name="citation_author" content="Gordon J. Freeman"><meta name="citation_author_institution" content="Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"><meta name="citation_author" content="Keith L. Ligon"><meta name="citation_author_institution" content="Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA"><meta name="citation_author" content="Alexander Marson"><meta name="citation_author_institution" content="Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA"><meta name="citation_author_institution" content="Gladstone Institutes, San Francisco, CA 94158, USA"><meta name="citation_author_institution" content="Department of Medicine, University of California, San Francisco, San Francisco, CA, USA"><meta name="citation_author" content="E. Antonio Chiocca"><meta name="citation_author_institution" content="Department of Neurosurgery, Brigham and Women’s Hospital, Boston, MA, USA"><meta name="citation_author" content="David A. Reardon"><meta name="citation_author_email" content="david_reardon@dfci.harvard.edu"><meta name="citation_author_institution" content="Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"><meta name="citation_author_institution" content="Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA"><meta name="citation_author" content="Aviv Regev"><meta name="citation_author_email" content="aregev@broadinstitute.org"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author_institution" content="Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA"><meta name="citation_author_institution" content="Genentech, South San Francisco, CA, USA"><meta name="citation_author_institution" content="Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research, Department of Biology, MIT, Cambridge, MA 02139, USA"><meta name="citation_author" content="Mario L. Suvà"><meta name="citation_author_email" content="suva.mario@mgh.harvard.edu"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_author_institution" content="Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA"><meta name="citation_author_institution" content="Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA"><meta name="citation_author" content="Kai W. Wucherpfennig"><meta name="citation_author_email" content="kai_wucherpfennig@dfci.harvard.edu"><meta name="citation_author_institution" content="Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA"><meta name="citation_author_institution" content="Department of Immunology, Harvard Medical School, Boston, MA, USA"><meta name="citation_author_institution" content="Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA"><meta name="citation_author_institution" content="Broad Institute of MIT and Harvard, Cambridge, MA, USA"><meta name="citation_keywords" content="CD161; T cells; single-cell RNA-seq; glioblastoma; IDH-mutant gliomas"><meta name="citation_reference" content="citation_title=Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor; citation_author=H. Aldemir; citation_author=V. Prod’homme; citation_author=M.J. Dumaurier; citation_author=C. Retiere; citation_author=G. Poupon; citation_author=J. Cazareth; citation_author=F. Bihl; citation_author=V.M. Braud; citation_journal_title=J.&nbsp;Immunol.; citation_volume=175; citation_firstpage=7791; citation_lastpage=7795; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Fast unfolding of communities in large networks; citation_author=V.D. Blondel; citation_author=J.-L. Guillaume; citation_author=R. Lambiotte; citation_author=E. Lefebvre; citation_journal_title=J.&nbsp;Stat. Mech.; citation_doi=10.1088/1742-5468/2008/10/P10008; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy; citation_author=C.E. Brown; citation_author=D. Alizadeh; citation_author=R. Starr; citation_author=L. Weng; citation_author=J.R. Wagner; citation_author=A. Naranjo; citation_author=J.R. Ostberg; citation_author=M.S. Blanchard; citation_author=J. Kilpatrick; citation_author=J. Simpson; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=375; citation_firstpage=2561; citation_lastpage=2569; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Suppression of antitumor T&nbsp;cell immunity by the oncometabolite (R)-2-hydroxyglutarate; citation_author=L. Bunse; citation_author=S. Pusch; citation_author=T. Bunse; citation_author=F. Sahm; citation_author=K. Sanghvi; citation_author=M. Friedrich; citation_author=D. Alansary; citation_author=J.K. Sonner; citation_author=E. Green; citation_author=K. Deumelandt; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=24; citation_firstpage=1192; citation_lastpage=1203; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Integrating single-cell transcriptomic data across different conditions, technologies, and species; citation_author=A. Butler; citation_author=P. Hoffman; citation_author=P. Smibert; citation_author=E. Papalexi; citation_author=R. Satija; citation_journal_title=Nature Biotechnology; citation_volume=36; citation_firstpage=411; citation_lastpage=420; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions; citation_author=C.J. Chan; citation_author=L. Martinet; citation_author=S. Gilfillan; citation_author=F. Souza-Fonseca-Guimaraes; citation_author=M.T. Chow; citation_author=L. Town; citation_author=D.S. Ritchie; citation_author=M. Colonna; citation_author=D.M. Andrews; citation_author=M.J. Smyth; citation_journal_title=Nat. Immunol.; citation_volume=15; citation_firstpage=431; citation_lastpage=438; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Sequestration of T&nbsp;cells in bone marrow in the setting of glioblastoma and other intracranial tumors; citation_author=P. Chongsathidkiet; citation_author=C. Jackson; citation_author=S. Koyama; citation_author=F. Loebel; citation_author=X. Cui; citation_author=S.H. Farber; citation_author=K. Woroniecka; citation_author=A.A. Elsamadicy; citation_author=C.A. Dechant; citation_author=H.R. Kemeny; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=24; citation_firstpage=1459; citation_lastpage=1468; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=CD161 defines a transcriptional and functional phenotype across distinct human T&nbsp;cell lineages; citation_author=J.R. Fergusson; citation_author=K.E. Smith; citation_author=V.M. Fleming; citation_author=N. Rajoriya; citation_author=E.W. Newell; citation_author=R. Simmons; citation_author=E. Marchi; citation_author=S. Björkander; citation_author=Y.H. Kang; citation_author=L. Swadling; citation_author=et al.; citation_journal_title=Cell Rep.; citation_volume=9; citation_firstpage=1075; citation_lastpage=1088; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection; citation_author=J. Eyquem; citation_author=J. Mansilla-Soto; citation_author=T. Giavridis; citation_author=S. van der Stegen; citation_author=M. Hamieh; citation_author=K. Cunanan; citation_author=A. Odak; citation_author=M. Gönen; citation_author=M. Sadelain; citation_journal_title=Nature; citation_volume=543; citation_firstpage=113; citation_lastpage=117; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=CD161(int)CD8+ T&nbsp;cells: a novel population of highly functional, memory CD8+ T&nbsp;cells enriched within the gut; citation_author=J.R. Fergusson; citation_author=M.H. Hühn; citation_author=L. Swadling; citation_author=L.J. Walker; citation_author=A. Kurioka; citation_author=A. Llibre; citation_author=A. Bertoletti; citation_author=G. Holländer; citation_author=E.W. Newell; citation_author=M.M. Davis; citation_author=et al.; citation_journal_title=Mucosal Immunol.; citation_volume=9; citation_firstpage=401; citation_lastpage=413; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Recurrent glioma clinical trial, CheckMate-143: the game is not over yet; citation_author=A.C. Filley; citation_author=M. Henriquez; citation_author=M. Dey; citation_journal_title=Oncotarget; citation_volume=8; citation_firstpage=91779; citation_lastpage=91794; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes; citation_author=E. Friebel; citation_author=K. Kapolou; citation_author=S. Unger; citation_author=N.G. Nunez; citation_author=S. Utz; citation_author=E.J. Rushing; citation_author=L. Regli; citation_author=M. Weller; citation_author=M. Greter; citation_author=S. Tugues; citation_author=et al.; citation_journal_title=Cell; citation_volume=181; citation_firstpage=1626; citation_lastpage=1642; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=CD155, an onco-immunologic molecule in human tumors; citation_author=J. Gao; citation_author=Q. Zheng; citation_author=N. Xin; citation_author=W. Wang; citation_author=C. Zhao; citation_journal_title=Cancer Sci.; citation_volume=108; citation_firstpage=1934; citation_lastpage=1938; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=A flexible R package for nonnegative matrix factorization; citation_author=R. Gaujoux; citation_author=C. Seoighe; citation_journal_title=BMC Bioinformatics; citation_volume=11; citation_firstpage=367; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma; citation_author=P.C. Gedeon; citation_author=T.H. Schaller; citation_author=S.K. Chitneni; citation_author=B.D. Choi; citation_author=C.T. Kuan; citation_author=C.M. Suryadevara; citation_author=D.J. Snyder; citation_author=R.J. Schmittling; citation_author=S.E. Szafranski; citation_author=X. Cui; citation_author=et al.; citation_journal_title=Clin. Cancer Res.; citation_volume=24; citation_firstpage=3611; citation_lastpage=3631; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses; citation_author=C. Germain; citation_author=A. Meier; citation_author=T. Jensen; citation_author=P. Knapnougel; citation_author=G. Poupon; citation_author=A. Lazzari; citation_author=A. Neisig; citation_author=K. Håkansson; citation_author=T. Dong; citation_author=N. Wagtmann; citation_author=et al.; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=286; citation_firstpage=37964; citation_lastpage=37975; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin’s lymphomas dampening natural killer cell functions; citation_author=C. Germain; citation_author=T. Guillaudeux; citation_author=E.D. Galsgaard; citation_author=C. Hervouet; citation_author=N. Tekaya; citation_author=A.S. Gallouet; citation_author=J. Fassy; citation_author=F. Bihl; citation_author=G. Poupon; citation_author=A. Lazzari; citation_author=et al.; citation_journal_title=OncoImmunology; citation_volume=4; citation_firstpage=e1026503; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Full-length transcriptome assembly from RNA-Seq data without a reference genome; citation_author=M.G. Grabherr; citation_author=B.J. Haas; citation_author=M. Yassour; citation_author=J.Z. Levin; citation_author=D.A. Thompson; citation_author=I. Amit; citation_author=X. Adiconis; citation_author=L. Fan; citation_author=R. Raychowdhury; citation_author=Q. Zeng; citation_author=et al.; citation_journal_title=Nat. Biotechnol.; citation_volume=29; citation_firstpage=644; citation_lastpage=652; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide; citation_author=S.A. Grossman; citation_author=X. Ye; citation_author=G. Lesser; citation_author=A. Sloan; citation_author=H. Carraway; citation_author=S. Desideri; citation_author=S. Piantadosi; citation_author=NABTT CNS Consortium; citation_journal_title=Clin. Cancer Res.; citation_volume=17; citation_firstpage=5473; citation_lastpage=5480; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Global characterization of T&nbsp;cells in non-small-cell lung cancer by single-cell sequencing; citation_author=X. Guo; citation_author=Y. Zhang; citation_author=L. Zheng; citation_author=C. Zheng; citation_author=J. Song; citation_author=Q. Zhang; citation_author=B. Kang; citation_author=Z. Liu; citation_author=L. Jin; citation_author=R. Xing; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=24; citation_firstpage=978; citation_lastpage=985; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone; citation_author=M.P. Gustafson; citation_author=Y. Lin; citation_author=K.C. New; citation_author=P.A. Bulur; citation_author=B.P. O’Neill; citation_author=D.A. Gastineau; citation_author=A.B. Dietz; citation_journal_title=Neuro-oncol.; citation_volume=12; citation_firstpage=631; citation_lastpage=644; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide; citation_author=F. Higuchi; citation_author=A.L. Fink; citation_author=J. Kiyokawa; citation_author=J.J. Miller; citation_author=M.V.A. Koerner; citation_author=D.P. Cahill; citation_author=H. Wakimoto; citation_journal_title=Mol. Cancer Ther.; citation_volume=17; citation_firstpage=2551; citation_lastpage=2563; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade; citation_author=L. Jerby-Arnon; citation_author=P. Shah; citation_author=M.S. Cuoco; citation_author=C. Rodman; citation_author=M.J. Su; citation_author=J.C. Melms; citation_author=R. Leeson; citation_author=A. Kanodia; citation_author=S. Mei; citation_author=J.R. Lin; citation_author=et al.; citation_journal_title=Cell; citation_volume=175; citation_firstpage=984; citation_lastpage=997.e24; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Interleukin-18: Biological properties and role in disease pathogenesis; citation_author=G. Kaplanski; citation_journal_title=Immunol. Rev.; citation_volume=281; citation_firstpage=138; citation_lastpage=153; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=MAIT cells and MR1-antigen recognition; citation_author=A.N. Keller; citation_author=A.J. Corbett; citation_author=J.M. Wubben; citation_author=J. McCluskey; citation_author=J. Rossjohn; citation_journal_title=Curr. Opin. Immunol.; citation_volume=46; citation_firstpage=66; citation_lastpage=74; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Neoantigen vaccine generates intratumoral T&nbsp;cell responses in phase Ib glioblastoma trial; citation_author=D.B. Keskin; citation_author=A.J. Anandappa; citation_author=J. Sun; citation_author=I. Tirosh; citation_author=N.D. Mathewson; citation_author=S. Li; citation_author=G. Oliveira; citation_author=A. Giobbie-Hurder; citation_author=K. Felt; citation_author=E. Gjini; citation_author=et al.; citation_journal_title=Nature; citation_volume=565; citation_firstpage=234; citation_lastpage=239; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells; citation_author=F. Klemm; citation_author=R.R. Maas; citation_author=R.L. Bowman; citation_author=M. Kornete; citation_author=K. Soukup; citation_author=S. Nassiri; citation_author=J.P. Brouland; citation_author=C.A. Iacobuzio-Donahue; citation_author=C. Brennan; citation_author=V. Tabar; citation_author=et al.; citation_journal_title=Cell; citation_volume=181; citation_firstpage=1643; citation_lastpage=1660; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites; citation_author=B.V. Kumar; citation_author=W. Ma; citation_author=M. Miron; citation_author=T. Granot; citation_author=R.S. Guyer; citation_author=D.J. Carpenter; citation_author=T. Senda; citation_author=X. Sun; citation_author=S.H. Ho; citation_author=H. Lerner; citation_author=et al.; citation_journal_title=Cell Rep.; citation_volume=20; citation_firstpage=2921; citation_lastpage=2934; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering; citation_author=K. Labun; citation_author=T.G. Montague; citation_author=J.A. Gagnon; citation_author=S.B. Thyme; citation_author=E. Valen; citation_journal_title=Nucleic Acids Res.; citation_volume=44; citation_number=W1; citation_firstpage=W272-6; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Phenotype molding of stromal cells in the lung tumor microenvironment; citation_author=D. Lambrechts; citation_author=E. Wauters; citation_author=B. Boeckx; citation_author=S. Aibar; citation_author=D. Nittner; citation_author=O. Burton; citation_author=A. Bassez; citation_author=H. Decaluwé; citation_author=A. Pircher; citation_author=K. Van den Eynde; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=24; citation_firstpage=1277; citation_lastpage=1289; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Ultrafast and memory-efficient alignment of short DNA sequences to the human genome; citation_author=B. Langmead; citation_author=C. Trapnell; citation_author=M. Pop; citation_author=S.L. Salzberg; citation_journal_title=Genome Biol.; citation_volume=10; citation_firstpage=R25; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=MAIT cells detect and efficiently lyse bacterially-infected epithelial cells; citation_author=L. Le Bourhis; citation_author=M. Dusseaux; citation_author=A. Bohineust; citation_author=S. Bessoles; citation_author=E. Martin; citation_author=V. Premel; citation_author=M. Coré; citation_author=D. Sleurs; citation_author=N.E. Serriari; citation_author=E. Treiner; citation_author=et al.; citation_journal_title=PLoS Pathog.; citation_volume=9; citation_firstpage=e1003681; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome; citation_author=B. Li; citation_author=C.N. Dewey; citation_journal_title=BMC Bioinformatics; citation_volume=12; citation_firstpage=323; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation; citation_author=A. Llibre; citation_author=C. López-Macías; citation_author=T. Marafioti; citation_author=H. Mehta; citation_author=A. Partridge; citation_author=C. Kanzig; citation_author=F. Rivellese; citation_author=J.D. Galson; citation_author=L.J. Walker; citation_author=P. Milne; citation_author=et al.; citation_journal_title=J.&nbsp;Immunol.; citation_volume=196; citation_firstpage=2085; citation_lastpage=2094; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy; citation_author=A.M. Luoma; citation_author=S. Suo; citation_author=H.L. Williams; citation_author=T. Sharova; citation_author=K. Sullivan; citation_author=M. Manos; citation_author=P. Bowling; citation_author=F.S. Hodi; citation_author=O. Rahma; citation_author=R.J. Sullivan; citation_author=et al.; citation_journal_title=Cell; citation_volume=182; citation_firstpage=655; citation_lastpage=671.e22; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=CD8&nbsp;T Cell Exhaustion During Chronic Viral Infection and Cancer; citation_author=L.M. McLane; citation_author=M.S. Abdel-Hakeem; citation_author=E.J. Wherry; citation_journal_title=Annu. Rev. Immunol.; citation_volume=37; citation_firstpage=457; citation_lastpage=495; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Reprogramming of CTLs into natural killer-like cells in celiac disease; citation_author=B. Meresse; citation_author=S.A. Curran; citation_author=C. Ciszewski; citation_author=G. Orbelyan; citation_author=M. Setty; citation_author=G. Bhagat; citation_author=L. Lee; citation_author=M. Tretiakova; citation_author=C. Semrad; citation_author=E. Kistner; citation_author=et al.; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=203; citation_firstpage=1343; citation_lastpage=1355; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=EGFRvIII-specific chimeric antigen receptor T&nbsp;cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma; citation_author=H. Miao; citation_author=B.D. Choi; citation_author=C.M. Suryadevara; citation_author=L. Sanchez-Perez; citation_author=S. Yang; citation_author=G. De Leon; citation_author=E.J. Sayour; citation_author=R. McLendon; citation_author=J.E. Herndon; citation_author=P. Healy; citation_author=et al.; citation_journal_title=PLoS ONE; citation_volume=9; citation_firstpage=e94281; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=The Immunology of CD1- and MR1-Restricted T Cells; citation_author=L. Mori; citation_author=M. Lepore; citation_author=G. De Libero; citation_journal_title=Annu. Rev. Immunol.; citation_volume=34; citation_firstpage=479; citation_lastpage=510; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma; citation_author=C. Neftel; citation_author=J. Laffy; citation_author=M.G. Filbin; citation_author=T. Hara; citation_author=M.E. Shore; citation_author=G.J. Rahme; citation_author=A.R. Richman; citation_author=D. Silverbush; citation_author=M.L. Shaw; citation_author=C.M. Hebert; citation_author=et al.; citation_journal_title=Cell; citation_volume=178; citation_firstpage=835; citation_lastpage=849.e21; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment; citation_author=F. Nigim; citation_author=J. Cavanaugh; citation_author=A.P. Patel; citation_author=W.T. Curry; citation_author=S. Esaki; citation_author=E.M. Kasper; citation_author=A.S. Chi; citation_author=D.N. Louis; citation_author=R.L. Martuza; citation_author=S.D. Rabkin; citation_author=H. Wakimoto; citation_journal_title=J.&nbsp;Neuropathol. Exp. Neurol.; citation_volume=74; citation_firstpage=710; citation_lastpage=722; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Full-length RNA-seq from single cells using Smart-seq2; citation_author=S. Picelli; citation_author=O.R. Faridani; citation_author=A.K. Björklund; citation_author=G. Winberg; citation_author=S. Sagasser; citation_author=R. Sandberg; citation_journal_title=Nat. Protoc.; citation_volume=9; citation_firstpage=171; citation_lastpage=181; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=NY-ESO-1-specific TCR-engineered T&nbsp;cells mediate sustained antigen-specific antitumor effects in myeloma; citation_author=A.P. Rapoport; citation_author=E.A. Stadtmauer; citation_author=G.K. Binder-Scholl; citation_author=O. Goloubeva; citation_author=D.T. Vogl; citation_author=S.F. Lacey; citation_author=A.Z. Badros; citation_author=A. Garfall; citation_author=B. Weiss; citation_author=J. Finklestein; citation_author=et al.; citation_journal_title=Nat. Med.; citation_volume=21; citation_firstpage=914; citation_lastpage=921; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Randomized phase 3 study evaluating the efficacy and safety of nivolumab versus bevacizumab in patients with recurrent glioblastoma: Checkmate 143; citation_author=D.A. Reardon; citation_author=A. Omuro; citation_author=A. Brandes; citation_author=J. Rieger; citation_author=A. Wick; citation_author=J. Sepulveda; citation_author=S. Phuphanich; citation_author=P. de Souza; citation_author=M.S. Ahluwalia; citation_author=M. Lim; citation_author=et al.; citation_journal_title=Neuro-Oncol.; citation_volume=19; citation_number=Suppl 3; citation_firstpage=iii21; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial; citation_author=D.A. Reardon; citation_author=A.A. Brandes; citation_author=A. Omuro; citation_author=P. Mulholland; citation_author=M. Lim; citation_author=A. Wick; citation_author=J. Baehring; citation_author=M.S. Ahluwalia; citation_author=P. Roth; citation_author=O. Bähr; citation_author=et al.; citation_journal_title=JAMA Oncol.; citation_volume=6; citation_firstpage=1003; citation_lastpage=1010; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions; citation_author=P. Robbins; citation_author=Y. Li; citation_author=M. El-Gamil; citation_author=Y. Zhao; citation_author=J. Wargo; citation_author=Z. Zheng; citation_author=H. Xu; citation_author=R. Morgan; citation_author=S. Feldman; citation_author=L. Johnson; citation_author=et al.; citation_journal_title=J. Immunol.; citation_volume=180; citation_firstpage=6116; citation_lastpage=6131; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1; citation_author=P.F. Robbins; citation_author=R.A. Morgan; citation_author=S.A. Feldman; citation_author=J.C. Yang; citation_author=R.M. Sherry; citation_author=M.E. Dudley; citation_author=J.R. Wunderlich; citation_author=A.V. Nahvi; citation_author=L.J. Helman; citation_author=C.L. Mackall; citation_author=et al.; citation_journal_title=J.&nbsp;Clin. Oncol.; citation_volume=29; citation_firstpage=917; citation_lastpage=924; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor; citation_author=D.B. Rosen; citation_author=J. Bettadapura; citation_author=M. Alsharifi; citation_author=P.A. Mathew; citation_author=H.S. Warren; citation_author=L.L. Lanier; citation_journal_title=J.&nbsp;Immunol.; citation_volume=175; citation_firstpage=7796; citation_lastpage=7799; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells; citation_author=D.B. Rosen; citation_author=W. Cao; citation_author=D.T. Avery; citation_author=S.G. Tangye; citation_author=Y.J. Liu; citation_author=J.P. Houchins; citation_author=L.L. Lanier; citation_journal_title=J.&nbsp;Immunol.; citation_volume=180; citation_firstpage=6508; citation_lastpage=6517; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1; citation_author=P. Roth; citation_author=M. Mittelbronn; citation_author=W. Wick; citation_author=R. Meyermann; citation_author=M. Tatagiba; citation_author=M. Weller; citation_journal_title=Cancer Res.; citation_volume=67; citation_firstpage=3540; citation_lastpage=3544; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Reprogramming human T&nbsp;cell function and specificity with non-viral genome targeting; citation_author=T.L. Roth; citation_author=C. Puig-Saus; citation_author=R. Yu; citation_author=E. Shifrut; citation_author=J. Carnevale; citation_author=P.J. Li; citation_author=J. Hiatt; citation_author=J. Saco; citation_author=P. Krystofinski; citation_author=H. Li; citation_author=et al.; citation_journal_title=Nature; citation_volume=559; citation_firstpage=405; citation_lastpage=409; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma; citation_author=M. Sade-Feldman; citation_author=K. Yizhak; citation_author=S.L. Bjorgaard; citation_author=J.P. Ray; citation_author=C.G. de Boer; citation_author=R.W. Jenkins; citation_author=D.J. Lieb; citation_author=J.H. Chen; citation_author=D.T. Frederick; citation_author=M. Barzily-Rokni; citation_author=et al.; citation_journal_title=Cell; citation_volume=175; citation_firstpage=998; citation_lastpage=1013.e20; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Enriched CD161high CCR6+ γδ T&nbsp;cells in the cerebrospinal fluid of patients with multiple sclerosis; citation_author=L. Schirmer; citation_author=V. Rothhammer; citation_author=B. Hemmer; citation_author=T. Korn; citation_journal_title=JAMA Neurol.; citation_volume=70; citation_firstpage=345; citation_lastpage=351; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis; citation_author=C.S. Smillie; citation_author=M. Biton; citation_author=J. Ordovas-Montanes; citation_author=K.M. Sullivan; citation_author=G. Burgin; citation_author=D.B. Graham; citation_author=R.H. Herbst; citation_author=N. Rogel; citation_author=M. Slyper; citation_author=J. Waldman; citation_author=et al.; citation_journal_title=Cell; citation_volume=178; citation_firstpage=714; citation_lastpage=730.e22; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Tissue-resident memory T&nbsp;cells populate the human brain; citation_author=J. Smolders; citation_author=K.M. Heutinck; citation_author=N.L. Fransen; citation_author=E.B.M. Remmerswaal; citation_author=P. Hombrink; citation_author=I.J.M. Ten Berge; citation_author=R.A.W. van Lier; citation_author=I. Huitinga; citation_author=J. Hamann; citation_journal_title=Nat. Commun.; citation_volume=9; citation_firstpage=4593; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=T cell fate and clonality inference from single-cell transcriptomes; citation_author=M.J.T. Stubbington; citation_author=T. Lönnberg; citation_author=V. Proserpio; citation_author=S. Clare; citation_author=A.O. Speak; citation_author=G. Dougan; citation_author=S.A. Teichmann; citation_journal_title=Nat. Methods; citation_volume=13; citation_firstpage=329; citation_lastpage=332; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq; citation_author=I. Tirosh; citation_author=B. Izar; citation_author=S.M. Prakadan; citation_author=M.H. Wadsworth; citation_author=D. Treacy; citation_author=J.J. Trombetta; citation_author=A. Rotem; citation_author=C. Rodman; citation_author=C. Lian; citation_author=G. Murphy; citation_author=et al.; citation_journal_title=Science; citation_volume=352; citation_firstpage=189; citation_lastpage=196; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma; citation_author=I. Tirosh; citation_author=A.S. Venteicher; citation_author=C. Hebert; citation_author=L.E. Escalante; citation_author=A.P. Patel; citation_author=K. Yizhak; citation_author=J.M. Fisher; citation_author=C. Rodman; citation_author=C. Mount; citation_author=M.G. Filbin; citation_author=et al.; citation_journal_title=Nature; citation_volume=539; citation_firstpage=309; citation_lastpage=313; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq; citation_author=A.S. Venteicher; citation_author=I. Tirosh; citation_author=C. Hebert; citation_author=K. Yizhak; citation_author=C. Neftel; citation_author=M.G. Filbin; citation_author=V. Hovestadt; citation_author=L.E. Escalante; citation_author=M.L. Shaw; citation_author=C. Rodman; citation_author=et al.; citation_journal_title=Science; citation_volume=355; citation_firstpage=eaai8478; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma; citation_author=K. Woroniecka; citation_author=P. Chongsathidkiet; citation_author=K. Rhodin; citation_author=H. Kemeny; citation_author=C. Dechant; citation_author=S.H. Farber; citation_author=A.A. Elsamadicy; citation_author=X. Cui; citation_author=S. Koyama; citation_author=C. Jackson; citation_author=et al.; citation_journal_title=Clin. Cancer Res.; citation_volume=24; citation_firstpage=4175; citation_lastpage=4186; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Mouse Nkrp1-Clr gene cluster sequence and expression analyses reveal conservation of tissue-specific MHC-independent immunosurveillance; citation_author=Q. Zhang; citation_author=M.M. Rahim; citation_author=D.S. Allan; citation_author=M.M. Tu; citation_author=S. Belanger; citation_author=E. Abou-Samra; citation_author=J. Ma; citation_author=H.S. Sekhon; citation_author=T. Fairhead; citation_author=H.S. Zein; citation_author=et al.; citation_journal_title=PLoS ONE; citation_volume=7; citation_firstpage=e50561; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells; citation_author=L. Zhang; citation_author=M.D. Sorensen; citation_author=B.W. Kristensen; citation_author=G. Reifenberger; citation_author=T.M. McIntyre; citation_author=F. Lin; citation_journal_title=Clin. Cancer Res.; citation_volume=24; citation_firstpage=5381; citation_lastpage=5391; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Lineage tracking reveals dynamic relationships of T&nbsp;cells in colorectal cancer; citation_author=L. Zhang; citation_author=X. Yu; citation_author=L. Zheng; citation_author=Y. Zhang; citation_author=Y. Li; citation_author=Q. Fang; citation_author=R. Gao; citation_author=B. Kang; citation_author=Q. Zhang; citation_author=J.Y. Huang; citation_author=et al.; citation_journal_title=Nature; citation_volume=564; citation_firstpage=268; citation_lastpage=272; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines; citation_author=Y. Zhao; citation_author=Z. Zheng; citation_author=P.F. Robbins; citation_author=H.T. Khong; citation_author=S.A. Rosenberg; citation_author=R.A. Morgan; citation_journal_title=J.&nbsp;Immunol.; citation_volume=174; citation_firstpage=4415; citation_lastpage=4423; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing; citation_author=C. Zheng; citation_author=L. Zheng; citation_author=J.K. Yoo; citation_author=H. Guo; citation_author=Y. Zhang; citation_author=X. Guo; citation_author=B. Kang; citation_author=R. Hu; citation_author=J.Y. Huang; citation_author=Q. Zhang; citation_author=et al.; citation_journal_title=Cell; citation_volume=169; citation_firstpage=1342; citation_lastpage=1356.e16; citation_publication_date=2017; "><meta name="citation_abstract" content="<h2>Summary</h2><p>T cells are critical effectors of cancer immunotherapies, but little is known about their gene expression programs in diffuse gliomas. Here, we leverage single-cell RNA sequencing (RNA-seq) to chart the gene expression and clonal landscape of tumor-infiltrating T&nbsp;cells across 31 patients with isocitrate dehydrogenase (IDH) wild-type glioblastoma and IDH mutant glioma. We identify potential effectors of anti-tumor immunity in subsets of T&nbsp;cells that co-express cytotoxic programs and several natural killer (NK) cell genes. Analysis of clonally expanded tumor-infiltrating T&nbsp;cells further identifies the NK gene <i>KLRB1</i> (encoding CD161) as a candidate inhibitory receptor. Accordingly, genetic inactivation of <i>KLRB1</i> or antibody-mediated CD161 blockade enhances T&nbsp;cell-mediated killing of glioma cells <i>in&nbsp;vitro</i> and their anti-tumor function <i>in&nbsp;vivo</i>. <i>KLRB1</i> and its associated transcriptional program are also expressed by substantial T&nbsp;cell populations in other human cancers. Our work provides an atlas of T&nbsp;cells in gliomas and highlights CD161 and other NK cell receptors as immunotherapy targets.</p>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=6668&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(21)00065-9&amp;be=4210&amp;fe=6300&amp;dc=5564&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749589450627,%22n%22:0,%22f%22:3572,%22dn%22:3573,%22dne%22:3573,%22c%22:3573,%22s%22:3573,%22ce%22:3573,%22rq%22:3573,%22rp%22:4186,%22rpe%22:5228,%22dl%22:4192,%22di%22:5557,%22ds%22:5563,%22de%22:5579,%22dc%22:6300,%22l%22:6300,%22le%22:6330%7D,%22navigation%22:%7B%7D%7D&amp;fp=5404&amp;fcp=5404&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script><style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style></style><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900065-9" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(21)00065-9"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(21)00065-9"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900065-9" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-28765" aria-expanded="false" aria-controls="login-links-28765" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-28765" id="login-links--28765" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900065-9" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900065-9" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900065-9" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-28765" data-opens="#links-dialog-28765" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-28765" aria-modal="true"><button data-closes="#links-dialog-28765" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900065-9" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900065-9" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2900065-9" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2021.01.022">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(21)00065-9" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="free" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(20)X0006-7"><span>Volume 184</span>, <span>Issue 5</span></a></span><span class="meta-panel__pages"><span>p1281-1298.e26</span></span><span class="meta-panel__onlineDate">March 04, 2021</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--archive"><span>Open Archive</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=184&amp;issue=5&amp;pii=S0092-8674%2820%29X0006-7" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">Inhibitory CD161 receptor identified in glioma-infiltrating T&nbsp;cells by single-cell analysis</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Nathan D.</span> <span property="familyName">Mathewson</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Nathan D.</span> <span property="familyName">Mathewson</span> <a class="orcid-id" href="https://orcid.org/0000-0002-8895-2609" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-8895-2609</a></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">25</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Harvard Medical School, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Mathewson/Nathan+D" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a role="doc-noteref">25</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">Orr</span> <span property="familyName">Ashenberg</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Orr</span> <span property="familyName">Ashenberg</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">25</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Ashenberg/Orr" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a role="doc-noteref">25</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Itay</span> <span property="familyName">Tirosh</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Itay</span> <span property="familyName">Tirosh</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">25</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 761001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Tirosh/Itay" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a>,<a role="doc-noteref">25</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">Simon</span> <span property="familyName">Gritsch</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Simon</span> <span property="familyName">Gritsch</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">25</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Gritsch/Simon" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a>,<a role="doc-noteref">25</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Elizabeth M.</span> <span property="familyName">Perez</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Elizabeth M.</span> <span property="familyName">Perez</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">25</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Systems Biology, Harvard Medical School, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Perez/Elizabeth+M" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">8</a>,<a role="doc-noteref">25</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Sascha</span> <span property="familyName">Marx</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Sascha</span> <span property="familyName">Marx</span> <a class="orcid-id" href="https://orcid.org/0000-0002-6451-5404" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-6451-5404</a></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">25</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Harvard Medical School, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Marx/Sascha" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a role="doc-noteref">25</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Livnat</span> <span property="familyName">Jerby-Arnon</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Livnat</span> <span property="familyName">Jerby-Arnon</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Chan Zuckerberg Biohub, San Francisco, CA 94158, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Jerby-Arnon/Livnat" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">10</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">Rony</span> <span property="familyName">Chanoch-Myers</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Rony</span> <span property="familyName">Chanoch-Myers</span> <a class="orcid-id" href="https://orcid.org/0000-0002-8197-5795" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-8197-5795</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 761001, Israel</span></div></div><div class="core-author-link"><a href="/authored-by/Chanoch-Myers/Rony" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au9" aria-controls="axel_author_au9"><span property="givenName">Toshiro</span> <span property="familyName">Hara</span></a><div id="au9" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Toshiro</span> <span property="familyName">Hara</span> <a class="orcid-id" href="https://orcid.org/0000-0002-4389-3393" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-4389-3393</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Hara/Toshiro" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au10" aria-controls="axel_author_au10"><span property="givenName">Alyssa R.</span> <span property="familyName">Richman</span></a><div id="au10" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Alyssa R.</span> <span property="familyName">Richman</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Richman/Alyssa+R" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au11" aria-controls="axel_author_au11"><span property="givenName">Yoshinaga</span> <span property="familyName">Ito</span></a><div id="au11" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yoshinaga</span> <span property="familyName">Ito</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Harvard Medical School, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Ito/Yoshinaga" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au12" aria-controls="axel_author_au12"><span property="givenName">Jason</span> <span property="familyName">Pyrdol</span></a><div id="au12" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jason</span> <span property="familyName">Pyrdol</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Pyrdol/Jason" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au13" aria-controls="axel_author_au13"><span property="givenName">Mirco</span> <span property="familyName">Friedrich</span></a><div id="au13" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Mirco</span> <span property="familyName">Friedrich</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Friedrich/Mirco" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au14" aria-controls="axel_author_au14"><span property="givenName">Kathrin</span> <span property="familyName">Schumann</span></a><div id="au14" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Kathrin</span> <span property="familyName">Schumann</span> <a class="orcid-id" href="https://orcid.org/0000-0002-0993-3910" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-0993-3910</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany</span></div></div><div class="core-author-link"><a href="/authored-by/Schumann/Kathrin" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au15" aria-controls="axel_author_au15"><span property="givenName">Michael J.</span> <span property="familyName">Poitras</span></a><div id="au15" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Michael J.</span> <span property="familyName">Poitras</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Poitras/Michael+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">13</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au16" aria-controls="axel_author_au16"><span property="givenName">Prafulla C.</span> <span property="familyName">Gokhale</span></a><div id="au16" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Prafulla C.</span> <span property="familyName">Gokhale</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Gokhale/Prafulla+C" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">13</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au17" aria-controls="axel_author_au17"><span property="givenName">L. Nicolas</span> <span property="familyName">Gonzalez Castro</span></a><div id="au17" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">L. Nicolas</span> <span property="familyName">Gonzalez Castro</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Gonzalez+Castro/L+Nicolas" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">14</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au18" aria-controls="axel_author_au18"><span property="givenName">Marni E.</span> <span property="familyName">Shore</span></a><div id="au18" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Marni E.</span> <span property="familyName">Shore</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Shore/Marni+E" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au19" aria-controls="axel_author_au19"><span property="givenName">Christine M.</span> <span property="familyName">Hebert</span></a><div id="au19" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Christine M.</span> <span property="familyName">Hebert</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Hebert/Christine+M" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au20" aria-controls="axel_author_au20"><span property="givenName">Brian</span> <span property="familyName">Shaw</span></a><div id="au20" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Brian</span> <span property="familyName">Shaw</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Departments of Neurology and Radiation Oncology, Divisions of Hematology/Oncology and Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Shaw/Brian" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">15</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au21" aria-controls="axel_author_au21"><span property="givenName">Heather L.</span> <span property="familyName">Cahill</span></a><div id="au21" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Heather L.</span> <span property="familyName">Cahill</span> <a class="orcid-id" href="https://orcid.org/0000-0003-0829-9580" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-0829-9580</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Cahill/Heather+L" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au22" aria-controls="axel_author_au22"><span property="givenName">Matthew</span> <span property="familyName">Drummond</span></a><div id="au22" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Matthew</span> <span property="familyName">Drummond</span> <a class="orcid-id" href="https://orcid.org/0000-0001-9669-4489" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-9669-4489</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Drummond/Matthew" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au23" aria-controls="axel_author_au23"><span property="givenName">Wubing</span> <span property="familyName">Zhang</span></a><div id="au23" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Wubing</span> <span property="familyName">Zhang</span> <a class="orcid-id" href="https://orcid.org/0000-0003-2233-299X" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-2233-299X</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Data Science, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Zhang/Wubing" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">16</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au24" aria-controls="axel_author_au24"><span property="givenName">Olamide</span> <span property="familyName">Olawoyin</span></a><div id="au24" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Olamide</span> <span property="familyName">Olawoyin</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Olawoyin/Olamide" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au25" aria-controls="axel_author_au25"><span property="givenName">Hiroaki</span> <span property="familyName">Wakimoto</span></a><div id="au25" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Hiroaki</span> <span property="familyName">Wakimoto</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 USA</span></div></div><div class="core-author-link"><a href="/authored-by/Wakimoto/Hiroaki" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">17</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au26" aria-controls="axel_author_au26"><span property="givenName">Orit</span> <span property="familyName">Rozenblatt-Rosen</span></a><div id="au26" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au26"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Orit</span> <span property="familyName">Rozenblatt-Rosen</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Genentech, South San Francisco, CA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Rozenblatt-Rosen/Orit" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">18</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au27" aria-controls="axel_author_au27"><span property="givenName">Priscilla K.</span> <span property="familyName">Brastianos</span></a><div id="au27" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Priscilla K.</span> <span property="familyName">Brastianos</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Departments of Neurology and Radiation Oncology, Divisions of Hematology/Oncology and Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Brastianos/Priscilla+K" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">15</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au28" aria-controls="axel_author_au28"><span property="givenName">X. Shirley</span> <span property="familyName">Liu</span></a><div id="au28" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">X. Shirley</span> <span property="familyName">Liu</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Data Science, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Liu/X+Shirley" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">16</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au29" aria-controls="axel_author_au29"><span property="givenName">Pamela S.</span> <span property="familyName">Jones</span></a><div id="au29" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au29"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Pamela S.</span> <span property="familyName">Jones</span> <a class="orcid-id" href="https://orcid.org/0000-0002-4573-3641" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-4573-3641</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 USA</span></div></div><div class="core-author-link"><a href="/authored-by/Jones/Pamela+S" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">17</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au30" aria-controls="axel_author_au30"><span property="givenName">Daniel P.</span> <span property="familyName">Cahill</span></a><div id="au30" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Daniel P.</span> <span property="familyName">Cahill</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 USA</span></div></div><div class="core-author-link"><a href="/authored-by/Cahill/Daniel+P" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">17</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au31" aria-controls="axel_author_au31"><span property="givenName">Matthew P.</span> <span property="familyName">Frosch</span></a><div id="au31" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au31"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Matthew P.</span> <span property="familyName">Frosch</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Frosch/Matthew+P" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au32" aria-controls="axel_author_au32"><span property="givenName">David N.</span> <span property="familyName">Louis</span></a><div id="au32" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">David N.</span> <span property="familyName">Louis</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Louis/David+N" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au33" aria-controls="axel_author_au33"><span property="givenName">Gordon J.</span> <span property="familyName">Freeman</span></a><div id="au33" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au33"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Gordon J.</span> <span property="familyName">Freeman</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Freeman/Gordon+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">14</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au34" aria-controls="axel_author_au34"><span property="givenName">Keith L.</span> <span property="familyName">Ligon</span></a><div id="au34" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au34"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Keith L.</span> <span property="familyName">Ligon</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Ligon/Keith+L" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">19</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au35" aria-controls="axel_author_au35"><span property="givenName">Alexander</span> <span property="familyName">Marson</span></a><div id="au35" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au35"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Alexander</span> <span property="familyName">Marson</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Gladstone Institutes, San Francisco, CA 94158, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, University of California, San Francisco, San Francisco, CA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Marson/Alexander" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">20</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">21</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au36" aria-controls="axel_author_au36"><span property="givenName">E. Antonio</span> <span property="familyName">Chiocca</span></a><div id="au36" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au36"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">E. Antonio</span> <span property="familyName">Chiocca</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Neurosurgery, Brigham and Women’s Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Chiocca/E+Antonio" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">22</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au37" aria-controls="axel_author_au37"><span property="givenName">David A.</span> <span property="familyName">Reardon</span></a><div id="au37" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au37"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">David A.</span> <span property="familyName">Reardon</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0010" href="mailto:david_reardon@dfci.harvard.edu" property="email" title="Send email to David A. Reardon">david_reardon@dfci.harvard.edu</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">26</div><div id="fn2"><div id="ntpara0015" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Reardon/David+A" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">14</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">23</a>,<a role="doc-noteref">26</a></sup> <a id="eadd0010" href="mailto:david_reardon@dfci.harvard.edu" property="email" title="Send email to David A. Reardon">david_reardon@dfci.harvard.edu</a></span></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au38" aria-controls="axel_author_au38"><span property="givenName">Aviv</span> <span property="familyName">Regev</span></a><div id="au38" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au38"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Aviv</span> <span property="familyName">Regev</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0015" href="mailto:aregev@broadinstitute.org" property="email" title="Send email to Aviv Regev">aregev@broadinstitute.org</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">26</div><div id="fn2"><div id="ntpara0015" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Genentech, South San Francisco, CA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research, Department of Biology, MIT, Cambridge, MA 02139, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Regev/Aviv" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">18</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">24</a>,<a role="doc-noteref">26</a></sup> <a id="eadd0015" href="mailto:aregev@broadinstitute.org" property="email" title="Send email to Aviv Regev">aregev@broadinstitute.org</a></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au39" aria-controls="axel_author_au39"><span property="givenName">Mario L.</span> <span property="familyName">Suvà</span></a><div id="au39" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au39"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Mario L.</span> <span property="familyName">Suvà</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0020" href="mailto:suva.mario@mgh.harvard.edu" property="email" title="Send email to Mario L. Suvà">suva.mario@mgh.harvard.edu</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">26</div><div id="fn2"><div id="ntpara0015" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Suv%C3%A0/Mario+L" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">7</a>,<a role="doc-noteref">26</a></sup> <a id="eadd0020" href="mailto:suva.mario@mgh.harvard.edu" property="email" title="Send email to Mario L. Suvà">suva.mario@mgh.harvard.edu</a></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au40" aria-controls="axel_author_au40"><span property="givenName">Kai W.</span> <span property="familyName">Wucherpfennig</span></a><div id="au40" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au40"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Kai W.</span> <span property="familyName">Wucherpfennig</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0025" href="mailto:kai_wucherpfennig@dfci.harvard.edu" property="email" title="Send email to Kai W. Wucherpfennig">kai_wucherpfennig@dfci.harvard.edu</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">26</div><div id="fn2"><div id="ntpara0015" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">27</div><div id="fn3"><div id="ntpara0020" role="paragraph">Lead contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Harvard Medical School, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Wucherpfennig/Kai+W" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a role="doc-noteref">26</a>,<a role="doc-noteref">27</a></sup> <a id="eadd0025" href="mailto:kai_wucherpfennig@dfci.harvard.edu" property="email" title="Send email to Kai W. Wucherpfennig">kai_wucherpfennig@dfci.harvard.edu</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">Department of Immunology, Harvard Medical School, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Broad Institute of MIT and Harvard, Cambridge, MA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">5</span><span id="aff5" property="name">Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">6</span><span id="aff6" property="name">Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 761001, Israel</span></div><div property="affiliation" typeof="Organization"><span class="label">7</span><span id="aff7" property="name">Department of Pathology and Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">8</span><span id="aff8" property="name">Department of Systems Biology, Harvard Medical School, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">9</span><span id="aff9" property="name">Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">10</span><span id="aff10" property="name">Chan Zuckerberg Biohub, San Francisco, CA 94158, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">11</span><span id="aff11" property="name">Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">12</span><span id="aff12" property="name">Institute for Medical Microbiology, Immunology and Hygiene, Technische Universität München (TUM), Munich, Germany</span></div><div property="affiliation" typeof="Organization"><span class="label">13</span><span id="aff13" property="name">Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">14</span><span id="aff14" property="name">Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">15</span><span id="aff15" property="name">Departments of Neurology and Radiation Oncology, Divisions of Hematology/Oncology and Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">16</span><span id="aff16" property="name">Department of Data Science, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">17</span><span id="aff17" property="name">Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 USA</span></div><div property="affiliation" typeof="Organization"><span class="label">18</span><span id="aff18" property="name">Genentech, South San Francisco, CA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">19</span><span id="aff19" property="name">Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">20</span><span id="aff20" property="name">Gladstone Institutes, San Francisco, CA 94158, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">21</span><span id="aff21" property="name">Department of Medicine, University of California, San Francisco, San Francisco, CA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">22</span><span id="aff22" property="name">Department of Neurosurgery, Brigham and Women’s Hospital, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">23</span><span id="aff23" property="name">Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">24</span><span id="aff24" property="name">Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research, Department of Biology, MIT, Cambridge, MA 02139, USA</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">25</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">26</div><div id="fn2"><div id="ntpara0015" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">27</div><div id="fn3"><div id="ntpara0020" role="paragraph">Lead contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received August 28, 2019</span>; <span>Revised November 3, 2020</span>; <span>Accepted January 19, 2021</span>; <span>Published online February 15, 2021</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2021.01.022" property="sameAs" target="_blank">10.1016/j.cell.2021.01.022 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S0092867421000659" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2021 Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://www.elsevier.com/open-access/userlicense/1.0/" target="_blank">Elsevier user license</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2021.01.022" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(20)X0006-7"><img src="/cms/asset/30f73b63-b48b-4f99-8afd-18334d02293c/cov200h.gif" alt="Cover Image - Cell, Volume 184, Issue 5"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2821%2900065-9" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical Abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (6)</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2900065-9" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.01.022">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2821%2900065-9" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2021.01.022&amp;pii=S0092-8674%2821%2900065-9" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2900065-9" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.01.022">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2021.01.022" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0092867421000659&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S0092867421000659&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=184&amp;issue=5&amp;pii=S0092-8674%2820%29X0006-7" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(21)00169-0" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(21)00077-5" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract" aria-current="true">Highlights</a></li><li><a href="#author-abstract" aria-current="false">Summary</a></li><li><a href="#graphical-abstract" aria-current="false">Graphical Abstract</a></li><li><a href="#keywords" aria-current="false">Keywords</a></li><li><a href="#sec-1" aria-current="false">Introduction</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li><a href="#sec-4" aria-current="false">STAR★methods</a></li><li><a href="#acknowledgments" aria-current="false">Acknowledgments</a></li><li><a href="#supplementary-material" aria-current="false">Supplemental information (6)</a></li><li><a href="#references" aria-current="false">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">Single-cell analysis charts expression, clonal landscape of glioma-infiltrating T&nbsp;cells</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">T cells with a cytotoxicity program express multiple NK cell receptors</div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">The NK cell receptor CD161 inhibits killing of glioma cells by T&nbsp;cells</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">Tumor cells and immunosuppressive myeloid cells express the CLEC2D ligand</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">T cells are critical effectors of cancer immunotherapies, but little is known about their gene expression programs in diffuse gliomas. Here, we leverage single-cell RNA sequencing (RNA-seq) to chart the gene expression and clonal landscape of tumor-infiltrating T&nbsp;cells across 31 patients with isocitrate dehydrogenase (IDH) wild-type glioblastoma and IDH mutant glioma. We identify potential effectors of anti-tumor immunity in subsets of T&nbsp;cells that co-express cytotoxic programs and several natural killer (NK) cell genes. Analysis of clonally expanded tumor-infiltrating T&nbsp;cells further identifies the NK gene <i>KLRB1</i> (encoding CD161) as a candidate inhibitory receptor. Accordingly, genetic inactivation of <i>KLRB1</i> or antibody-mediated CD161 blockade enhances T&nbsp;cell-mediated killing of glioma cells <i>in&nbsp;vitro</i> and their anti-tumor function <i>in&nbsp;vivo</i>. <i>KLRB1</i> and its associated transcriptional program are also expressed by substantial T&nbsp;cell populations in other human cancers. Our work provides an atlas of T&nbsp;cells in gliomas and highlights CD161 and other NK cell receptors as immunotherapy targets.</div></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical Abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/a5336fbc-0f59-4ae4-a2f0-6b302ca40cf7/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2021.01.022/asset/859e801e-5f80-44f6-8e16-27fb0d48de46/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/a5336fbc-0f59-4ae4-a2f0-6b302ca40cf7/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;CD161&quot;" alt="Search on this keyword" rel="nofollow">CD161</a></li><li><a href="/action/doSearch?AllField=&quot;T+cells&quot;" alt="Search on this keyword" rel="nofollow">T cells</a></li><li><a href="/action/doSearch?AllField=&quot;single-cell+RNA-seq&quot;" alt="Search on this keyword" rel="nofollow">single-cell RNA-seq</a></li><li><a href="/action/doSearch?AllField=&quot;glioblastoma&quot;" alt="Search on this keyword" rel="nofollow">glioblastoma</a></li><li><a href="/action/doSearch?AllField=&quot;IDH-mutant+gliomas&quot;" alt="Search on this keyword" rel="nofollow">IDH-mutant gliomas</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0030" role="paragraph">Diffuse gliomas are the most common type of primary human brain tumor and remain incurable. Current therapeutic approaches largely fail to prevent relapse in the major classes of diffuse gliomas—isocitrate dehydrogenase (IDH) mutant glioma (IDH-G) and IDH-wild-type glioblastoma (GBM)—likely due to striking genetic and cellular heterogeneity of malignant cells. Endogenous or therapy-induced T&nbsp;cell responses typically target diverse tumor antigens, offering the potential of treating heterogeneous tumors like diffuse gliomas through T&nbsp;cell-mediated immunity. Although blockade of the inhibitory PD-1 and/or CTLA-4 receptors represent major therapeutic advances in several cancer types, a recent phase 3 clinical trial of anti-PD-1 therapy failed to demonstrate benefit in recurrent GBM patients (<span class="dropBlock reference-citations"><a id="body-ref-sref9" href="#" role="doc-biblioref" data-xml-rid="bib9" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref9" aria-controls="sref9">Filley et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Filley, A.C. ∙ Henriquez, M. ∙ Dey, M.</div><div><strong>Recurrent glioma clinical trial, CheckMate-143: the game is not over yet</strong></div><div><em>Oncotarget.</em> 2017; <strong>8</strong>:91779-91794</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.18632/oncotarget.21586" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85032635307" target="_blank" aria-label="Open Scopus in new tab">Scopus (267)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29207684/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.18632%2Foncotarget.21586&amp;pmid=29207684" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref41" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41" aria-controls="sref41">Reardon et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref41"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Reardon, D.A. ∙ Omuro, A. ∙ Brandes, A. ...</div><div><strong>Randomized phase 3 study evaluating the efficacy and safety of nivolumab versus bevacizumab in patients with recurrent glioblastoma: Checkmate 143</strong></div><div><em>Neuro-Oncol.</em> 2019; <strong>19</strong>:iii21</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.A.ReardonA.OmuroA.BrandesJ.RiegerA.WickJ.SepulvedaS.PhuphanichP.de+SouzaM.S.AhluwaliaM.LimRandomized+phase+3+study+evaluating+the+efficacy+and+safety+of+nivolumab+versus+bevacizumab+in+patients+with+recurrent+glioblastoma%3A+Checkmate+143Neuro-Oncol.19Suppl+32019iii21" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref42" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" aria-label="Reference 2020" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42" aria-controls="sref42">2020</a><div class="dropBlock__holder" data-db-target-of="sref42"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Reardon, D.A. ∙ Brandes, A.A. ∙ Omuro, A. ...</div><div><strong>Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial</strong></div><div><em>JAMA Oncol.</em> 2020; <strong>6</strong>:1003-1010</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jamaoncol.2020.1024" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85085281407" target="_blank" aria-label="Open Scopus in new tab">Scopus (818)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32437507/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1001%2Fjamaoncol.2020.1024&amp;pmid=32437507" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Several factors have been postulated to limit the efficacy of PD-1 monotherapy, including a highly immunosuppressive microenvironment with prominence of immunosuppressive myeloid cells, release of the onco-metabolite 2-hydroxyglutarate (2-HG) in IDH-G (<span class="dropBlock reference-citations"><a id="body-ref-sref4-1" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4-1" aria-controls="sref4-1">Bunse et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref4-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Bunse, L. ∙ Pusch, S. ∙ Bunse, T. ...</div><div><strong>Suppression of antitumor T&nbsp;cell immunity by the oncometabolite (R)-2-hydroxyglutarate</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1192-1203</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0095-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85049652256" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29988124/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0095-6&amp;pmid=29988124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), lymphopenia due to dexamethasone and chemo-radiation treatment, and sequestration of T&nbsp;cells in the bone marrow (<span class="dropBlock reference-citations"><a id="body-ref-sref6" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6" aria-controls="sref6">Chongsathidkiet et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Chongsathidkiet, P. ∙ Jackson, C. ∙ Koyama, S. ...</div><div><strong>Sequestration of T&nbsp;cells in bone marrow in the setting of glioblastoma and other intracranial tumors</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1459-1468</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0135-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85052329798" target="_blank" aria-label="Open Scopus in new tab">Scopus (427)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30104766/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0135-2&amp;pmid=30104766" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref17" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17" aria-controls="sref17">Grossman et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Grossman, S.A. ∙ Ye, X. ∙ Lesser, G. ..., NABTT CNS Consortium</div><div><strong>Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide</strong></div><div><em>Clin. Cancer Res.</em> 2011; <strong>17</strong>:5473-5480</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-11-0774" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-80051693219" target="_blank" aria-label="Open Scopus in new tab">Scopus (422)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21737504/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-11-0774&amp;pmid=21737504" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref19-1" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-1" aria-controls="sref19-1">Gustafson et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref19-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Gustafson, M.P. ∙ Lin, Y. ∙ New, K.C. ...</div><div><strong>Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone</strong></div><div><em>Neuro-oncol.</em> 2010; <strong>12</strong>:631-644</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/neuonc/noq001" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-78349293679" target="_blank" aria-label="Open Scopus in new tab">Scopus (191)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20179016/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fneuonc%2Fnoq001&amp;pmid=20179016" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0035" role="paragraph">Glioma-infiltrating T&nbsp;cells express several inhibitory receptors, including PD-1, CTLA-4, and LAG-3, (<span class="dropBlock reference-citations"><a id="body-ref-sref56" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56" aria-controls="sref56">Woroniecka et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref56"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Woroniecka, K. ∙ Chongsathidkiet, P. ∙ Rhodin, K. ...</div><div><strong>T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma</strong></div><div><em>Clin. Cancer Res.</em> 2018; <strong>24</strong>:4175-4186</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-17-1846" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85050928290" target="_blank" aria-label="Open Scopus in new tab">Scopus (394)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29437767/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-17-1846&amp;pmid=29437767" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and recent mass cytometry efforts have begun to unmask the immune landscape of brain tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref10" href="#" role="doc-biblioref" data-xml-rid="bib10" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref10" aria-controls="sref10">Friebel et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Friebel, E. ∙ Kapolou, K. ∙ Unger, S. ...</div><div><strong>Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes</strong></div><div><em>Cell.</em> 2020; <strong>181</strong>:1626-1642</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.04.055&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.04.055&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85086403846" target="_blank" aria-label="Open Scopus in new tab">Scopus (366)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32470397/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2020.04.055&amp;pmid=32470397" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref24-1" href="#" role="doc-biblioref" data-xml-rid="bib24" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref24-1" aria-controls="sref24-1">Klemm et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref24-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Klemm, F. ∙ Maas, R.R. ∙ Bowman, R.L. ...</div><div><strong>Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells</strong></div><div><em>Cell.</em> 2020; <strong>181</strong>:1643-1660</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.05.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.05.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85086386623" target="_blank" aria-label="Open Scopus in new tab">Scopus (533)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32470396/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2020.05.007&amp;pmid=32470396" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, little is known about the comprehensive expression programs and functional states of glioma-infiltrating T&nbsp;cell populations. Here, we profiled and characterized the types, programs, and states of glioma-infiltrating T&nbsp;cells isolated from fresh tumor samples using full-length or 5′end single-cell RNA-seq (scRNA-seq) in 31 adult patients with either GBM or IDH-G. We used this T&nbsp;cell atlas to identify new pathways regulating T&nbsp;cell function in diffuse gliomas. We focused on subsets of cytotoxic glioma-infiltrating T&nbsp;cells that co-expressed several natural killer (NK) cell genes and may serve as potential effectors of anti-tumor immunity. These analyses highlighted the NK gene <i>KLRB1</i> (encoding CD161) as a potential inhibitory receptor. CLEC2D, the ligand for CD161, is a surface molecule expressed by myeloid cells and malignant cells, suggesting a ligand-receptor pathway for immunotherapy. <i>In&nbsp;vitro</i> and <i>in&nbsp;vivo</i> experiments demonstrated that the CD161 receptor inhibits key aspects of T&nbsp;cell function, including cytotoxicity and cytokine secretion. Generalizing our observations, we found that <i>KLRB1</i>, and the gene expression signature of a <i>KLRB1</i>-expressing T&nbsp;cell, was shared across diverse cancer types. Our atlas of T&nbsp;cell expression programs across the major classes of diffuse gliomas thus identified the CD161-CLEC2D pathway as a potential target for immunotherapy of diffuse gliomas and other human cancers.</div></section><section id="sec-2"><h2>Results</h2><section id="sec-2-1"><h3>A single-cell atlas of glioma-infiltrating T&nbsp;cell populations</h3><div id="p0040" role="paragraph">We profiled T&nbsp;cells from 16 GBM and 15 IDH-G patients, 18 of who did not receive dexamethasone within 4&nbsp;weeks prior to surgery (<a id="crosref0540" href="#fig1">Figure&nbsp;1</a>A; <a id="crosref0545" href="#mmc1">Table S1</a>). High-dose corticosteroids (dexamethasone) have a substantial negative impact on T&nbsp;cell function (<span class="dropBlock reference-citations"><a id="body-ref-sref19-2" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19-2" aria-controls="sref19-2">Gustafson et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref19-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Gustafson, M.P. ∙ Lin, Y. ∙ New, K.C. ...</div><div><strong>Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone</strong></div><div><em>Neuro-oncol.</em> 2010; <strong>12</strong>:631-644</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/neuonc/noq001" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-78349293679" target="_blank" aria-label="Open Scopus in new tab">Scopus (191)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20179016/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fneuonc%2Fnoq001&amp;pmid=20179016" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref23" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23" aria-controls="sref23">Keskin et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Keskin, D.B. ∙ Anandappa, A.J. ∙ Sun, J. ...</div><div><strong>Neoantigen vaccine generates intratumoral T&nbsp;cell responses in phase Ib glioblastoma trial</strong></div><div><em>Nature.</em> 2019; <strong>565</strong>:234-239</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0792-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85059785792" target="_blank" aria-label="Open Scopus in new tab">Scopus (938)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30568305/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0792-9&amp;pmid=30568305" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Indeed, flow cytometry analysis demonstrated that dexamethasone therapy was associated with substantially reduced numbers of infiltrating T&nbsp;cells (average reduction was 4.14- and 7.72-fold for CD3<sup>+</sup> and CD4<sup>+</sup> T&nbsp;cells, respectively, <a id="crosref0560" href="#fig1">Figure&nbsp;1</a>B). We sorted T&nbsp;cells from 26 freshly dissociated tumors (<a id="crosref0565" href="#figs1">Figures S1</a>A and S1B; <a id="crosref0570" href="#sec-4">STAR methods</a>) and profiled them by full-length scRNA-seq (<span class="dropBlock reference-citations"><a id="body-ref-sref39-1" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-1" aria-controls="sref39-1">Picelli et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref39-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Picelli, S. ∙ Faridani, O.R. ∙ Björklund, A.K. ...</div><div><strong>Full-length RNA-seq from single cells using Smart-seq2</strong></div><div><em>Nat. Protoc.</em> 2014; <strong>9</strong>:171-181</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nprot.2014.006" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84891677425" target="_blank" aria-label="Open Scopus in new tab">Scopus (2539)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24385147/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnprot.2014.006&amp;pmid=24385147" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), retaining 8,252 T&nbsp;cells after quality control filtering for all subsequent analyses (<a id="crosref0580" href="#figs1">Figure&nbsp;S1</a>C; <a id="crosref0585" href="#sec-4">STAR methods</a>). Four major T&nbsp;cell clusters were identified across GBM and IDH-G (<a id="crosref0590" href="#sec-4">STAR methods</a>): CD8 T&nbsp;cells, CD4 conventional T&nbsp;cells (CD4 T<sub>conv</sub>), CD4 regulatory T&nbsp;cells (T<sub>reg</sub>), and cycling T&nbsp;cells (<a id="crosref0595" href="#fig1">Figure&nbsp;1</a>C). The overall representation of these clusters was similar in GBM and IDH-G and in patients receiving different prior therapies (<a id="crosref0600" href="#fig1">Figures 1</a>D and <a id="crosref0605" href="#figs1">S1</a>D–S1G).</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/cf027cc7-232f-4a8f-9206-4df06d2423aa/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2021.01.022/asset/60d9467a-adad-4456-9f2d-72a21c0e5c0e/main.assets/gr1.jpg" height="952" width="723" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/cf027cc7-232f-4a8f-9206-4df06d2423aa/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">Transcriptional features of glioma-infiltrating T&nbsp;cells</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">(A) Experimental strategy.</div><div id="fspara0020" role="paragraph">(B) Quantification of GBM infiltrating T&nbsp;cells from patients who did or did not receive prior dexamethasone. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01 (Mann-Whitney U test). Error bars denote SEM.</div><div id="fspara0025" role="paragraph">(C) Uniform manifold approximation and projection (UMAP) visualization of 8,252 T&nbsp;cells from 26 glioma patients colored by T&nbsp;cell sub-cluster.</div><div id="fspara0030" role="paragraph">(D) UMAP representation from (C) colored based on patient ID (left) and tumor mutational status (right).</div><div id="fspara0035" role="paragraph">(E) Sub-clustering and UMAP visualization of CD8 T&nbsp;cells and CD4 T&nbsp;cells, colored based on NMF clustering; ND, not determined.</div><div id="fspara0040" role="paragraph">(F) Heatmap showing relative expression of selected genes across glioma T&nbsp;cell subsets (clusters numbered at bottom as in E). Gene expression is shown separately for T&nbsp;cells from IDH-G and GBM based on subsets identified using NMF clustering (E). Gene expression is zero-centered and given in units of ln(TP100K+1).</div><div id="fspara0045" role="paragraph">See also <a id="crosref1630" href="#figs1">Figure&nbsp;S1</a> and <a id="crosref1635" href="#mmc2">Table S2</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/5f4fc166-35f2-4db6-9b33-2b8b926a09b2/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2021.01.022/asset/980b33ad-3a02-4a01-a80d-6c7856e7e0de/main.assets/figs1.jpg" height="894" width="727" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/5f4fc166-35f2-4db6-9b33-2b8b926a09b2/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">Analysis of glioma-infiltrating T&nbsp;cells, related to <a id="crosref1740" href="#fig1">Figure&nbsp;1</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0310" role="paragraph">(A) Sorting of T&nbsp;cells from surgical glioma specimens. Single cell suspensions were generated for isolation of T&nbsp;cells by FACS. Individual live T&nbsp;cells were sorted into 96 well plates for scRNA-seq using the SMART-seq2 chemistry. T&nbsp;cells were sorted at two different facilities: T&nbsp;cells from GBM that were processed at DFCI were sorted as CD3+CD4+ and CD3+CD8+ cells; T&nbsp;cells from IDH-G that were processed at MGH were sorted as CD3+ cells. (B) Impact of tissue dissociation procedure on CD8 surface protein levels. Peripheral blood T&nbsp;cells were treated with PBS (left) or tumor dissociation buffer (right) and then analyzed for expression of CD4 and CD8 proteins following gating on live CD45+CD3+ cells. Incubation with the tumor dissociation buffer reduced the staining intensity with the CD8 mAb. (C) Quality-control analysis of scRNA-seq (SMART-seq2) data based on the number of detected genes (top) and housekeeping genes (bottom; dotted line indicates interrogated number of genes) for which transcripts were detected per cell. T&nbsp;cells from patients E88, E119, and MGH142 were excluded from further analysis. (D) UMAP plot with cell annotation based on prior dexamethasone (left) or immune checkpoint inhibitor (ICI) treatment (right). (E) Fraction of T&nbsp;cells assigned to the indicated T&nbsp;cell clusters based on glioma subtype (GBM or IDH-G) and prior treatment (dexamethasone, left; immune checkpoint inhibitor, right). (F) Fraction of T&nbsp;cells assigned to CD8 T&nbsp;cell, CD4 T&nbsp;cell, Treg, and cycling T&nbsp;cell clusters based on tumor type (IDH-G, GBM) and disease state (new onset versus recurrent). (G) Quantification of each tumor for CD8 T&nbsp;cell, CD4 T&nbsp;cell, regulatory T&nbsp;cell (Treg), and cycling T&nbsp;cell clusters; higher frequency of CD8 T&nbsp;cells in IDH-G versus GBM may be related to differences in details of cell isolation procedures as described in (A). (H) RNA-ISH for mRNA expression of three different cellular stress genes (<i>HSPA1A</i>, <i>HSPH1</i>, <i>HSPA6</i>) by <i>CD3E</i>+ T&nbsp;cells; labeling is shown for IDH-G (top) and GBM (bottom).</div></div></div></div></figcaption></figure></div><div id="p0045" role="paragraph">Further clustering of CD8 and CD4 T&nbsp;cell subsets highlighted six sub-clusters for each population that were robustly identified using non-negative matrix factorization (NMF) (<a id="crosref0610" href="#fig1">Figure&nbsp;1</a>E; <a id="crosref0615" href="#sec-4">STAR methods</a>). The sub-clusters spanned several distinct T&nbsp;cell states (<a id="crosref0620" href="#fig1">Figures 1</a>E and 1F; <a id="crosref0625" href="#mmc2">Table S2</a>). Cytotoxicity-related genes were most highly expressed in one of the six CD8 T&nbsp;cell clusters that also showed increased expression of NK cell genes. Interestingly, expression of cytotoxicity genes was also detected in one cluster of CD4 T&nbsp;cells (<a id="crosref0630" href="#fig1">Figures 1</a>E and 1F). In both CD8 and CD4 T&nbsp;cells, there were clusters with an interferon signature, an effector memory signature, or a stress signature (<a id="crosref0635" href="#fig1">Figures 1</a>E and 1F). We confirmed expression of genes of the stress signature by RNA <i>in situ</i> hybridization (RNA-ISH) for glioma-infiltrating <i>CD3E</i><sup>+</sup> T&nbsp;cells (<a id="crosref0640" href="#figs1">Figure&nbsp;S1</a>H), excluding a potential artifact of tissue dissociation. To further demonstrate the robustness of the clusters, we generated transcriptomic profiles by single-cell droplet-based RNA sequencing (RNA-seq) for 25,256 CD3<sup>+</sup> single T&nbsp;cells from five additional GBM patients (3,424 to 6,026 cells/tumor) and found expression signatures to be highly consistent with the CD8 and CD4 T&nbsp;cell clusters identified in the initial 26 patients (<a id="crosref0645" href="#figs2">Figures S2</a>A–S2C; <a id="crosref0650" href="#mmc3">Table S3</a>; <a id="crosref0655" href="#sec-4">STAR methods</a>).</div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/372e1f12-4afb-481d-ab2b-a083891ed3de/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2021.01.022/asset/d0f9d8bf-dbef-4ac7-80c6-ba5ad2c7a6f5/main.assets/figs2.jpg" height="949" width="711" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/372e1f12-4afb-481d-ab2b-a083891ed3de/main.assets/figs2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">Transcriptional signatures of glioma-infiltrating T&nbsp;cells, related to <a id="crosref1745" href="#fig2">Figures 2</a> and <a id="crosref1750" href="#fig3">3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0320" role="paragraph">(A-C) scRNA-seq analysis of T&nbsp;cells from five GBM samples by 5′ sequencing using the 10X Genomics platform. (A) UMAP visualization of T&nbsp;cells color-coded based on tumor specimen. (B) UMAP visualization of major T&nbsp;cell subpopulations. (C) Heatmap showing top differentially expressed genes for clusters of CD8 (left) and CD4 (right) T&nbsp;cells. Similar cluster designation is shown as in <a id="crosref1755" href="#fig1">Figure&nbsp;1</a>F for T&nbsp;cells from the SMART-seq2 dataset. (D-E) Analysis of TCGA datasets from GBM and IDH-G for expression of T&nbsp;cell specific genes. T&nbsp;cell-specific genes were identified using T&nbsp;cell scRNA-seq data from this study and our previously published GBM scRNA-seq data (<span class="dropBlock reference-citations"><a id="body-ref-sref37-1" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-1" aria-controls="sref37-1">Neftel et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref37-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Neftel, C. ∙ Laffy, J. ∙ Filbin, M.G. ...</div><div><strong>An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma</strong></div><div><em>Cell.</em> 2019; <strong>178</strong>:835-849.e21</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2019.06.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2019.06.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85071345728" target="_blank" aria-label="Open Scopus in new tab">Scopus (1252)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31327527/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.06.024&amp;pmid=31327527" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). These genes were used to interrogate bulk RNA-seq data from TCGA, limiting the analysis to those gliomas with a sufficient T&nbsp;cell signal (129 of 148 GBM and 161 of 428 IDH-G samples). Expression of these genes is shown without (D) and with (E) normalization of the total T&nbsp;cell signal (average expression of <i>CD2</i>, <i>CD3D</i>, <i>CD3E,</i> and <i>CD3G</i>). Volcano plots compare expression of these genes in IDH-G (left) versus GBM (right); genes are color coded with respect to T&nbsp;cell cluster in scRNA-seq data (<a id="crosref1765" href="#fig1">Figure&nbsp;1</a>E). (F) Heatmap showing relative expression of selected genes across CD8 T&nbsp;cells in cytotoxicity-NK (1) cluster (<a id="crosref1770" href="#fig1">Figure&nbsp;1</a>E), with emphasis on key cytotoxicity, NK cell receptor, and T&nbsp;cell markers. Gene expression is zero-centered and given in units of ln(TP100K+1). (G, H) Expression of inhibitory receptor genes (<i>PDCD1</i>, <i>HAVCR2</i> and <i>TIGIT</i>) in CD8 (G) and CD4 (H) T&nbsp;cells.</div></div></div></div></figcaption></figure></div><div id="p0050" role="paragraph">Even though similar T&nbsp;cell clusters were identified in both types of gliomas, we performed further analyses to identify differences in T&nbsp;cell states. First, gene expression signatures reflecting T&nbsp;cell cytotoxicity, interferon, and cellular stress programs gave a stronger signal in the respective clusters for both CD8 and CD4 T&nbsp;cell populations in GBM than IDH-G (<a id="crosref0660" href="#fig2">Figures 2</a>A and 2B; <a id="crosref0665" href="#mmc4">Table S4</a>). Second, interrogation of TCGA bulk RNA-seq profiles based on our scRNA-seq data revealed that T&nbsp;cell-specific genes were more highly expressed in GBM than IDH-G (<a id="crosref0670" href="#figs2">Figures S2</a>D and S2E), which is similar to results of prior studies (<span class="dropBlock reference-citations"><a id="body-ref-sref4-2" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4-2" aria-controls="sref4-2">Bunse et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref4-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Bunse, L. ∙ Pusch, S. ∙ Bunse, T. ...</div><div><strong>Suppression of antitumor T&nbsp;cell immunity by the oncometabolite (R)-2-hydroxyglutarate</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1192-1203</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0095-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85049652256" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29988124/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0095-6&amp;pmid=29988124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref58" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58" aria-controls="sref58">Zhang et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref58"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Zhang, L. ∙ Sorensen, M.D. ∙ Kristensen, B.W. ...</div><div><strong>D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells</strong></div><div><em>Clin. Cancer Res.</em> 2018; <strong>24</strong>:5381-5391</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-17-3855" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85055912662" target="_blank" aria-label="Open Scopus in new tab">Scopus (63)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30006485/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-17-3855&amp;pmid=30006485" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). When the expression of T&nbsp;cell-specific genes was normalized to the T&nbsp;cell signal per tumor, we observed higher expression of cytotoxicity genes (<i>PRF1</i> and <i>GZMA</i>) in GBM than IDH-G (<a id="crosref0685" href="#figs2">Figure&nbsp;S2</a>E), consistent with the higher cytotoxicity signature observed in the single-cell data. Overall, these data suggest that GBM and IDH-G share similar composition in subsets of infiltrating T&nbsp;cells, but that the total abundance of T&nbsp;cells and their cytotoxicity program is higher in GBM, corresponding with an immunosuppressive role of 2-HG (<span class="dropBlock reference-citations"><a id="body-ref-sref4-3" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4-3" aria-controls="sref4-3">Bunse et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref4-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Bunse, L. ∙ Pusch, S. ∙ Bunse, T. ...</div><div><strong>Suppression of antitumor T&nbsp;cell immunity by the oncometabolite (R)-2-hydroxyglutarate</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1192-1203</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0095-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85049652256" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29988124/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0095-6&amp;pmid=29988124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/461ae7ae-cc38-42ae-88f8-b7eb9687e685/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2021.01.022/asset/ed402f3d-e78b-4d93-8f57-fad45799ef94/main.assets/gr2.jpg" height="892" width="759" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/461ae7ae-cc38-42ae-88f8-b7eb9687e685/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">Expression of NK cell receptors by population of CD8 T&nbsp;cells</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0055" role="paragraph">(A and B) Expression of gene signatures for cytotoxicity (CD8: p&nbsp;&lt; 2.2&nbsp;× 10<sup>16</sup>; CD4: p&nbsp;= 1.52&nbsp;× 10<sup>13</sup>), interferon (CD8: p&nbsp;&lt; 2.2&nbsp;× 10<sup>16</sup>; CD4: p&nbsp;&lt; 2.2&nbsp;× 10<sup>16</sup>) and stress (CD8: p&nbsp;&lt; 2.2&nbsp;× 10<sup>16</sup>; CD4: p&nbsp;&lt; 2.2&nbsp;× 10<sup>16</sup>) are elevated in their respective sub-clusters for GBM compared to IDH-G in both CD8 (A) and CD4 (B) T&nbsp;cells (Kolmogorov-Smirnov two-sample test); cluster designation corresponds to <a id="crosref1640" href="#fig1">Figures 1</a>E and 1F.</div><div id="fspara0060" role="paragraph">(C) Correlation of cytotoxicity signature (x axis) and NK signature scores (y axis) for CD8 T&nbsp;cells from cluster 1 (green) or other clusters (2–6, black); clusters as defined in <a id="crosref1645" href="#fig1">Figure&nbsp;1</a>E (<a id="crosref1650" href="#sec-4">STAR methods</a>).</div><div id="fspara0065" role="paragraph">(D) CD8 T&nbsp;cells from all gliomas were split into those with high and low NK signature scores. Heatmap shows relative expression of the 20 most differentially expressed genes for each subset, separately for IDH-G and GBM. NK signature genes are bolded red, cytotoxicity signature genes are bolded black.</div><div id="fspara0070" role="paragraph">(E) UMAP visualization of CD8 T&nbsp;cells colored by expression of cytotoxicity, NK receptor, or inhibitory receptor signatures (<a id="crosref1655" href="#sec-4">STAR methods</a>).</div><div id="fspara0075" role="paragraph">(F) Expression of three cytotoxicity markers in CD8 T&nbsp;cells.</div><div id="fspara0080" role="paragraph">(G) UMAP visualization of CD4 T&nbsp;cells colored by expression of cytotoxicity or inhibitory receptor signatures.</div><div id="fspara0085" role="paragraph">(H) Cytotoxic markers in CD4 T&nbsp;cells. (E–H) Displayed on UMAP visualizations as in <a id="crosref1660" href="#fig1">Figure&nbsp;1</a>E. Gene expression is given in units of ln(TP100K+1).</div><div id="fspara0090" role="paragraph">See also <a id="crosref1665" href="#figs2">Figure&nbsp;S2</a> and <a id="crosref1670" href="#mmc2">Tables S2</a> and <a id="crosref1675" href="#mmc4">S4</a>.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-2"><h3>High cytotoxicity in glioma-infiltrating CD8 T&nbsp;cells is associated with NK cell-like signature</h3><div id="p0055" role="paragraph">We hypothesized that the increased expression of NK cell genes by cytotoxic CD8 T&nbsp;cells may be related to their functionality and may assist in identifying subsets of T&nbsp;cells with anti-tumor effector function. We scored each T&nbsp;cell across the 26 patients from the full-length scRNA-seq dataset for a cytotoxicity signature (<i>PRF1</i>, <i>GZMB</i>, <i>GZMA</i>, <i>GZMH</i>, <i>NKG7</i>, and <i>GNLY</i>) and a NK cell signature (<i>KLRD1</i>, <i>FGFBP2</i>, <i>FCGR3A</i>, <i>S1PR5</i>, <i>KLRC1</i>, <i>KLRC3</i>, <i>KLRB1</i>, and <i>KLRC2</i>) (<a id="crosref0695" href="#sec-4">STAR methods</a>). Higher cytotoxicity signature scores correlated with higher NK cell signatures (<a id="crosref0700" href="#fig2">Figures 2</a>C–2H). Key cytotoxicity genes (<a id="crosref0705" href="#fig2">Figures 2</a>D, bold black, <a id="crosref0710" href="#fig2">2</a>E, and 2F) were more highly expressed in CD8 T&nbsp;cells with a high NK signature score (<a id="crosref0715" href="#fig2">Figures 2</a>D, bold red, and <a id="crosref0720" href="#fig2">2</a>E; <a id="crosref0725" href="#mmc2">Table S2</a>). Consistently, several NK cell receptors, including <i>KLRC2</i> (NKG2C protein), <i>KLRC3</i> (NKG2E protein), <i>KLRC1</i> (NKG2A protein), <i>KLRD1</i> (CD94 protein), and <i>KLRB1</i> (CD161 protein) were expressed by CD8 T&nbsp;cells with high cytotoxicity (<a id="crosref0730" href="#fig2">Figures 2</a>E and <a id="crosref0735" href="#figs2">S2</a>F; <a id="crosref0740" href="#mmc2">Table S2</a>). High cytotoxicity and NK scores were also associated with lower expression of the <i>PDCD1</i> gene (PD-1 protein) (<a id="crosref0745" href="#fig2">Figure&nbsp;2</a>D, bold black, underlined) and lower expression of a signature of well-known co-inhibitory receptors (<i>PDCD1</i>, <i>CTLA4</i>, <i>HAVCR2</i>, <i>LAG3</i>, and <i>TIGIT</i>) (<a id="crosref0750" href="#fig2">Figures 2</a>E and <a id="crosref0755" href="#figs2">S2</a>G). In CD4 T&nbsp;cells, we detected the highest level of <i>PDCD1</i> in cytotoxic CD4 T&nbsp;cells, whereas <i>TIGIT</i> was most highly expressed by T<sub>regs</sub> (<a id="crosref0760" href="#fig2">Figures 2</a>G, 2H, and <a id="crosref0765" href="#figs2">S2</a>H). We validated the expression of a subset of these NK cell receptors by GBM-infiltrating T&nbsp;cells at the protein level by flow cytometry (<a id="crosref0770" href="#fig3">Figures 3</a>A and 3B). The inhibitory CD161 receptor (<i>KLRB1</i>) and the activating NKG2C/CD94 receptor (<i>KLRC2</i> and <i>KLRD1</i>) were expressed by substantial populations of CD8 T&nbsp;cells.</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/aaf1ffeb-8b46-4a57-bbf4-1fae8a36fe7e/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2021.01.022/asset/e8f199c2-6a54-4700-8c4b-27b67b4eb90c/main.assets/gr3.jpg" height="949" width="747" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/aaf1ffeb-8b46-4a57-bbf4-1fae8a36fe7e/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">Transcriptional signatures of clonally expanded T&nbsp;cells</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0100" role="paragraph">(A) Flow cytometric analysis of GBM-infiltrating CD8 T&nbsp;cells from one patient for protein levels of CD161 (x axis), NKp80, NKG2C, and TIGIT (y axis).</div><div id="fspara0105" role="paragraph">(B) Summary of data from (A) for tumor-infiltrating T&nbsp;cells from two GBM patients. Error bars denote SEM.</div><div id="fspara0110" role="paragraph">(C) TCR α and β chain sequences were reconstructed for each cell from scRNA-seq reads for the full-length scRNA-seq dataset and displayed as mean percent of T&nbsp;cells with recurrent TCRs within each T&nbsp;cell subset. The mean percent is taken across all individual patient samples and the error bars show the SEM.</div><div id="fspara0115" role="paragraph">(D) Size of TCR clonotypes for five GBM samples based on 5′ scRNA-seq analysis. Clonotype sizes are grouped by colors, and the number of clonotypes for each size group is indicated for each tumor.</div><div id="fspara0120" role="paragraph">(E) Comparison of expression for each gene in clonal versus non-clonal T&nbsp;cells from GBM tumors. <i>Z</i> score of expression (y axis) and <i>Z</i> score of coefficient of variation (CV) of expression (x axis) is shown for each gene separately for CD8 (left) and CD4 (right) T&nbsp;cells (<a id="crosref1680" href="#sec-4">STAR methods</a>).</div><div id="fspara0125" role="paragraph">(F) Heatmap comparing gene expression of clonally expanded, <i>KLRB1</i>-positive and -negative T&nbsp;cells from five GBM samples based on 5′ scRNA-seq analysis. Gene expression is zero-centered and given in units of ln(TP100K+1).</div><div id="fspara0130" role="paragraph">See also <a id="crosref1685" href="#figs2">Figures S2</a> and <a id="crosref1690" href="#figs3">S3</a> and <a id="crosref1695" href="#mmc3">Table S3</a>.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-3"><h3>Distinct gene expression programs in clonal T&nbsp;cell populations</h3><div id="p0060" role="paragraph">We reconstructed T&nbsp;cell receptor (TCR) sequences from the scRNA-seq reads to identify clonal T&nbsp;cells that may have proliferated following tumor antigen recognition (<span class="dropBlock reference-citations"><a id="body-ref-sref52-1" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52-1" aria-controls="sref52-1">Stubbington et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref52-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Stubbington, M.J.T. ∙ Lönnberg, T. ∙ Proserpio, V. ...</div><div><strong>T cell fate and clonality inference from single-cell transcriptomes</strong></div><div><em>Nat. Methods.</em> 2016; <strong>13</strong>:329-332</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.3800" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84960194523" target="_blank" aria-label="Open Scopus in new tab">Scopus (320)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26950746/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.3800&amp;pmid=26950746" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0780" href="#sec-4">STAR methods</a>). We detected full-length, productive TCR sequences (α and/or β chains) for 4,630 of 8,252 T&nbsp;cells (56%) across the 26 patients in the full-length scRNA-seq dataset (<a id="crosref0785" href="#fig3">Figures 3</a>C and <a id="crosref0790" href="#figs3">S3</a>A–S3E). A substantial number (13 ± 8) of distinct clonotypes (≥2 sequenced T&nbsp;cells with the same TCR sequences) were identified in most patients (<a id="crosref0795" href="#figs3">Figures S3</a>B and S3C). The degree of detected clonality is likely still an underestimate, due to the number of sampled T&nbsp;cells per patient. We therefore also examined the TCR repertoire for the five additional GBM cases using the V(D)J T&nbsp;cell profiling protocol (10X Genomics), which enabled analysis of a considerably larger number of T&nbsp;cells per patient (3,424 to 6,026 T&nbsp;cells per tumor). This analysis revealed the presence of highly expanded clonotypes in each patient (<a id="crosref0800" href="#fig3">Figure&nbsp;3</a>D), thus providing important evidence for T&nbsp;cell activation and expansion in gliomas.</div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/0f85a9a4-c06f-4d2b-a02c-6328e20b636a/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2021.01.022/asset/48a76bbc-e340-4c1e-aebb-345a698bc51b/main.assets/figs3.jpg" height="773" width="759" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/0f85a9a4-c06f-4d2b-a02c-6328e20b636a/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">Transcriptional programs of clonally expanded T&nbsp;cells, related to <a id="crosref1775" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0330" role="paragraph">(A-F) Analysis of gene expression in clonally expanded T&nbsp;cells using the SMART-seq2 dataset. (A) Number of T&nbsp;cells from each patient passing quality control and number of those cells with reconstructed TCR α and/or β chains. (B) Quantification of clonally expanded T&nbsp;cells in each patient’s tumor. TCR sequences were used to identify T&nbsp;cells with identical TCR sequences (clonotypes). For each patient tumor, the number of T&nbsp;cells belonging to each clonotype (clonotype size) is shown; the number of clonotypes composed of two T&nbsp;cells is also indicated. (C) Percentage of T&nbsp;cells from each patient that shared a TCR chain with another T&nbsp;cell (recurrent TCRs) (y axis) and the number of distinct identified T&nbsp;cell clonotypes per patient (x axis). GBM shown in dark black and IDH-G shown in light green. (D) UMAP visualization of T&nbsp;cells with recurrent TCRs colored by subsets. (E) Heatmap showing relative expression of selected cluster-related marker genes across subsets of clonally expanded T&nbsp;cells defined in (D). The gliomas are separated into IDH-G and GBM. Gene expression is zero-centered and given in units of ln(TP100K+1). (F) Comparison of expression for each gene in clonal versus non-clonal T&nbsp;cells in IDH-G. Z-score of gene expression (y axis) and Z-score of the coefficient of variation (CV; x axis) of gene expression is shown separately for each gene in CD8 (left) and CD4 (right) T&nbsp;cells.</div></div></div></div></figcaption></figure></div><div id="p0065" role="paragraph">Analysis of the expression patterns of clonally expanded T&nbsp;cells identified four major clusters (<a id="crosref0805" href="#figs3">Figure&nbsp;S3</a>D), with no marked difference between GBM and IDH-G (<a id="crosref0810" href="#figs3">Figure&nbsp;S3</a>E; <a id="crosref0815" href="#mmc2">Table S2</a>), but with distinct expression features compared to non-clonal cells. For each gene, we compared the difference in mean expression (y axis) as well as variance in expression (x axis) between clonal and non-clonal T&nbsp;cells in CD8 T&nbsp;cells or CD4 T<sub>conv</sub> cells (excluding T<sub>regs</sub>), separately for GBM (<a id="crosref0820" href="#fig3">Figure&nbsp;3</a>E) and IDH-G (<a id="crosref0825" href="#figs3">Figure&nbsp;S3</a>F; <a id="crosref0830" href="#sec-4">STAR methods</a>). Clonal CD8 T&nbsp;cells had higher expression of cytotoxicity genes (<i>GZMB</i> and <i>NKG7</i>) and NK receptors (<i>KLRB1</i> and <i>KLRD1</i>) than non-clonal cells in GBM (<a id="crosref0835" href="#fig3">Figure&nbsp;3</a>E), supporting that these programs may identify tumor-reactive T&nbsp;cells. In particular, <i>KLRB1</i> expression was both higher and less variable in clonal CD8 T&nbsp;cells compared to non-clonal cells in GBM (<a id="crosref0840" href="#fig3">Figure&nbsp;3</a>E; <a id="crosref0845" href="#sec-4">STAR methods</a>) and less variable in clonal CD8 T&nbsp;cells in IDH-G (<a id="crosref0850" href="#figs3">Figure&nbsp;S3</a>F, p&nbsp;&lt; 0.01, permutation test; <a id="crosref0855" href="#sec-4">STAR methods</a>). <i>KLRB1</i> encodes the CD161 protein that was previously shown to inhibit NK cell-mediated cytotoxicity following binding to CLEC2D (LLT1) (<span class="dropBlock reference-citations"><a id="body-ref-sref1" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1" aria-controls="sref1">Aldemir et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Aldemir, H. ∙ Prod’homme, V. ∙ Dumaurier, M.J. ...</div><div><strong>Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor</strong></div><div><em>J.&nbsp;Immunol.</em> 2005; <strong>175</strong>:7791-7795</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.175.12.7791" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-29144438027" target="_blank" aria-label="Open Scopus in new tab">Scopus (227)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16339512/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.175.12.7791&amp;pmid=16339512" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref44" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44" aria-controls="sref44">Rosen et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref44"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Rosen, D.B. ∙ Bettadapura, J. ∙ Alsharifi, M. ...</div><div><strong>Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor</strong></div><div><em>J.&nbsp;Immunol.</em> 2005; <strong>175</strong>:7796-7799</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.175.12.7796" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-29144444611" target="_blank" aria-label="Open Scopus in new tab">Scopus (222)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16339513/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.175.12.7796&amp;pmid=16339513" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Clonal CD4 T&nbsp;cells also more highly expressed several cytotoxicity genes (<i>PRF1</i>, <i>GZMA</i>, and <i>GZMH</i>) (<a id="crosref0870" href="#fig3">Figures 3</a>E and <a id="crosref0875" href="#figs3">S3</a>F). These conclusions were confirmed by comparing the gene expression of clonally expanded, <i>KLRB1</i> positive and negative T&nbsp;cell populations using the five additional GBM samples analyzed by 5′ scRNA-seq: in CD8 T&nbsp;cells, <i>KLRB1</i><sup>+</sup> cells expressed higher levels of cytotoxicity (<i>GNLY</i> and <i>GZMB</i>) and NK cell genes (<i>NCR3</i> and <i>KLRD1</i>) (<a id="crosref0880" href="#fig3">Figures 3</a>F and <a id="crosref0885" href="#figs2">S2</a>C; <a id="crosref0890" href="#mmc3">Table S3</a>).</div></section><section id="sec-2-4"><h3>Expression of CD161 receptor by T&nbsp;cells and its ligand CLEC2D by malignant and myeloid cells</h3><div id="p0070" role="paragraph">We selected the <i>KLRB1</i> gene for further investigation because (1) the gene was overexpressed by CD8 T&nbsp;cells with a cytotoxicity signature and CD4 effector T&nbsp;cells, but importantly not Tregs, (2) it encodes a surface protein that could be therapeutically modulated, and (3) it was more highly expressed in clonally expanded T&nbsp;cells in human gliomas. Given that clonal expansion is induced by TCR signaling, this analysis enriched for genes overexpressed by tumor-reactive T&nbsp;cells. Because glioma cells express CLEC2D mRNA and protein (<span class="dropBlock reference-citations"><a id="body-ref-sref46" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46" aria-controls="sref46">Roth et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref46"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Roth, P. ∙ Mittelbronn, M. ∙ Wick, W. ...</div><div><strong>Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1</strong></div><div><em>Cancer Res.</em> 2007; <strong>67</strong>:3540-3544</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-06-4783" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-34248529706" target="_blank" aria-label="Open Scopus in new tab">Scopus (84)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17440061/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-06-4783&amp;pmid=17440061" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), we hypothesized that the CD161 receptor could inhibit activation of T&nbsp;cell populations following CLEC2D binding. <i>CLEC2D</i> mRNA was expressed in both malignant cells and myeloid cells in GBM and IDH-G scRNA-seq datasets (<span class="dropBlock reference-citations"><a id="body-ref-sref37-2" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-2" aria-controls="sref37-2">Neftel et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref37-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Neftel, C. ∙ Laffy, J. ∙ Filbin, M.G. ...</div><div><strong>An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma</strong></div><div><em>Cell.</em> 2019; <strong>178</strong>:835-849.e21</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2019.06.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2019.06.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85071345728" target="_blank" aria-label="Open Scopus in new tab">Scopus (1252)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31327527/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.06.024&amp;pmid=31327527" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref54" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54" aria-controls="sref54">Tirosh et&nbsp;al., 2016b</a><div class="dropBlock__holder" data-db-target-of="sref54"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Tirosh, I. ∙ Venteicher, A.S. ∙ Hebert, C. ...</div><div><strong>Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma</strong></div><div><em>Nature.</em> 2016; <strong>539</strong>:309-313</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature20123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85016091925" target="_blank" aria-label="Open Scopus in new tab">Scopus (721)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27806376/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature20123&amp;pmid=27806376" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref55" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55" aria-controls="sref55">Venteicher et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref55"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Venteicher, A.S. ∙ Tirosh, I. ∙ Hebert, C. ...</div><div><strong>Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq</strong></div><div><em>Science.</em> 2017; <strong>355</strong>:eaai8478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aai8478" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85016574289" target="_blank" aria-label="Open Scopus in new tab">Scopus (612)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28360267/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aai8478&amp;pmid=28360267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <a id="crosref0915" href="#fig4">Figure&nbsp;4</a>A). <i>KLRB1</i> was preferentially expressed by CD8 and CD4 T<sub>conv</sub> cells in diffuse gliomas; expression was lower in CD4 T<sub>regs</sub> (<a id="crosref0920" href="#figs4">Figure&nbsp;S4</a>A). Critically, these cells were polyclonal T&nbsp;cells and not NK T&nbsp;cells or mucosal-associated invariant T&nbsp;cells (MAIT): they used diverse TCR V and J segments by both TCR α and β chains (<a id="crosref0925" href="#fig4">Figures 4</a>B, <a id="crosref0930" href="#figs4">S4</a>B, and S4C), whereas both NKT cells and MAIT cells have a highly restricted TCR repertoire (<span class="dropBlock reference-citations"><a id="body-ref-sref36" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36" aria-controls="sref36">Mori et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref36"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Mori, L. ∙ Lepore, M. ∙ De Libero, G.</div><div><strong>The Immunology of CD1- and MR1-Restricted T Cells</strong></div><div><em>Annu. Rev. Immunol.</em> 2016; <strong>34</strong>:479-510</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1146/annurev-immunol-032414-112008" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84969752983" target="_blank" aria-label="Open Scopus in new tab">Scopus (130)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26927205/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1146%2Fannurev-immunol-032414-112008&amp;pmid=26927205" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Furthermore, the polyclonal T&nbsp;cells expressed key T&nbsp;cell genes, including TCR-CD3 subunits (<i>CD3G</i>, <i>CD3D</i>, and <i>CD3E)</i> and co-receptors (<i>CD4</i> or <i>CD8A</i>/<i>CD8B</i>) (<a id="crosref0940" href="#figs4">Figure&nbsp;S4</a>D). We did not detect rearranged TCR δ chains, indicating that these cells were αβ rather than γδ T&nbsp;cells. <i>KLRB1</i>-expressing T&nbsp;cells were also not T helper (Th)17 cells, based on very low expression of <i>IL17A</i>, <i>IL17F</i>, <i>IL22</i>, <i>IL23R</i>, and <i>RORC</i> (<a id="crosref0945" href="#figs4">Figure&nbsp;S4</a>D). This is particularly relevant for <i>KLRB1</i>-expressing T&nbsp;cells because CD161 is used as a marker for MAIT cells that provide protection against intracellular bacterial infection (<span class="dropBlock reference-citations"><a id="body-ref-sref22" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22" aria-controls="sref22">Keller et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Keller, A.N. ∙ Corbett, A.J. ∙ Wubben, J.M. ...</div><div><strong>MAIT cells and MR1-antigen recognition</strong></div><div><em>Curr. Opin. Immunol.</em> 2017; <strong>46</strong>:66-74</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.coi.2017.04.002" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85018411759" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28494326/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.coi.2017.04.002&amp;pmid=28494326" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). <i>KLRB1</i>-expressing T&nbsp;cells in glioma are thus distinct from CD161<sup>+</sup> γδ T&nbsp;cells that produce interleukin (IL)-17, which were previously shown to be enriched in the cerebrospinal fluid of patients with multiple sclerosis (<span class="dropBlock reference-citations"><a id="body-ref-sref49" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49" aria-controls="sref49">Schirmer et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref49"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Schirmer, L. ∙ Rothhammer, V. ∙ Hemmer, B. ...</div><div><strong>Enriched CD161high CCR6+ γδ T&nbsp;cells in the cerebrospinal fluid of patients with multiple sclerosis</strong></div><div><em>JAMA Neurol.</em> 2013; <strong>70</strong>:345-351</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/2013.jamaneurol.409" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84874864228" target="_blank" aria-label="Open Scopus in new tab">Scopus (63)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23599932/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1001%2F2013.jamaneurol.409&amp;pmid=23599932" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/a3c53b18-1d0b-4e28-b3f9-98061d97df6b/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2021.01.022/asset/84680bfa-fb67-44b5-a7d9-81ba29ce7928/main.assets/gr4.jpg" height="948" width="747" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/a3c53b18-1d0b-4e28-b3f9-98061d97df6b/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text">Investigation of CLEC2D-CD161 pathway in GBM</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0140" role="paragraph">(A) Quantification of transcript levels for <i>CLEC2D</i> and selected genes in malignant cells, myeloid cells, and oligodendrocytes from published glioma datasets. Gene expression is zero-centered and given in units of ln(TP100K+1).</div><div id="fspara0145" role="paragraph">(B) Diversity of TCRα V and J gene segment usage by CD8 T&nbsp;cells expressing <i>KLRB1</i>.</div><div id="fspara0150" role="paragraph">(C) Flow cytometric analysis of CD161 protein on the surface of CD8 (top) and CD4 (bottom) T&nbsp;cells in GBM (filled colors) versus blood T&nbsp;cells (blue line) from the same patient. Dotted line indicates staining with isotype control antibody; percentage of CD161<sup>+</sup> tumor-infiltrating T&nbsp;cells is indicated.</div><div id="fspara0155" role="paragraph">(D and E) Quantification of CD161- and PD-1-positive T&nbsp;cells in two GBM (E208 and E161), based on fluorescence minus one (FMO) and isotype controls, (D) and summary of data for five GBM (E). Percentage of CD161- versus PD-1-positive T&nbsp;cells, p&nbsp;&lt; 0.006 for CD8 and p&nbsp;&lt; 0.003 for CD4 T&nbsp;cells, Mann-Whitney U test. Error bars denote SEM.</div><div id="fspara0160" role="paragraph">(F) <i>In situ</i> hybridization in two IDH-G (upper panel) and two GBM (lower panel) with probes for <i>KLRB1</i> and <i>CD3E</i> (top) as well as <i>CLEC2D</i> and <i>CD45</i> (bottom), counterstained with hematoxylin (light purple). Top row shows subsets of cells co-expressing <i>CD3E</i> and <i>KLRB1</i> (black arrowheads); bottom row highlights <i>CLEC2D</i> expression in malignant cells (yellow arrowheads) and <i>CD45</i> positive immune cells (black arrowheads); <sup>∗</sup>lumen of blood vessels.</div><div id="fspara0165" role="paragraph">(G and H) Quantification of infiltrating CD3<sup>+</sup> T&nbsp;cells and CD3<sup>-</sup>CD56<sup>+</sup> NK cells in five GBM.</div><div id="fspara0170" role="paragraph">See also <a id="crosref1700" href="#figs4">Figure&nbsp;S4</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/4fcddd1f-1609-4772-bce6-18d906cfe0b2/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2021.01.022/asset/69a120cc-44fe-4c9d-9604-069130672905/main.assets/figs4.jpg" height="766" width="759" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/4fcddd1f-1609-4772-bce6-18d906cfe0b2/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">Expression of <i>KLRB1</i> in glioma-infiltrating T&nbsp;cells, related to <a id="crosref1780" href="#fig4">Figure&nbsp;4</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0340" role="paragraph">(A-D) Analysis of <i>KLRB1</i> expressing T&nbsp;cells in SMART-seq2 dataset. (A) Violin plots showing <i>KLRB1</i> expression across major T&nbsp;cell subpopulations in GBM (left) and IDH-G (right). Gene expression is given in units of ln(TP100K+1). (B-C) Diversity of TCR V-segment (left) and J-segment (right) rearrangements of <i>KLRB1</i> expressing T&nbsp;cells shown for TCRβ chains of <i>KLRB1</i> expressing CD8 T&nbsp;cells (B) and TCRα and β chains of <i>KLRB1</i> expressing CD4 T&nbsp;cells (C). (D) Heatmap showing absolute expression of selected genes across <i>KLRB1</i> expressing CD4 and CD8 T&nbsp;cells with emphasis on key T&nbsp;cell, Th17, and MAIT cell markers. Gene expression is given in units of ln(TP100K+1). (E, F) Quantification of GBM-infiltrating T&nbsp;cell populations for CD161 and PD-1 protein surface levels in three additional patients (E). CD161 gating is based on labeling with an isotype control mAb for each patient, shown for one patient in (F); live CD45+ CD3+ GBM T&nbsp;cells were stained with isotype control mAb (isotype matching CD161 mAb). (G) Specific detection of CD161 protein by flow cytometry with mAb used to study GBM-infiltrating T&nbsp;cells. Jurkat [E6-1] cells were transduced with the human <i>KLRB1</i> cDNA using a lentiviral vector and labeling with a CD161 mAb was compared between WT control Jurkat cells (left) and <i>KLRB1</i> cDNA transduced Jurkat cells (right). (H-J) Analysis of dendritic cells from murine GL261 tumors for expression of CLEC2D. (H) Gating strategy for analysis of murine dendritic cells (DCs). (I) Representative examples of CLEC2D mAb labeling (filled red) compared to mIgG1 isotype staining control (gray dashed line) on dendritic cells in GL261 tumors from mice treated with isotype control antibody (left) or PD-1 blocking antibody (right). (J) Summary of CLEC2D protein levels on dendritic cells in GL261 tumors from mice treated with isotype control antibody (left) or PD-1 blocking antibody (right). <sup>∗∗</sup>p&nbsp;&lt; 0.01 (Mann-Whitney U test), error bars denote SEM. MFI, mean fluorescent intensity. n&nbsp;= 6 tumors/group. (J) was performed twice.</div></div></div></div></figcaption></figure></div><div id="p0075" role="paragraph">We confirmed these expression patterns by flow cytometry and <i>in situ</i> hybridization (<a id="crosref0960" href="#sec-4">STAR methods</a>). Flow cytometry showed that a large fraction (&gt;90%) of GBM-infiltrating CD8 T&nbsp;cells and most CD4 T&nbsp;cells were CD161-positive, whereas CD161 was detected in only a small subset of peripheral blood T&nbsp;cells from the same patients (<a id="crosref0965" href="#fig4">Figure&nbsp;4</a>C). The proportion of CD161<sup>+</sup> T&nbsp;cells was substantially larger (p&nbsp;&lt; 0.005, Mann-Whitney U test) and less variable (p&nbsp;&lt; 0.001, F test) than that of PD-1<sup>+</sup> T&nbsp;cells (<a id="crosref0970" href="#fig4">Figures 4</a>D, 4E, and <a id="crosref0975" href="#figs4">S4</a>E). Detection of CD161 with this antibody was specific based on isotype control staining (<a id="crosref0980" href="#fig4">Figures 4</a>C and <a id="crosref0985" href="#figs4">S4</a>F), labeling of a cell line transduced with full-length <i>KLRB1</i> cDNA (<a id="crosref0990" href="#figs4">Figure&nbsp;S4</a>G), and lack of detection for primary T&nbsp;cells in which the <i>KLRB1</i> gene was inactivated by CRISPR/Cas9 (<a id="crosref0995" href="#sec-4">STAR methods</a>). RNA-ISH further confirmed that <i>KLRB1</i> was expressed in populations of <i>CD3E</i><sup>+</sup> T&nbsp;cells, and <i>CLEC2D</i> mRNA was expressed primarily in malignant cells, but also in <i>CD45</i><sup><i>+</i></sup> immune cells (<a id="crosref1000" href="#fig4">Figure&nbsp;4</a>F). CD161 is known to be expressed by NK cells, but flow cytometric analysis identified only small numbers of CD3<sup>−</sup> CD56<sup>+</sup> NK cells in five GBM samples (<a id="crosref1005" href="#fig4">Figure&nbsp;4</a>G,H), consistent with recent studies (<span class="dropBlock reference-citations"><a id="body-ref-sref24-2" href="#" role="doc-biblioref" data-xml-rid="bib24" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref24-2" aria-controls="sref24-2">Klemm et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref24-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Klemm, F. ∙ Maas, R.R. ∙ Bowman, R.L. ...</div><div><strong>Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells</strong></div><div><em>Cell.</em> 2020; <strong>181</strong>:1643-1660</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.05.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.05.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85086386623" target="_blank" aria-label="Open Scopus in new tab">Scopus (533)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32470396/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2020.05.007&amp;pmid=32470396" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We also identified CLEC2D protein expression on tumor-infiltrating dendritic cells in a murine glioma model (<a id="crosref1015" href="#figs4">Figures S4</a>H–S4J). Expression of <i>CLEC2D</i> by myeloid cells is consistent with published studies demonstrating transcription of this gene following activation of monocytes, dendritic cells, B cells, and T&nbsp;cells (<span class="dropBlock reference-citations"><a id="body-ref-sref14" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14" aria-controls="sref14">Germain et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Germain, C. ∙ Meier, A. ∙ Jensen, T. ...</div><div><strong>Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2011; <strong>286</strong>:37964-37975</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1074%2Fjbc.M111.285312&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1074%2Fjbc.M111.285312&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-80055065444" target="_blank" aria-label="Open Scopus in new tab">Scopus (100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21930700/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M111.285312&amp;pmid=21930700" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref45" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45" aria-controls="sref45">Rosen et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref45"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Rosen, D.B. ∙ Cao, W. ∙ Avery, D.T. ...</div><div><strong>Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells</strong></div><div><em>J.&nbsp;Immunol.</em> 2008; <strong>180</strong>:6508-6517</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.180.10.6508" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-45549100768" target="_blank" aria-label="Open Scopus in new tab">Scopus (140)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18453569/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.180.10.6508&amp;pmid=18453569" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-2-5"><h3>CD161 acts as an inhibitory receptor for tumor-specific T&nbsp;cells</h3><div id="p0080" role="paragraph">We interrogated the CD161-CLEC2D pathway using a co-culture system with primary human T&nbsp;cells and patient-derived gliomasphere cultures (<a id="crosref1030" href="#fig5">Figure&nbsp;5</a>A; <a id="crosref1035" href="#sec-4">STAR methods</a>). We focused on studying the interaction of human T&nbsp;cells and glioma cells because the human genome carries a single <i>KLRB1</i> gene, whereas multiple <i>Klrb1</i> homologs are present in the murine genome that encode both inhibitory and activating receptors (<span class="dropBlock reference-citations"><a id="body-ref-sref57" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57" aria-controls="sref57">Zhang et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref57"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Zhang, Q. ∙ Rahim, M.M. ∙ Allan, D.S. ...</div><div><strong>Mouse Nkrp1-Clr gene cluster sequence and expression analyses reveal conservation of tissue-specific MHC-independent immunosurveillance</strong></div><div><em>PLoS ONE.</em> 2012; <strong>7</strong>:e50561</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0050561" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84870727260" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23226525/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0050561&amp;pmid=23226525" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). These gliomasphere cultures expressed <i>CLEC2D</i> mRNA as shown by qPCR analysis (<a id="crosref1045" href="#fig5">Figure&nbsp;5</a>B) and also expressed the HLA-A<sup>∗</sup>02:01 protein (<a id="crosref1050" href="#sec-4">STAR methods</a>), thus enabling co-culture assays with T&nbsp;cells that recognized the NY-ESO-1 tumor peptide presented by HLA-A<sup>∗</sup>02:01. We isolated CD161<sup>+</sup> T&nbsp;cells (negative for Vα7.2, a marker for MAIT cells) from peripheral blood samples of healthy donors. These cells were edited with high efficiency by electroporation of Cas9 protein with bound gRNAs (&gt;90% editing efficiency for <i>KLRB1</i>) (<a id="crosref1055" href="#figs5">Figures S5</a>A–S5F). We introduced a NY-ESO-1-specific TCR (1G4) into <i>KLRB1</i>-inactivated or control T&nbsp;cells to generate a population of T&nbsp;cells with defined tumor antigen specificity (<a id="crosref1060" href="#figs5">Figures S5</a>G–S5K; <a id="crosref1065" href="#sec-4">STAR methods</a>; <span class="dropBlock reference-citations"><a id="body-ref-sref60" href="#" role="doc-biblioref" data-xml-rid="bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60" aria-controls="sref60">Zhao et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref60"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Zhao, Y. ∙ Zheng, Z. ∙ Robbins, P.F. ...</div><div><strong>Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines</strong></div><div><em>J.&nbsp;Immunol.</em> 2005; <strong>174</strong>:4415-4423</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.174.7.4415" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-15444371764" target="_blank" aria-label="Open Scopus in new tab">Scopus (175)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15778407/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.174.7.4415&amp;pmid=15778407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This TCR recognized a NY-ESO-1 peptide presented by HLA-A<sup>∗</sup>02:01, and previous clinical trials with TCR transduced T&nbsp;cells demonstrated therapeutic responses in multiple myeloma and synovial sarcoma (<span class="dropBlock reference-citations"><a id="body-ref-sref40" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40" aria-controls="sref40">Rapoport et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref40"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Rapoport, A.P. ∙ Stadtmauer, E.A. ∙ Binder-Scholl, G.K. ...</div><div><strong>NY-ESO-1-specific TCR-engineered T&nbsp;cells mediate sustained antigen-specific antitumor effects in myeloma</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:914-921</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.3910" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84938963928" target="_blank" aria-label="Open Scopus in new tab">Scopus (694)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26193344/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.3910&amp;pmid=26193344" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref43" href="#" role="doc-biblioref" data-xml-rid="bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref43" aria-controls="sref43">Robbins et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref43"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Robbins, P.F. ∙ Morgan, R.A. ∙ Feldman, S.A. ...</div><div><strong>Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2011; <strong>29</strong>:917-924</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2010.32.2537" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-79952304769" target="_blank" aria-label="Open Scopus in new tab">Scopus (1352)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21282551/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1200%2FJCO.2010.32.2537&amp;pmid=21282551" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/370b14aa-87a8-4974-a667-f4b0f5ff5705/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2021.01.022/asset/b7317d76-78ec-4327-bd23-c345b9fb4d0d/main.assets/gr5.jpg" height="913" width="761" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/370b14aa-87a8-4974-a667-f4b0f5ff5705/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text">Targeting of CD161 pathway enhances T&nbsp;cell activation and reduces PD-1 expression</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0180" role="paragraph">(A) Workflow of experimental strategy to interrogate the function of the <i>KLRB1</i> gene in primary human T&nbsp;cells.</div><div id="fspara0185" role="paragraph">(B) qPCR analysis of <i>CLEC2D</i> and <i>GAPDH</i> mRNA in four gliomasphere cultures and U-87 MG cell line.</div><div id="fspara0190" role="paragraph">(C) T&nbsp;cell cytotoxicity assay. Gliomaspheres (MGG123, MGG75, or D270) were co-cultured with <i>KLRB1</i>- or control-edited T&nbsp;cells at an effector to target (E:T) ratio of 1:1 or 0.25:1 for 8 h. The percentage of killed (Zombie UV+) tumor cells was quantified by flow cytometry; cultures without T&nbsp;cells (0:1) were used to assess background levels of apoptosis.</div><div id="fspara0195" role="paragraph">(D) Strategy for evaluation of the CD161-CLEC2D pathway with a CD161-blocking mAb.</div><div id="fspara0200" role="paragraph">(E) T&nbsp;cell killing assay with CD161-blocking mAb (HP-3G10) or isotype control immunoglobulin G (IgG).</div><div id="fspara0205" role="paragraph">(F) Labeling of CD8 T&nbsp;cells after 24&nbsp;h for surface localization of CD107a degranulation marker.</div><div id="fspara0210" role="paragraph">(G–I) Analysis of PD-1 expression by CD8 T&nbsp;cells. T&nbsp;cells were co-cultured for 72&nbsp;h with patient-derived gliomaspheres at the indicated E:T ratios, and PD-1 surface expression was evaluated by flow cytometry. Pathway was targeted by editing of <i>KLRB1</i> gene in T&nbsp;cells or addition of CD161-blocking mAb.</div><div id="fspara0215" role="paragraph">(J and K) Cytokine release by T&nbsp;cells. T&nbsp;cells were co-cultured for 72&nbsp;h with gliomaspheres from GBM (MGG123 and MGG75) (J) or IDH-G (BT142) (K) at the indicated E:T ratios. Experiments in (C) were performed three times, experiments in (E–K) were performed two times, and experiments in (B) were performed once. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, all error bars denote SEM. Mann-Whitney U test (C, E, F, and H–K).</div><div id="fspara0220" role="paragraph">See also <a id="crosref1705" href="#figs5">Figures S5</a> and <a id="crosref1710" href="#figs6">S6</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/acab84a5-5444-4c96-a1f3-68763cdeb90c/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2021.01.022/asset/1cda8c3d-9625-4b23-b916-374011c99ada/main.assets/figs5.jpg" height="949" width="726" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/acab84a5-5444-4c96-a1f3-68763cdeb90c/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">Engineering of human T&nbsp;cells for functional studies, related to <a id="crosref1785" href="#fig5">Figure&nbsp;5</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0350" role="paragraph">(A) Efficiency of gene editing procedure. Editing of primary human CD4<sup>+</sup> T&nbsp;cells by electroporation of Cas9 protein with bound control (<i>LacZ</i>, left) or <i>CD4</i> (right) gRNAs. Loss of CD4 protein expression (ExCD4) was quantified three days following editing. (B) CD161<sup>+</sup> T&nbsp;cells negative for Vα7.2 (MAIT cell marker) were sorted from peripheral blood mononuclear cells (PBMCs) of a healthy donor. (C) CD161<sup>+</sup> T&nbsp;cells were edited by electroporation of Cas9 protein with a bound control or <i>KLRB1</i> gRNA and CD161 surface protein levels were quantified by flow cytometry. (D) CD161<sup>+</sup> T&nbsp;cells were sorted from PBMCs of a healthy donor. T&nbsp;cells were either not edited (no electroporation) or edited by electroporation with Cas9 protein with bound gRNAs, using either control (Cntrl)&nbsp;+ <i>TRAC</i> gRNAs, Cntrl&nbsp;+ <i>KLRB1</i> gRNAs, or <i>KLRB1</i>&nbsp;+ <i>TRAC</i> gRNAs. The <i>TRAC</i> gRNA targeted an exon encoding the constant domain of the TCR α chain to inactivate endogenous TCR α chains. Surface levels of TCR and CD161 proteins were quantified by flow cytometry three days following editing. (E) Quantification of editing efficiency for <i>KLRB1</i> gene by Sanger sequencing using TIDE software, illustrating the frequency of nucleotide deletions/insertions. (F) CD161+ T&nbsp;cells were edited by electroporation of Cas9 protein with a bound control (intergenic) gRNA or with one of two <i>KLRB1</i> gRNAs. CD161 surface protein levels were quantified by flow cytometry; both <i>KLRB1</i> gRNAs yielded similar editing efficiencies. (G) Schema of endogenous TCR replacement with NY-ESO-1 (1G4) TCR by homology directed repair (HDR) template (2214 nt), used for all experiments utilizing gliomasphere models. The NY-ESO-1 β-chain and ⍺-chain were preceded by a PC tag and HA tag, respectively, to enable identification of the individual NY-ESO-1 TCR chains by flow cytometry. Each was preceded by a self-cleaving peptide enabling translation of separate TCR chains. An ~300nt homology arm was placed on either side of the construct which allowed site directed insertion into the TRAC gRNA cut site (<a id="crosref1790" href="#figs5">Figure&nbsp;S5</a>D), enabling the 3′ portion of the endogenous ⍺-constant region to be utilized, thereby decreasing the size of the required HDR template. T&nbsp;cells generated with this approach were used for all <i>in&nbsp;vitro</i> and <i>in&nbsp;vivo</i> experiments with patient-derived gliomasphere models (<a id="crosref1795" href="#fig5">Figures 5</a>, <a id="crosref1800" href="#fig6">6</a>B–6J, <a id="crosref1805" href="#figs5">S5</a>M–S5O, <a id="crosref1810" href="#figs6">S6</a>A–S6C, and S6H–S6J). (H) Construct design for expression of NY-ESO-1 specific (1G4) TCR by lentivirus in primary human T&nbsp;cells, used for U-87 model experiments (<a id="crosref1815" href="#fig6">Figures 6</a>K–6N and <a id="crosref1820" href="#figs6">S6</a>D–S6F). HA and PC epitope tags were placed at the N terminus of the mature TCR α and β chains, respectively, to enable identification of both TCR chains on the cell surface. (I) Map of lentiviral construct with EF-1ɑ promoter regulated expression of the NY-ESO-1 protein containing the 1G4 epitope. A T2A skip sequence was used for co-expression of luciferase and an IRES was used for expression of the extracellular (EC), non-functional, domain of NGFR as a marker for transduced cells. (J) Labeling of transduced, unsorted T&nbsp;cells with PC and HA tag antibodies to identify 1G4 TCR α and β chains, respectively. (K) Characterization of T&nbsp;cells used for functional experiments shown in <a id="crosref1825" href="#fig5">Figure&nbsp;5</a>. Edited T&nbsp;cells that expressed the NY-ESO-1 TCR were labeled with antibodies specific for CD161 and HA tag (NY-ESO-1 TCRα chain). T&nbsp;cells had been edited with Cas9 plus either Cntrl&nbsp;+ <i>TRAC</i> or <i>KLRB1</i>&nbsp;+ <i>TRAC</i> gRNAs. The <i>TRAC</i> gRNA targeted the endogenous TCRα chain but not the introduced NY-ESO-1 TCR. Editing of the <i>KLRB1</i> gene resulted in loss of CD161 protein at the cell surface (which also demonstrated the antigen specificity of the mAb used to quantify CD161 surface levels in <a id="crosref1830" href="#fig4">Figures 4</a>C–4E). (L-N) T&nbsp;cell cytotoxicity assay with patient-derived gliomaspheres. After an 8-h co-culture period, the percentage of Zombie UV<sup>+</sup> (dead) glioma cells was quantified by gating first on single, CD3<sup>−</sup> cells (L) and then identifying the percentage of Zombie UV<sup>+</sup> tumors cells (M, N). (M, N) Example flow cytometry plots for quantification of Zombie UV<sup>+</sup> MGG123 (M) and MGG75 (N) glioma cells co-cultured either with control or <i>KLRB1</i> edited T&nbsp;cells; data correspond to <a id="crosref1835" href="#fig5">Figure&nbsp;5</a>C. (O) Cytokine release by T&nbsp;cells co-cultured with MGG75 glioma cells in the presence of CD161 blocking mAb or control IgG Ab for 72&nbsp;h at the indicated E:T ratios. Secretion of IFNγ and IL-2 was quantified by ELISA. (P) Validation of HP-3G10 as a mAb that blocks CLEC2D ligand binding by the CD161 receptor. Detection of CD161 on the surface of WT Jurkat [E6-1] or Jurkat cells transduced with <i>KLRB1</i> cDNA. Transfectants were stained with a biotinylated CLEC2D-Ig fusion protein (CLEC2D, green histogram) or biotinylated CD161 mAb [HP-3G10-biotin] (blue histogram) and bound proteins were detected with streptavidin-PE (SA 2°). Preincubation of CD161<sup>+</sup> Jurkat cells with non-biotinylated HP-3G10 Ab (10&nbsp;μg/ml) fully blocked binding of the biotinylated CLEC2D fusion protein (red histogram); bound CLEC2D fusion protein was detected with SA 2°-PE. Experiments in (A-E) and (K) were performed more than three times; (F), (L-O) were performed two times, (J) and (P) were performed once. <sup>∗</sup>p&nbsp;&lt;&nbsp;0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, error bars denote SEM. Mann-Whitney U test (O).</div></div></div></div></figcaption></figure></div><div id="p0085" role="paragraph"><i>KLRB1</i>-edited compared to control-edited T&nbsp;cells had higher cytotoxic activity (p&nbsp;&lt; 0.005, Mann-Whitney U test) against gliomaspheres (<a id="crosref1085" href="#fig5">Figures 5</a>C and <a id="crosref1090" href="#figs5">S5</a>L–S5N). Enhanced T&nbsp;cell-mediated cytotoxicity (<a id="crosref1095" href="#fig5">Figures 5</a>D and 5E) and cytokine secretion (<a id="crosref1100" href="#figs5">Figure&nbsp;S5</a>O) were also observed when a CD161 specific monoclonal antibody (mAb) (HP-3G10) (<a id="crosref1105" href="#figs5">Figure&nbsp;S5</a>P; <a id="crosref1110" href="#sec-4">STAR methods</a>) was used to inhibit CLEC2D binding. Consistent with their higher cytotoxic activity, T&nbsp;cells edited for <i>KLRB1</i> or blocked by HP-3G10 mAb had higher surface levels of the degranulation marker CD107a (p&nbsp;&lt; 0.003, Mann-Whitney U test) (<a id="crosref1115" href="#fig5">Figure&nbsp;5</a>F) and increased expression of T&nbsp;cell activation markers (CD25 and CD69) (<a id="crosref1120" href="#figs6">Figures S6</a>A and S6B). Inactivation of the <i>KLRB1</i> gene with two different gRNAs resulted in a similar enhancement of T&nbsp;cell function (<a id="crosref1125" href="#figs6">Figure&nbsp;S6</a>C). Interestingly, a significantly smaller fraction of CD8 T&nbsp;cells co-cultured with patient-derived gliomaspheres or the U-87 MG cell line became positive for PD-1 protein (p&nbsp;&lt; 0.0016, Mann-Whitney U test) when the <i>KLRB1</i> pathway was inactivated (<a id="crosref1130" href="#fig5">Figures 5</a>G–5I and <a id="crosref1135" href="#figs6">S6</a>D–S6F). Expression of CTLA-4 and LAG-3 receptors was not affected by <i>KLRB1</i> inactivation (<a id="crosref1140" href="#figs6">Figure&nbsp;S6</a>F). Editing of the <i>KLRB1</i> gene also enhanced secretion of cytokines important in anti-tumor immunity (p&nbsp;&lt; 0.0004, Mann-Whitney U test), including IL-2 and interferon (IFN)γ, in co-cultures with two GBM and one IDH-G gliomaspheres (<a id="crosref1145" href="#fig5">Figures 5</a>J and 5K). Overall, these data demonstrated that targeting of the CD161 pathway enhanced T&nbsp;cell-mediated cytotoxicity against patient-derived gliomaspheres and other critical aspects of T&nbsp;cell function. Signaling through the inhibitory CD161 receptor may contribute to regulation of PD-1 expression. Previous studies had suggested that CD161 represents either an activating or inhibitory receptor (<span class="dropBlock reference-citations"><a id="body-ref-sref7-1" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-1" aria-controls="sref7-1">Fergusson et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref7-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Fergusson, J.R. ∙ Smith, K.E. ∙ Fleming, V.M. ...</div><div><strong>CD161 defines a transcriptional and functional phenotype across distinct human T&nbsp;cell lineages</strong></div><div><em>Cell Rep.</em> 2014; <strong>9</strong>:1075-1088</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.celrep.2014.09.045&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.celrep.2014.09.045&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84919777275" target="_blank" aria-label="Open Scopus in new tab">Scopus (215)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25437561/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2014.09.045&amp;pmid=25437561" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref29" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29" aria-controls="sref29">Le Bourhis et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref29"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Le Bourhis, L. ∙ Dusseaux, M. ∙ Bohineust, A. ...</div><div><strong>MAIT cells detect and efficiently lyse bacterially-infected epithelial cells</strong></div><div><em>PLoS Pathog.</em> 2013; <strong>9</strong>:e1003681</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1003681" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84887281193" target="_blank" aria-label="Open Scopus in new tab">Scopus (300)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24130485/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1003681&amp;pmid=24130485" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), but had limitations due to the artificial stimulation conditions (CD3&nbsp;+ CD28 antibodies) that were used in the assays.</div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/12725f93-aa62-41ee-a8ea-dc52a0a6e516/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2021.01.022/asset/f42814ff-4eb8-4780-8899-e8e64afb311c/main.assets/figs6.jpg" height="951" width="759" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/12725f93-aa62-41ee-a8ea-dc52a0a6e516/main.assets/figs6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">Enhanced function of T&nbsp;cells against glioma cells following inactivation of <i>KLRB1</i> gene, related to <a id="crosref1840" href="#fig5">Figures 5</a> and <a id="crosref1845" href="#fig6">6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0360" role="paragraph">(A-B) Analysis of T&nbsp;cell activation markers (CD25 and CD69) following co-culture with the patient-derived gliomasphere MGG75 for 72 h. T&nbsp;cells that expressed the NY-ESO-1 TCR were co-cultured with glioma cells at the indicated effector to target ratio (E:T). The CD161 pathway was investigated by editing T&nbsp;cells with a <i>KLRB1</i> or control gRNA (A); alternatively, a CD161 blocking mAb or control IgG was added to co-cultures (B). (C) Cytokine release by T&nbsp;cells edited with two different <i>KLRB1</i> gRNAs. <i>KLRB1 gRNA#1 or KLRB1 gRNA#2</i> or control edited T&nbsp;cells were co-cultured for 72&nbsp;h with GBM (MGG75) gliomaspheres at the indicated E:T ratios. Secretion of IFNγ and IL-2 was quantified by ELISA. (D-F) Co-culture experiments with T&nbsp;cells and U-87 MG tumor cells. (D) <i>KLRB1</i> or control edited primary T&nbsp;cells that expressed a NY-ESO-1 specific TCR were co-cultured with U-87 MG cells that expressed NY-ESO-1 protein, and secreted cytokines (IFNγ and IL-2) were quantified by ELISA after 72&nbsp;h for the indicated T&nbsp;cell to tumor cell ratios. (E, F) Quantification of surface levels of PD-1 (E) and a larger panel of inhibitory receptors (F) on CD8 T&nbsp;cells edited with control or <i>KLRB1</i> gRNAs. PD-1 expression is shown for different T&nbsp;cell to tumor ratios (E); analysis of a panel of inhibitory receptors is shown for 2:1 ratio of T&nbsp;cells to tumors (F), gated on CD161 positive or negative cells. (G) Proof of concept stereotactic injection of 1.75% Brilliant blue R into the lateral ventricle of an anesthetized mouse. Mice were immediately euthanized following injection and the intact brain was removed at necropsy. Gross examination revealed the needle track lateral of the sinus artery (top). A coronal section intersecting the injection site visualized the dye in both lateral ventricles (which are connected), even though the needle was inserted to predetermined coordinates (right) of only one ventricle. No staining of the lateral ventricles was observed when the needle was withheld at the corpus callosum (control injection, left). (H) H&amp;E stained coronal section of the mouse brain shows MGG123 GBM in the left hemisphere, accompanied by mass effect with midline shift and hemorrhage. Insets 1 (white matter) and 2 (cortex) highlight infiltration of brain parenchyma by pleomorphic GBM cells (arrowheads) (corresponds to <a id="crosref1850" href="#fig6">Figure&nbsp;6</a>B). (I-J) Second <i>in&nbsp;vivo</i> experiment with GBM formed by patient-derived MGG123 gliomaspheres implanted into NSG mice. Mice received T&nbsp;cells that expressed a NY-ESO-1 TCR and had been edited with a <i>KLRB1</i> or control gRNA. Tracking of tumor burden by BLI (I) and analysis of survival (J) for the experimental and control groups; corresponds to similar experiment in <a id="crosref1855" href="#fig6">Figures 6</a>C–6E. (K) BLI tracking of tumor burden for U-87 MG model; mice received a single transfer of <i>KLRB1</i> or control edited T&nbsp;cells that expressed a NY-ESO-1 TCR; experiment corresponds to survival curve shown in <a id="crosref1860" href="#fig6">Figure&nbsp;6</a>K. Experiments in (D) were performed three times; (A-C), (E-F) and (I-K) were performed two times; (H) was performed once. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.001, error bars denote SEM. Mann-Whitney U test (A-F), (I) and Log-rank (Mantel-Cox) test (J).</div></div></div></div></figcaption></figure></div></section><section id="sec-2-6"><h3>Inactivation of <i>KLRB1</i> in tumor-infiltrating T&nbsp;cells enhances their anti-tumor activity <i>in&nbsp;vivo</i></h3><div id="p0090" role="paragraph">We generated two different humanized mouse models to assess the impact of the <i>KLRB1</i> gene on <i>in&nbsp;vivo</i> T&nbsp;cell function. In the first model, we implanted 5&nbsp;× 10<sup>4</sup> tumor cells from MGG123 gliomaspheres derived from a recurrent GBM (<span class="dropBlock reference-citations"><a id="body-ref-sref38-1" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38-1" aria-controls="sref38-1">Nigim et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref38-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Nigim, F. ∙ Cavanaugh, J. ∙ Patel, A.P. ...</div><div><strong>Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment</strong></div><div><em>J.&nbsp;Neuropathol. Exp. Neurol.</em> 2015; <strong>74</strong>:710-722</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/NEN.0000000000000210" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84934343090" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26083570/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FNEN.0000000000000210&amp;pmid=26083570" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (HLA-A<sup>∗</sup>02:01 positive, transduced to express NY-ESO-1 antigen) into the CNS of immunodeficient mice (<a id="crosref1165" href="#fig6">Figure&nbsp;6</a>A). GBM implantation was followed 8&nbsp;days later by injection of human T&nbsp;cells into the cerebrospinal fluid (CSF) via the contralateral ventricle (<a id="crosref1170" href="#fig6">Figures 6</a>A and <a id="crosref1175" href="#figs6">S6</a>G), as performed for CAR T&nbsp;cell delivery in patients (<span class="dropBlock reference-citations"><a id="body-ref-sref3" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3" aria-controls="sref3">Brown et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Brown, C.E. ∙ Alizadeh, D. ∙ Starr, R. ...</div><div><strong>Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2016; <strong>375</strong>:2561-2569</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1610497" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85007288271" target="_blank" aria-label="Open Scopus in new tab">Scopus (1297)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28029927/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1610497&amp;pmid=28029927" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Transferred T&nbsp;cells expressed the NY-ESO-1 TCR and were edited with either a <i>KLRB1</i> or control gRNA (<a id="crosref1185" href="#sec-4">STAR methods</a>). Tumor cells from MGG123 formed highly aggressive tumors, with evidence of brain infiltration, mass effect, and intratumoral hemorrhage (<a id="crosref1190" href="#fig6">Figures 6</a>B and <a id="crosref1195" href="#figs6">S6</a>H). We used bioluminescence imaging (BLI), starting on day −1 relative to T&nbsp;cell treatment, to assign mice with a similar BLI signals to the two experimental groups (<a id="crosref1200" href="#fig6">Figure&nbsp;6</a>C); a second dose of T&nbsp;cells was administered 27&nbsp;days later. Transfer of <i>KLRB1</i> compared to control edited T&nbsp;cells resulted in significantly slower tumor growth at all time points starting ∼2&nbsp;weeks following initial T&nbsp;cell transfer based on BLI imaging, a finding that was reproducible in two independent experiments (<a id="crosref1205" href="#fig6">Figures 6</a>D and <a id="crosref1210" href="#figs6">S6</a>I). Importantly, transfer of <i>KLRB1</i> compared to control edited T&nbsp;cells conferred a significant survival benefit in both experiments, despite the aggressive nature of this model (p&nbsp;= 0.0001, log-rank Mantel-Cox test) (<a id="crosref1215" href="#fig6">Figures 6</a>E and <a id="crosref1220" href="#figs6">S6</a>J).</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/df9aadb2-34ea-4619-9d3c-f75214c5586e/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2021.01.022/asset/bbc3f616-4946-4a0b-9373-c43e0cf334d1/main.assets/gr6.jpg" height="949" width="737" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/df9aadb2-34ea-4619-9d3c-f75214c5586e/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text"><i>KLRB1</i> gene inactivation in T&nbsp;cells improves survival in two humanized GBM models</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0230" role="paragraph">(A) Schematic indicating injection sites of GBM cells into the striatum and T&nbsp;cells into the contralateral lateral ventricle.</div><div id="fspara0235" role="paragraph">(B) Coronal section of the mouse brain at survival endpoint.</div><div id="fspara0240" role="paragraph">(C) Bioluminescence imaging (BLI) on day −1 (relative to first T&nbsp;cell injection).</div><div id="fspara0245" role="paragraph">(D) Kinetic analysis of tumor burden based on BLI signal from mice that received <i>KLRB1</i>- or control-edited T&nbsp;cells; day 0 corresponds to first T&nbsp;cell injection; 2<sup>nd</sup> T&nbsp;cell injection is indicated.</div><div id="fspara0250" role="paragraph">(E) Survival analysis for MGG123 model following transfer of <i>KLRB1</i>- or control-edited T&nbsp;cells.</div><div id="fspara0255" role="paragraph">(F–J) Flow cytometry analysis of <i>KLRB1</i>- or control-edited T&nbsp;cells infiltrating MGG123 at a late disease stage (moribund).</div><div id="fspara0260" role="paragraph">(K) Survival analysis for U87 model following transfer of <i>KLRB1</i>- or control-edited T&nbsp;cells.</div><div id="fspara0265" role="paragraph">(L–N) Flow cytometry analysis of T&nbsp;cells from U-87 MG tumors 8&nbsp;days following T&nbsp;cell injection. Experiments in (C–E) and (K) were performed twice; (F–J) and (L–N) were performed once. <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, all error bars denote SEM. Mann-Whitney U test (D, F–J, L–N) and log-rank (Mantel-Cox) test (E and K).</div><div id="fspara0270" role="paragraph">See also <a id="crosref1715" href="#figs6">Figure&nbsp;S6</a>.</div></div></div></div></figcaption></figure></div><div id="p0095" role="paragraph">Flow cytometric analysis of T&nbsp;cells at a late disease time point demonstrated a significantly larger number of infiltrating granzyme B<sup>+</sup> CD8 T&nbsp;cells in MGG123 gliomas when transferred T&nbsp;cells were edited with <i>KLRB1</i> rather than control gRNAs (<a id="crosref1225" href="#fig6">Figure&nbsp;6</a>F) (p&nbsp;&lt; 0.007, Mann-Whitney U test). Further investigation provided evidence that <i>KLRB1</i>-edited T&nbsp;cells had a less exhausted state than control-edited T&nbsp;cells based on the following criteria: (1) a substantially larger fraction of granzyme B<sup>+</sup> CD8 T&nbsp;cells were PD-1 negative, and (2) a small percentage of CD8 T&nbsp;cells co-expressed the PD-1 and TIM-3 inhibitory receptors (<a id="crosref1230" href="#fig6">Figures 6</a>G–6I) (p&nbsp;&lt; 0.006, Mann-Whitney U test). The latter finding is relevant because exhausted T&nbsp;cells tend to co-express multiple inhibitory receptors (<span class="dropBlock reference-citations"><a id="body-ref-sref33" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33" aria-controls="sref33">McLane et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref33"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>McLane, L.M. ∙ Abdel-Hakeem, M.S. ∙ Wherry, E.J.</div><div><strong>CD8&nbsp;T Cell Exhaustion During Chronic Viral Infection and Cancer</strong></div><div><em>Annu. Rev. Immunol.</em> 2019; <strong>37</strong>:457-495</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1146/annurev-immunol-041015-055318" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85065028922" target="_blank" aria-label="Open Scopus in new tab">Scopus (1112)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30676822/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1146%2Fannurev-immunol-041015-055318&amp;pmid=30676822" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We also observed lower PD-1 expression by <i>KLRB1-</i>edited CD4 T&nbsp;cells (<a id="crosref1240" href="#fig6">Figure&nbsp;6</a>J).</div><div id="p0100" role="paragraph">In the second humanized mouse model of T&nbsp;cell-mediated tumor immunity, U-87 MG cells were similarly engineered and implanted into the CNS of immunodeficient mice, followed by a single injection of <i>KLRB1</i> or control edited human T&nbsp;cells expressing NY-ESO-1 TCR, 7&nbsp;days later. Again, mice that received <i>KLRB1</i> compared to control edited T&nbsp;cells showed significantly improved survival (<a id="crosref1245" href="#fig6">Figure&nbsp;6</a>K) (p&nbsp;= 0.0059, log-rank Mantel-Cox test) and lower BLI signal (<a id="crosref1250" href="#figs6">Figure&nbsp;S6</a>K). A limitation of the U-87 MG model was that tumors did not grow in an infiltrative manner as observed for the MGG123 model. <i>Ex&nbsp;vivo</i> analysis of tumor-infiltrating T&nbsp;cells from a separate experiment on day 8 following T&nbsp;cell transfer showed that PD-1 expression was substantially lower in <i>KLRB1</i>-edited CD8 T&nbsp;cells (<a id="crosref1255" href="#fig6">Figure&nbsp;6</a>L) (p&nbsp;&lt; 0.004, Mann-Whitney U test), consistent with the <i>in&nbsp;vitro</i> findings (<a id="crosref1260" href="#figs6">Figures S6</a>E and S6F). Furthermore, we identified increased numbers of granzyme B, IL-2, and tumor necrosis factor alpha (TNF-α)-positive CD8 T&nbsp;cells, as well as granzyme B and IL-2-positive CD4 T&nbsp;cells, in mice that had received <i>KLRB1</i>-edited T&nbsp;cells (<a id="crosref1265" href="#fig6">Figures 6</a>M and 6N). Thus, inactivation of the <i>KLRB1</i> gene in transferred T&nbsp;cells provided a survival benefit in two humanized GBM mouse models. Together, <i>ex vivo</i> analysis demonstrated enhanced T&nbsp;cell function and reduced expression of the PD-1 inhibitory receptor.</div></section><section id="sec-2-7"><h3>The <i>KLRB1</i> program is present in tumor-infiltrating T&nbsp;cells across human cancer types</h3><div id="p0105" role="paragraph">We next examined whether <i>KLRB1</i> may be associated with similar transcriptional programs in tumor-infiltrating T&nbsp;cells in other human tumor types using published scRNA-seq datasets from melanoma, non-small cell lung cancer (NSCLC), hepatocellular carcinoma, and colorectal cancer (<a id="crosref1270" href="#fig7">Figures 7</a>A and <a id="crosref1275" href="#figs7">S7</a>A–S7C; <span class="dropBlock reference-citations"><a id="body-ref-sref18" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18" aria-controls="sref18">Guo et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Guo, X. ∙ Zhang, Y. ∙ Zheng, L. ...</div><div><strong>Global characterization of T&nbsp;cells in non-small-cell lung cancer by single-cell sequencing</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:978-985</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0045-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85049041084" target="_blank" aria-label="Open Scopus in new tab">Scopus (967)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29942094/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0045-3&amp;pmid=29942094" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref21-1" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21-1" aria-controls="sref21-1">Jerby-Arnon et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref21-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Jerby-Arnon, L. ∙ Shah, P. ∙ Cuoco, M.S. ...</div><div><strong>A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade</strong></div><div><em>Cell.</em> 2018; <strong>175</strong>:984-997.e24</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.09.006&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.09.006&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85055549585" target="_blank" aria-label="Open Scopus in new tab">Scopus (793)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30388455/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.09.006&amp;pmid=30388455" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref59-1" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-1" aria-controls="sref59-1">Zhang et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref59-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Zhang, L. ∙ Yu, X. ∙ Zheng, L. ...</div><div><strong>Lineage tracking reveals dynamic relationships of T&nbsp;cells in colorectal cancer</strong></div><div><em>Nature.</em> 2018; <strong>564</strong>:268-272</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0694-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85058518221" target="_blank" aria-label="Open Scopus in new tab">Scopus (694)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30479382/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0694-x&amp;pmid=30479382" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref61-1" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61-1" aria-controls="sref61-1">Zheng et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref61-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Zheng, C. ∙ Zheng, L. ∙ Yoo, J.K. ...</div><div><strong>Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:1342-1356.e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2017.05.035&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2017.05.035&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85020894317" target="_blank" aria-label="Open Scopus in new tab">Scopus (1381)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28622514/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.05.035&amp;pmid=28622514" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). <i>KLRB1</i> was expressed by a subset of tumor-infiltrating CD4 and CD8 T&nbsp;cells in each of these cancers (<a id="crosref1300" href="#fig7">Figures 7</a>A and <a id="crosref1305" href="#figs7">S7</a>A–S7C) and was particularly prominent in lung cancer (<i>KLRB1</i> detected in 40% of CD4 T&nbsp;cells and 25% of CD8 T&nbsp;cells) (<a id="crosref1310" href="#fig7">Figure&nbsp;7</a>A). <i>KLRB1</i> expression was low in <i>FOXP3</i>-positive T<sub>regs</sub> compared to CD4 T<sub>conv</sub> and CD8 T&nbsp;cells, suggesting that it may primarily restrain the function of effector T&nbsp;cells (<a id="crosref1315" href="#fig7">Figures 7</a>A and <a id="crosref1320" href="#figs7">S7</a>A–S7C) (t test: p&nbsp;&lt;&nbsp;2.2&nbsp;× 10<sup>−16</sup> for lung cancer; p&nbsp;&lt; 2.2&nbsp;× 10<sup>−16</sup> for hepatocellular carcinoma; p&nbsp;= 2.1&nbsp;× 10<sup>−9</sup> for colorectal cancer; T<sub>reg</sub> annotation unavailable for melanoma). Most <i>KLRB1</i>-positive T&nbsp;cells in liver and colorectal cancers did not express Th17 cell markers (<a id="crosref1325" href="#figs7">Figures S7</a>D and S7E), and only few MAIT cells were detected in either cancer type (<a id="crosref1330" href="#figs7">Figures S7</a>F and S7G). Notably, although <i>KLRB1</i> was expressed in both melanoma and diffuse gliomas, it was among the top 10 genes that were more highly expressed in diffuse gliomas versus melanoma-infiltrating CD8 and CD4 T&nbsp;cells (<a id="crosref1335" href="#fig7">Figures 7</a>B and <a id="crosref1340" href="#figs7">S7</a>H; <a id="crosref1345" href="#sec-4">STAR methods</a>) (t test: p&nbsp;= 7.5<sup>∗</sup>10<sup>−102</sup>).</div><div class="figure-wrap"><figure id="fig7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/230aa888-d306-4307-829c-e2f9221bb84b/main.assets/gr7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr7" src="/cms/10.1016/j.cell.2021.01.022/asset/98a5620c-9176-42ea-b863-ee510bc01a88/main.assets/gr7.jpg" height="934" width="759" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/230aa888-d306-4307-829c-e2f9221bb84b/main.assets/gr7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;7</span> <span class="figure__title__text">Identification of a T&nbsp;cell <i>KLRB1</i> program across multiple cancer types</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0280" role="paragraph">(A) t-Distributed stochastic neighbor embedding (t-SNE) visualization showing expression of key genes in T&nbsp;cells isolated from lung adenocarcinoma. Gene expression is given in units of ln(TP100K+1).</div><div id="fspara0285" role="paragraph">(B) Averaged expression of genes in tumor-infiltrating T&nbsp;cells (TILs) in GBM&nbsp;+ IDH-G (y axis) versus melanoma (x axis). The inset lists the genes with the greatest log2 fold change.</div><div id="fspara0290" role="paragraph">(C and D) Overlap of <i>KLRB1</i> transcriptional programs in CD8 T&nbsp;cells (left) and CD4 T&nbsp;cells (right) between the different pairs of cancer datasets. The p values (C) and observed versus expected ratio (D) express the significance (hypergeometric test) and magnitude of the overlap between genes in the <i>KLRB1</i> transcriptional programs from the different cancers. The Melanoma1 and Melanoma2 datasets refer to two separate melanoma scRNA-seq studies (<span class="dropBlock reference-citations"><a id="body-ref-sref21-2" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21-2" aria-controls="sref21-2">Jerby-Arnon et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref21-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Jerby-Arnon, L. ∙ Shah, P. ∙ Cuoco, M.S. ...</div><div><strong>A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade</strong></div><div><em>Cell.</em> 2018; <strong>175</strong>:984-997.e24</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.09.006&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.09.006&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85055549585" target="_blank" aria-label="Open Scopus in new tab">Scopus (793)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30388455/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.09.006&amp;pmid=30388455" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref48-1" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-1" aria-controls="sref48-1">Sade-Feldman et al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref48-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Sade-Feldman, M. ∙ Yizhak, K. ∙ Bjorgaard, S.L. ...</div><div><strong>Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma</strong></div><div><em>Cell.</em> 2018; <strong>175</strong>:998-1013.e20</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.10.038&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.10.038&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85055560004" target="_blank" aria-label="Open Scopus in new tab">Scopus (1075)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30388456/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.10.038&amp;pmid=30388456" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="fspara0295" role="paragraph">(E) Heatmap showing the expression of all genes for the pan-cancer <i>KLRB1</i> program. This pan-cancer <i>KLRB1</i> program was defined based on overlap in the individual <i>KLRB1</i> programs from six scRNA-seq cancer datasets. Gene expression of the pan-cancer program is shown for CD4 and CD8 T&nbsp;cells from the gliomas in this study (GBM and IDH-G), and T&nbsp;cells are further divided into <i>KLRB1</i>-expressing and <i>KLRB1</i>-non-expressing cells. Gene expression is zero-centered, and given in units of ln(TP100K+1).</div><div id="fspara0300" role="paragraph">See also <a id="crosref1725" href="#figs7">Figure&nbsp;S7</a> and <a id="crosref1730" href="#mmc5">Tables S5</a> and <a id="crosref1735" href="#mmc6">S6</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.01.022/asset/c030e331-814f-4cf8-9405-058233c5a6a3/main.assets/figs7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs7" src="/cms/10.1016/j.cell.2021.01.022/asset/4b3058fb-8413-46da-89cb-1761a6acb1b0/main.assets/figs7.jpg" height="949" width="743" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/c030e331-814f-4cf8-9405-058233c5a6a3/main.assets/figs7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S7</span> <span class="figure__title__text">T cell <i>KLRB1</i> program across multiple cancer types, related to <a id="crosref1865" href="#fig7">Figure&nbsp;7</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0370" role="paragraph">(A-C) t-SNE visualization of gene expression by T&nbsp;cells from three cancer types, colored by expression of T&nbsp;cell marker genes (<i>CD3D</i>, <i>CD4</i>, <i>CD8A,</i> and <i>FOXP3</i>) as well as <i>KLRB1</i> and <i>PDCD1</i> genes. Cancers include melanoma (A), liver cancer (B), and colorectal cancer (C). (D-E) t-SNE visualizations of tumor-infiltrating T&nbsp;cells showing low expression of signature genes for Th17 cells (<i>RORC, IL17A,</i> and <i>IL17F</i>) in liver cancer (D) and colorectal cancer (E). Gene expression is given in units of ln(TP100K+1) for (A-E). (F-G) t-SNE visualization of T&nbsp;cells from liver cancer (F) and colorectal cancer (G) colored by the authors’ annotations of T&nbsp;cell subsets (<span class="dropBlock reference-citations"><a id="body-ref-sref61-2" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61-2" aria-controls="sref61-2">Zheng et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref61-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Zheng, C. ∙ Zheng, L. ∙ Yoo, J.K. ...</div><div><strong>Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:1342-1356.e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2017.05.035&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2017.05.035&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85020894317" target="_blank" aria-label="Open Scopus in new tab">Scopus (1381)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28622514/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.05.035&amp;pmid=28622514" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref59-2" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-2" aria-controls="sref59-2">Zhang et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref59-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Zhang, L. ∙ Yu, X. ∙ Zheng, L. ...</div><div><strong>Lineage tracking reveals dynamic relationships of T&nbsp;cells in colorectal cancer</strong></div><div><em>Nature.</em> 2018; <strong>564</strong>:268-272</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0694-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85058518221" target="_blank" aria-label="Open Scopus in new tab">Scopus (694)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30479382/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0694-x&amp;pmid=30479382" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). MAIT cells represented 4% of T&nbsp;cells in liver cancer and 1% in colorectal cancer. The ‘unknown’ T&nbsp;cell subset in liver cancer is based on the author’s annotation. (H) Averaged expression of genes in tumor-infiltrating T&nbsp;cells in GBM&nbsp;+ IDH-G (y axis) versus melanoma (x axis) shown for CD8 T&nbsp;cells (left) and CD4 T&nbsp;cells (right). The insets list selected genes that were expressed at a higher level in gliomas (up) compared to melanoma; expression is log2 fold change. (I) Correlation of expression between <i>KLRB1</i> and genes encoding IL-18 receptor subunits (<i>IL18R1</i>, <i>IL18RAP</i>). The correlation between <i>KLRB1</i> and <i>IL18R1</i> was 0.12 (p&nbsp;&lt; 1e-15) and the correlation between <i>KLRB1</i> and <i>IL18RAP</i> was 0.19 (p&nbsp;&lt; 1e-15). Gene-gene correlations in single cell RNA-seq data are often lower due to technical dropout effects.</div></div></div></div></figcaption></figure></div><div id="p0110" role="paragraph">We next investigated whether the <i>KLRB1</i> transcriptional program we originally detected in glioma-infiltrating T&nbsp;cells generalized to other cancer types. Each <i>KLRB1</i> transcriptional program consisted of those genes whose expression was significantly greater (t test) (<a id="crosref1350" href="#sec-4">STAR methods</a>) in <i>KLRB1</i><sup>+</sup> T&nbsp;cells compared to <i>KLRB1</i><sup>−</sup> T&nbsp;cells in a tumor type. There was extensive and significant overlap in the <i>KLRB1</i> transcriptional programs from each of the five analyzed cancer types (<a id="crosref1355" href="#fig7">Figures 7</a>C and 7D; <a id="crosref1360" href="#mmc5">Table S5</a>), and we used this overlap to define a pan-cancer <i>KLRB1</i> program in both CD8 and CD4 T&nbsp;cells (<a id="crosref1365" href="#fig7">Figure&nbsp;7</a>E; <a id="crosref1370" href="#sec-4">STAR methods</a>). The CD8 T&nbsp;cell pan-cancer <i>KLRB1</i> program included several other NK cell genes (<i>KLRD1</i>, <i>KLRF1</i>, <i>TYROBP</i>, <i>ZBTB16</i>, and <i>CD96</i>) (<a id="crosref1375" href="#fig7">Figure&nbsp;7</a>E). CD96 was previously shown to act as an inhibitory receptor for NK cells, and its CD155 ligand (<i>PVR</i> gene) was expressed by malignant cells in GBM (<a id="crosref1380" href="#fig4">Figure&nbsp;4</a>A) and other cancer types (<span class="dropBlock reference-citations"><a id="body-ref-sref5" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5" aria-controls="sref5">Chan et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Chan, C.J. ∙ Martinet, L. ∙ Gilfillan, S. ...</div><div><strong>The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions</strong></div><div><em>Nat. Immunol.</em> 2014; <strong>15</strong>:431-438</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ni.2850" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84899099175" target="_blank" aria-label="Open Scopus in new tab">Scopus (374)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24658051/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fni.2850&amp;pmid=24658051" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref11" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11" aria-controls="sref11">Gao et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Gao, J. ∙ Zheng, Q. ∙ Xin, N. ...</div><div><strong>CD155, an onco-immunologic molecule in human tumors</strong></div><div><em>Cancer Sci.</em> 2017; <strong>108</strong>:1934-1938</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cas.13324" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85027534666" target="_blank" aria-label="Open Scopus in new tab">Scopus (135)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28730595/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcas.13324&amp;pmid=28730595" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). IL-18 is a major pro-inflammatory cytokine that activates NK and CD8 T&nbsp;cells <span class="dropBlock reference-citations"><a id="body-ref-opt0OZ8fupRej" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="opt0OZ8fupRej" aria-controls="opt0OZ8fupRej">(Kaplanski, 2018)</a><div class="dropBlock__holder" data-db-target-of="opt0OZ8fupRej"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Kaplanski, G.</div><div><strong>Interleukin-18: Biological properties and role in disease pathogenesis</strong></div><div><em>Immunol. Rev.</em> 2018; <strong>281</strong>:138-153</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/imr.12616" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85037980848" target="_blank" aria-label="Open Scopus in new tab">Scopus (385)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29247988/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fimr.12616&amp;pmid=29247988" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>. <i>IL18R1</i> and <i>IL18RAP</i>, the two genes encoding the IL-18 receptor, were expressed in <i>KLRB1</i>-expressing T&nbsp;cells in diffuse gliomas (<a id="crosref1395" href="#figs7">Figure&nbsp;S7</a>I). The functional role of these <i>KLRB1</i> signature genes will require further investigation. <i>KLRB1</i>-expressing T&nbsp;cells thus shared transcriptional features with “innate” effector T&nbsp;cells, but did not have a restricted TCR repertoire (<a id="crosref1400" href="#fig4">Figures 4</a>B, <a id="crosref1405" href="#figs4">S4</a>B, and S4C; <span class="dropBlock reference-citations"><a id="body-ref-sref7-2" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7-2" aria-controls="sref7-2">Fergusson et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref7-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Fergusson, J.R. ∙ Smith, K.E. ∙ Fleming, V.M. ...</div><div><strong>CD161 defines a transcriptional and functional phenotype across distinct human T&nbsp;cell lineages</strong></div><div><em>Cell Rep.</em> 2014; <strong>9</strong>:1075-1088</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.celrep.2014.09.045&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.celrep.2014.09.045&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84919777275" target="_blank" aria-label="Open Scopus in new tab">Scopus (215)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25437561/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2014.09.045&amp;pmid=25437561" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0115" role="paragraph">The <i>KLRB1</i> signature included several genes that were previously shown to be upregulated in tissue-resident memory T&nbsp;cells (Trm), including <i>ITGAE</i>, <i>ITGA1</i>, and <i>CXCR6</i>, and Trm were previously identified in human brain (<span class="dropBlock reference-citations"><a id="body-ref-sref51" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51" aria-controls="sref51">Smolders et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref51"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Smolders, J. ∙ Heutinck, K.M. ∙ Fransen, N.L. ...</div><div><strong>Tissue-resident memory T&nbsp;cells populate the human brain</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:4593</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-07053-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85055966401" target="_blank" aria-label="Open Scopus in new tab">Scopus (233)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30389931/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-07053-9&amp;pmid=30389931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, <i>KLRB1</i> expression did not correlate with a signature of genes upregulated in Trm (<span class="dropBlock reference-citations"><a id="body-ref-sref25" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25" aria-controls="sref25">Kumar et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Kumar, B.V. ∙ Ma, W. ∙ Miron, M. ...</div><div><strong>Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites</strong></div><div><em>Cell Rep.</em> 2017; <strong>20</strong>:2921-2934</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.celrep.2017.08.078&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.celrep.2017.08.078&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85029578875" target="_blank" aria-label="Open Scopus in new tab">Scopus (674)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28930685/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2017.08.078&amp;pmid=28930685" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) among glioma-infiltrating CD8 or CD4 T&nbsp;cell clusters (correlation value of &lt;0.1) (<a id="crosref1425" href="#mmc6">Table S6</a>). Our scRNA-seq data showed that <i>KLRB1</i> is&nbsp;expressed in multiple CD8 and CD4 T&nbsp;cell clusters in diffuse gliomas, including clusters with effector, effector memory or memory signatures, and some of these cells may be Trm. Consistent with this interpretation, CD161<sup>+</sup> CD8<sup>+</sup> T&nbsp;cells in the blood (non-MAIT T&nbsp;cells) were previously shown to represent highly functional effector memory T&nbsp;cells with higher cytotoxic potential than their CD161-negative counterparts (<span class="dropBlock reference-citations"><a id="body-ref-sref8" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8" aria-controls="sref8">Fergusson et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Fergusson, J.R. ∙ Hühn, M.H. ∙ Swadling, L. ...</div><div><strong>CD161(int)CD8+ T&nbsp;cells: a novel population of highly functional, memory CD8+ T&nbsp;cells enriched within the gut</strong></div><div><em>Mucosal Immunol.</em> 2016; <strong>9</strong>:401-413</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/mi.2015.69" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84961794382" target="_blank" aria-label="Open Scopus in new tab">Scopus (90)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26220166/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fmi.2015.69&amp;pmid=26220166" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Taken together, these analyses suggest that our observations based on the expression landscape of glioma-infiltrating T&nbsp;cells generalize to other cancer types and define a pan-cancer <i>KLRB1</i> program with additional candidate targets for T&nbsp;cell immunity.</div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0120" role="paragraph">Here, we charted the gene expression landscape of infiltrating T&nbsp;cells in GBM and IDH-G, providing insights into their expression programs and suggesting strategies for enhancing T&nbsp;cell-mediated immunity in diffuse gliomas and other human cancers. The identification of largely similar subsets of T&nbsp;cells across different classes of diffuse gliomas suggests that common strategies could be leveraged for T&nbsp;cell-mediated immunity. The expression program of <i>KLRB1</i>-expressing T&nbsp;cells suggests that these cells represent effectors that share features with innate T&nbsp;cells, despite the fact that they possess a diverse TCR repertoire. CLEC2D, the CD161 ligand, is expressed by both tumor cells and immunosuppressive myeloid cells, thus the CD161 pathway shares certain similarities with the PD-1 pathway. <i>PDCD1</i> or <i>KLRB1</i> mRNAs identified distinct, but partially overlapping, T&nbsp;cell populations. Antibody-mediated inhibition of the CLEC2D-CD161 pathway may provide synergistic therapeutic benefit with PD-1 blockade by enhancing the anti-tumor function of distinct T&nbsp;cell populations. Potential side effects of antibody-mediated blockade of the CLEC2D-CD161 pathway remain unknown and will need to be investigated in a non-human primate model. The significance of these findings may extend beyond diffuse gliomas, as illustrated by expression of <i>KLRB1</i> in tumor-infiltrating T&nbsp;cells from four other common human cancers. Several types of human lymphomas are characterized by high CLEC2D protein levels (<span class="dropBlock reference-citations"><a id="body-ref-sref15" href="#" role="doc-biblioref" data-xml-rid="bib15" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref15" aria-controls="sref15">Germain et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Germain, C. ∙ Guillaudeux, T. ∙ Galsgaard, E.D. ...</div><div><strong>Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin’s lymphomas dampening natural killer cell functions</strong></div><div><em>OncoImmunology.</em> 2015; <strong>4</strong>:e1026503</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/2162402X.2015.1026503" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84940488391" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26405582/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F2162402X.2015.1026503&amp;pmid=26405582" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref31" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31" aria-controls="sref31">Llibre et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref31"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Llibre, A. ∙ López-Macías, C. ∙ Marafioti, T. ...</div><div><strong>LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation</strong></div><div><em>J.&nbsp;Immunol.</em> 2016; <strong>196</strong>:2085-2094</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.1502462" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84962010443" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26829983/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.1502462&amp;pmid=26829983" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and inhibition of the CLEC2D-CD161 pathway may enhance T&nbsp;cell-mediated immunity against such hematological malignancies.</div><div id="p0125" role="paragraph">Our study highlights the significance of “NK cell” receptors that are expressed by tumor-infiltrating T&nbsp;cells that possess diverse TCR repertoires. We hypothesize that expression of these NK cell receptors is induced in T&nbsp;cells by inflammatory mediators in the tumor microenvironment. In celiac disease, tissue-infiltrating T&nbsp;cells were previously shown to express several NK cell receptors (<span class="dropBlock reference-citations"><a id="body-ref-sref34" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34" aria-controls="sref34">Meresse et&nbsp;al., 2006</a><div class="dropBlock__holder" data-db-target-of="sref34"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Meresse, B. ∙ Curran, S.A. ∙ Ciszewski, C. ...</div><div><strong>Reprogramming of CTLs into natural killer-like cells in celiac disease</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2006; <strong>203</strong>:1343-1355</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20060028" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-33646675580" target="_blank" aria-label="Open Scopus in new tab">Scopus (244)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16682498/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20060028&amp;pmid=16682498" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), including the NKG2C receptor that we also identified on glioma-infiltrating T&nbsp;cells. Inhibitory and activating NK cell receptors expressed by tumor-infiltrating T&nbsp;cells may offer opportunities for enhancing the efficacy of immunotherapy in diffuse gliomas and other malignancies.</div></section><section id="sec-4"><h2>STAR★methods</h2><section id="sec-4-1"><h3>KEY RESOURCES TABLE</h3><div id="p0130" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Antibodies</b></td></tr><tr><td>Anti-human CD45-BV605, (clone HI30)</td><td>BD Bioscience</td><td>Cat#563879; RRID:<a id="intref0010" href="https://antibodyregistry.org/AB_2744402" target="_blank">AB_2744402</a></td></tr><tr><td>Anti-human CD3-BV510, (clone HIT3a)</td><td>BD Bioscience</td><td>Cat# 564713, RRID:<a id="intref0015" href="https://antibodyregistry.org/AB_2738909" target="_blank">AB_2738909</a></td></tr><tr><td>Anti-human PD-1 (CD279)-PE, (clone MIH4)</td><td>BD Bioscience</td><td>Cat# 557946, RRID:<a id="intref0020" href="https://antibodyregistry.org/AB_647199" target="_blank">AB_647199</a></td></tr><tr><td>Anti-human CD161-BV421, (clone DX12)</td><td>BD Bioscience</td><td>Cat# 562615, RRID:<a id="intref0025" href="https://antibodyregistry.org/AB_2737678" target="_blank">AB_2737678</a></td></tr><tr><td>Anti-human CD45-VioBlue, (clone REA747)</td><td>Miltenyi Biotec</td><td>Cat# 130-110-775; RRID: <a id="intref0030" href="https://antibodyregistry.org/AB_2658242" target="_blank">AB_2658242</a></td></tr><tr><td>Anti-human CD3-PE, (clone BW264/56)</td><td>Miltenyi Biotec</td><td>Cat# 130-113-691; RRID: <a id="intref0035" href="https://antibodyregistry.org/AB_2726232" target="_blank">AB_2726232</a></td></tr><tr><td>Anti-human CD14-APC, (clone 63D3)</td><td>Biolegend</td><td>Cat# 367118, RRID:<a id="intref0040" href="https://antibodyregistry.org/AB_2566792" target="_blank">AB_2566792</a></td></tr><tr><td>Anti-human CD64-APC, (clone 10.1)</td><td>Biolegend</td><td>Cat# 305014, RRID:<a id="intref0045" href="https://antibodyregistry.org/AB_1595428" target="_blank">AB_1595428</a></td></tr><tr><td>Anti-human CD163-APC, (clone GHI/61)</td><td>Biolegend</td><td>Cat# 333610, RRID:<a id="intref0050" href="https://antibodyregistry.org/AB_2074533" target="_blank">AB_2074533</a></td></tr><tr><td>Anti-human CD15-APC, (clone HI98)</td><td>Biolegend</td><td>Cat# 301908, RRID:<a id="intref0055" href="https://antibodyregistry.org/AB_314200" target="_blank">AB_314200</a></td></tr><tr><td>Anti-human CD66b-APC, (clone G10F5)</td><td>ThermoFisher Scientific</td><td>Cat# 17-0666-42, RRID:<a id="intref0060" href="https://antibodyregistry.org/AB_2573152" target="_blank">AB_2573152</a></td></tr><tr><td>Anti-human CD45-PacificBlue, (clone HI30)</td><td>BioLegend</td><td>Cat# 304029, RRID:<a id="intref0065" href="https://antibodyregistry.org/AB_2174123" target="_blank">AB_2174123</a></td></tr><tr><td>Anti-human CD8ɑ-AlexaFluor488 (clone HIT8a)</td><td>BioLegend</td><td>Cat# 300916, RRID:<a id="intref0070" href="https://antibodyregistry.org/AB_756152" target="_blank">AB_756152</a></td></tr><tr><td>Anti-human CD4-AlexaFluor700, (clone OKT4)</td><td>BioLegend</td><td>Cat# 317426, RRID:<a id="intref0075" href="https://antibodyregistry.org/AB_571943" target="_blank">AB_571943</a></td></tr><tr><td>Anti-human CD16-BV570, (clone 3G8)</td><td>BioLegend</td><td>Cat# 302036, RRID:<a id="intref0080" href="https://antibodyregistry.org/AB_2632790" target="_blank">AB_2632790</a></td></tr><tr><td>Anti-human CD25-BV605, (clone BC96)</td><td>BioLegend</td><td>Cat# 302632, RRID:<a id="intref0085" href="https://antibodyregistry.org/AB_11218989" target="_blank">AB_11218989</a></td></tr><tr><td>Anti-human TIGIT-PE/Cy7, (clone A15153G)</td><td>BioLegend</td><td>Cat# 372714, RRID:<a id="intref0090" href="https://antibodyregistry.org/AB_2632929" target="_blank">AB_2632929</a></td></tr><tr><td>Anti-human CD279 (PD-1)-APC, (clone EH12.2H7)</td><td>BioLegend</td><td>Cat# 329908, RRID:<a id="intref0095" href="https://antibodyregistry.org/AB_940475" target="_blank">AB_940475</a></td></tr><tr><td>Anti-human CD56-PerCP/eFluor710, (clone CMSSB)</td><td>Invitrogen</td><td>Cat# 46-0567-42, RRID:<a id="intref0100" href="https://antibodyregistry.org/AB_10548939" target="_blank">AB_10548939</a></td></tr><tr><td>Anti-human NKG2C-PE, (clone REA205)</td><td>Miltenyi Biotec</td><td>Cat# 130-119-776, RRID:<a id="intref0105" href="https://antibodyregistry.org/AB_2751835" target="_blank">AB_2751835</a></td></tr><tr><td>Anti-human NKp80-AlexaFluor750, (clone 239127)</td><td>R&amp;D systems</td><td>Cat# FAB1900P, RRID:<a id="intref0110" href="https://antibodyregistry.org/AB_2249693" target="_blank">AB_2249693</a></td></tr><tr><td>Anti-human CD161-PerCP/Cy5.5, (clone HP-3G10)</td><td>eBioscience</td><td>Cat# 45-1619-42, RRID:<a id="intref0115" href="https://antibodyregistry.org/AB_1311148" target="_blank">AB_1311148</a></td></tr><tr><td>Anti-human TCR V⍺7.2-BV786, (clone 3C10)</td><td>BioLegend</td><td>Cat# 351722, RRID:<a id="intref0120" href="https://antibodyregistry.org/AB_2566042" target="_blank">AB_2566042</a></td></tr><tr><td>Anti-human CD45-APC/Cy7, (clone HI30)</td><td>BioLegend</td><td>Cat# 304014, RRID:<a id="intref0125" href="https://antibodyregistry.org/AB_314402" target="_blank">AB_314402</a></td></tr><tr><td>Anti-human CD8a-BV650, (clone RPA-T8)</td><td>BioLegend</td><td>Cat# 301042, RRID:<a id="intref0130" href="https://antibodyregistry.org/AB_2563505" target="_blank">AB_2563505</a></td></tr><tr><td>Anti-human CD69-BV421, (clone FN50)</td><td>BioLegend</td><td>Cat# 310930, RRID:<a id="intref0135" href="https://antibodyregistry.org/AB_2561909" target="_blank">AB_2561909</a></td></tr><tr><td>Anti-human CD25-BV785, (clone BC96)</td><td>BioLegend</td><td>Cat# 302638, RRID:<a id="intref0140" href="https://antibodyregistry.org/AB_2563808" target="_blank">AB_2563808</a></td></tr><tr><td>Anti-human CD107a-PE, (clone H4A3)</td><td>BioLegend</td><td>Cat# 328608, RRID:<a id="intref0145" href="https://antibodyregistry.org/AB_1186040" target="_blank">AB_1186040</a></td></tr><tr><td>Anti-human PD-1-PE/Dazzle594, (clone EH12.2H7)</td><td>BioLegend</td><td>Cat# 329940, RRID:<a id="intref0150" href="https://antibodyregistry.org/AB_2563659" target="_blank">AB_2563659</a></td></tr><tr><td>Anti-human CD4-APC/Cy7, (clone OKT4)</td><td>BioLegend</td><td>Cat# 317418, RRID:<a id="intref0155" href="https://antibodyregistry.org/AB_571947" target="_blank">AB_571947</a></td></tr><tr><td>Anti-human Perforin-PE, (clone B-D48)</td><td>BioLegend</td><td>Cat# 353304, RRID:<a id="intref0160" href="https://antibodyregistry.org/AB_2616860" target="_blank">AB_2616860</a></td></tr><tr><td>Anti-human GranzymeB-AlexaFluor647, (clone GB11)</td><td>BioLegend</td><td>Cat# 515406, RRID:<a id="intref0165" href="https://antibodyregistry.org/AB_2566333" target="_blank">AB_2566333</a></td></tr><tr><td>Anti-human IL-2-FITC, (clone MQ1-17H12)</td><td>BioLegend</td><td>Cat# 500304, RRID:<a id="intref0170" href="https://antibodyregistry.org/AB_315091" target="_blank">AB_315091</a></td></tr><tr><td>Anti-human IFNg-BV711, (clone 4S.B3)</td><td>BioLegend</td><td>Cat# 502540, RRID:<a id="intref0175" href="https://antibodyregistry.org/AB_2563506" target="_blank">AB_2563506</a></td></tr><tr><td>Anti-human TNFɑ-PE/Cy7, (clone MAb11)</td><td>BioLegend</td><td>Cat# 502930, RRID:<a id="intref0180" href="https://antibodyregistry.org/AB_2204079" target="_blank">AB_2204079</a></td></tr><tr><td>Anti-human LAG-3-FITC, (clone 11C3C65)</td><td>BioLegend</td><td>Cat# 369308, RRID:<a id="intref0185" href="https://antibodyregistry.org/AB_2629751" target="_blank">AB_2629751</a></td></tr><tr><td>Anti-human CTLA-4-PE/Cy7, (clone L3D10)</td><td>BioLegend</td><td>Cat# 349914, RRID:<a id="intref0190" href="https://antibodyregistry.org/AB_2563098" target="_blank">AB_2563098</a></td></tr><tr><td>Anti-human TIM-3-BV785, (clone F38-2E2)</td><td>BioLegend</td><td>Cat# 345032, RRID:<a id="intref0195" href="https://antibodyregistry.org/AB_2565833" target="_blank">AB_2565833</a></td></tr><tr><td>Anti-human TIGIT-PE, (clone A15153G)</td><td>BioLegend</td><td>Cat# 372704, RRID:<a id="intref0200" href="https://antibodyregistry.org/AB_2632730" target="_blank">AB_2632730</a></td></tr><tr><td>Anti-human PD-1-PE/Dazzle594, (clone EH12.2H7)</td><td>BioLegend</td><td>Cat# 329940, RRID:<a id="intref0205" href="https://antibodyregistry.org/AB_2563659" target="_blank">AB_2563659</a></td></tr><tr><td>Anti-human CD3-BV510, (clone UCHT1)</td><td>BioLegend</td><td>Cat# 300448, RRID:<a id="intref0210" href="https://antibodyregistry.org/AB_2563468" target="_blank">AB_2563468</a></td></tr><tr><td>Anti-human CD8-PerCP/Cy5.5, (clone HIT8a)</td><td>BioLegend</td><td>Cat# 300924, RRID:<a id="intref0215" href="https://antibodyregistry.org/AB_1575074" target="_blank">AB_1575074</a></td></tr><tr><td>Rat Anti-HA High Affinity</td><td>Roche</td><td>Cat# 11867431001, RRID:<a id="intref0220" href="https://antibodyregistry.org/AB_390919" target="_blank">AB_390919</a></td></tr><tr><td>Purified anti-human CD161, (clone HP-3G10)</td><td>BioLegend</td><td>Cat# 339902, RRID:<a id="intref0225" href="https://antibodyregistry.org/AB_1501090" target="_blank">AB_1501090</a></td></tr><tr><td>Purified Mouse IgG1, κ Isotype Control</td><td>BioLegend</td><td>Cat# 401402, RRID:<a id="intref0230" href="https://antibodyregistry.org/AB_2801451" target="_blank">AB_2801451</a></td></tr><tr><td>Human TruStain FcX</td><td>BioLegend</td><td>Cat# 422302, RRID:<a id="intref0235" href="https://antibodyregistry.org/AB_2818986" target="_blank">AB_2818986</a></td></tr><tr><td>Anti-mouse CD3-PE/Cy7, (clone 17A2)</td><td>BioLegend</td><td>Cat# 100220, RRID:<a id="intref0240" href="https://antibodyregistry.org/AB_1732057" target="_blank">AB_1732057</a></td></tr><tr><td>Anti-mouse CD45-AlexaFluor 700, (clone 30-F11)</td><td>BioLegend</td><td>Cat# 103128, RRID:<a id="intref0245" href="https://antibodyregistry.org/AB_493715" target="_blank">AB_493715</a></td></tr><tr><td>Anti-mouse NK1.1-Brilliant Violet 510, (clone PK136)</td><td>BioLegend</td><td>Cat# 108738, RRID:<a id="intref0250" href="https://antibodyregistry.org/AB_2562217" target="_blank">AB_2562217</a></td></tr><tr><td>Anti-mouse CD4-Brilliant Violet 650, (clone GK1.5)</td><td>BioLegend</td><td>Cat# 100469, RRID:<a id="intref0255" href="https://antibodyregistry.org/AB_2783035" target="_blank">AB_2783035</a></td></tr><tr><td>Anti-mouse CD8a-Brilliant Violet 785, (clone 53-6.7)</td><td>BioLegend</td><td>Cat# 100750, RRID:<a id="intref0260" href="https://antibodyregistry.org/AB_2562610" target="_blank">AB_2562610</a></td></tr><tr><td>Anti-mouse I-A/I-E-AlexaFluor 647, (clone M5/14.15.2)</td><td>BioLegend</td><td>Cat# 107618, RRID:<a id="intref0265" href="https://antibodyregistry.org/AB_493525" target="_blank">AB_493525</a></td></tr><tr class="rowsep"><td>Anti-mouse TruStain FcX</td><td>BioLegend</td><td>Cat# 101320, RRID:<a id="intref0270" href="https://antibodyregistry.org/AB_1574975" target="_blank">AB_1574975</a></td></tr><tr class="rowsep"><td colspan="3"><b>Biological samples</b></td></tr><tr class="rowsep"><td>Fresh glioma specimens were obtained following informed consent for IRB approved studies</td><td>Brigham and Women’s Hospital/Dana-Farber Cancer Institute, Massachusetts General Hospital</td><td>IRB# DF/HCC 10-417, 16-557</td></tr><tr class="rowsep"><td colspan="3"><b>Chemicals, peptides, and recombinant proteins</b></td></tr><tr><td>Zombie NIR</td><td>Biolegend</td><td>Cat# 423106</td></tr><tr><td>Calcein, AM</td><td>Life Technologies</td><td>Cat# C3100MP</td></tr><tr><td>Zombie UV</td><td>Biolegend</td><td>Cat# 423108</td></tr><tr><td>DELFIA Enhancement Solution</td><td>Perkin-Elmer</td><td>Cat# 1244-111</td></tr><tr><td>CLEC2D-Ig Fusion Protein</td><td>This paper</td><td>N/A</td></tr><tr><td>CD161-Ig Fusion Protein</td><td>This paper</td><td>N/A</td></tr><tr><td>Cas9-NLS Purified Protein</td><td>QB3 Macrolabs</td><td>N/A</td></tr><tr><td>DELFIA Eu-N1 Streptavidin</td><td>Perkin Elmer</td><td>Cat# 1244-360</td></tr><tr><td>Recombinant Human IL-2</td><td>PeproTech</td><td>Cat# 200-02</td></tr><tr><td>Buffer TCL</td><td>QIAGEN</td><td>Cat# 1031576</td></tr><tr><td>Bovine Serum Albumin</td><td>Sigma Aldrich</td><td>Cat# A3059</td></tr><tr><td>TO-PRO-3 Iodide</td><td>Invitrogen</td><td>Cat# T3605</td></tr><tr><td>Maxima H Minus Reverse Transcriptase</td><td>Thermo Scientific</td><td>Cat# EP0753</td></tr><tr><td>KAPA HiFi HotStart ReadyMix</td><td>Roche</td><td>Cat# KK2602</td></tr><tr><td>dNTP Mix (10&nbsp;mM each)</td><td>Thermo Scientific</td><td>Cat# R0192</td></tr><tr><td>Recombinant RNase Inhibitor</td><td>Takara</td><td>Cat# 2313B</td></tr><tr><td>D-(+)-Trehalose Solution, 1M</td><td>LifeSciences</td><td>Cat# TS1M-100</td></tr><tr><td>Magnesium chloride 1M</td><td>Invitrogen</td><td>Cat# AM9530G</td></tr><tr><td>RNAscope Hydrogen Peroxide</td><td>ACDbio</td><td>Cat# 322335</td></tr><tr><td>RNAscope Target Retrieval Reagent</td><td>ACDbio</td><td>Cat# 322000</td></tr><tr><td>RNAscope Protease Plus</td><td>ACDbio</td><td>Cat# 322331</td></tr><tr><td>2-Mercaptoethanol</td><td>Sigma-Aldrich</td><td>Cat# M6250</td></tr><tr class="rowsep"><td>VECTASHIELD Antifade Mounting Medium</td><td>Vectorlabs</td><td>Cat# H-1000 RRID: <a id="intref0275" href="https://antibodyregistry.org/AB_2336789" target="_blank">AB_2336789</a></td></tr><tr class="rowsep"><td colspan="3"><b>Critical commercial assays</b></td></tr><tr><td>Brain Tumor Dissociation Kit (P)</td><td>Miltenyi</td><td>Cat# 130-095-942</td></tr><tr><td>Agencourt RNAClean XP</td><td>Beckman Coulter</td><td>Cat# A66514</td></tr><tr><td>Agencourt AMPure XP</td><td>Beckman Coulter</td><td>Cat# A63882</td></tr><tr><td>Nextera XT DNA Library Preparation Kit (96 samples)</td><td>Illumina</td><td>Cat# FC-131-1096</td></tr><tr><td>NextSeq 500/550 High Output Kit v2.5 (75 Cycles)</td><td>Illumina</td><td>Cat# 20024906</td></tr><tr><td>Bioanalyzer High Sensitivity DNA Analysis</td><td>Agilent</td><td>Cat# 5067-4626</td></tr><tr><td>Qubit dsDNA HS Assay kit</td><td>Invitrogen</td><td>Cat# Q32854</td></tr><tr><td>RNAscope 2.5 HD Duplex Detection Kit</td><td>ACDbio</td><td>Cat# 322430</td></tr><tr><td>Human T&nbsp;cell isolation kit</td><td>EasySep</td><td>Cat# 17951</td></tr><tr><td>P3 Primary Cell 96-well Nucleofector Kit</td><td>Lonza</td><td>Cat# V4SP-3096</td></tr><tr><td>ELISA MAX Deluxe Human IL-2</td><td>BioLegend</td><td>Cat# 431804</td></tr><tr><td>ELISA MAX Deluxe Human IFN-γ</td><td>BioLegend</td><td>Cat# 430104</td></tr><tr><td>High Sensitivity D5000 ScreenTape</td><td>Agilent</td><td>Cat# 5067-5592</td></tr><tr><td>High Sensitivity D5000 Reagents</td><td>Agilent</td><td>Cat# 5067-5593</td></tr><tr><td>High Sensitivity D1000 ScreenTape</td><td>Agilent</td><td>Cat# 5067-5584</td></tr><tr><td>High Sensitivity D1000 Reagents</td><td>Agilent</td><td>Cat# 5067-5585</td></tr><tr><td>10X Chromium Single Cell 50 Library &amp; Gel Bead Kit</td><td>10X Genomics</td><td>Cat# 1000006</td></tr><tr><td>10X Chromium Single Cell A Chip Kit</td><td>10X Genomics</td><td>Cat# 1000009</td></tr><tr><td>10X Chromium Single Cell V(D)J Enrichment Kit, Human T Cell</td><td>10X Genomics</td><td>Cat# 1000005</td></tr><tr class="rowsep"><td>10X Chromium Single Cell 50 Library Construction Kit</td><td>10X Genomics</td><td>Cat# 1000020</td></tr><tr class="rowsep"><td colspan="3"><b>Deposited data</b></td></tr><tr><td>Processed single-cell RNA-sequencing data</td><td>Gene Expression Omnibus</td><td>GEO: <a id="intref0280" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163108" target="_blank">GSE163108</a> <a id="intref0285" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163108" target="_blank">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163108</a></td></tr><tr class="rowsep"><td>Raw single-cell RNA-sequencing data</td><td>Broad Institute Single-Cell Portal</td><td><a id="intref0290" href="https://duos.broadinstitute.org/" target="_blank">https://duos.broadinstitute.org/</a></td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: cell lines</b></td></tr><tr><td>Jurkat, Clone E6-1</td><td>ATCC</td><td>Cat# TIB-152, RRID:CVCL_0367</td></tr><tr><td>J.RT3-T3.5</td><td>ATCC</td><td>Cat# TIB-153, RRID:CVCL_1316</td></tr><tr class="rowsep"><td>GL261-luc2</td><td>Perkin Elmer</td><td>RRID:CVCL_X986</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: organisms/strains</b></td></tr><tr><td>Mouse: NOD.Cg-Prkdc&nbsp;&lt; scid &gt; IL2rg&nbsp;&lt; tm1Wjl &gt; /SzJ</td><td>Jackson Labs</td><td>Cat# JAX:005557, RRID:IMSR_JAX:005557</td></tr><tr class="rowsep"><td>Mouse: C57BL/6J</td><td>Jackson Labs</td><td>Cat# JAX:000664, RRID:IMSR_JAX:000664</td></tr><tr class="rowsep"><td colspan="3"><b>Oligonucleotides</b></td></tr><tr><td>CD4 crRNA: (5′-GGCAAGGCCACAATGAACCG-3′)</td><td>This paper; IDT</td><td>N/A</td></tr><tr><td>TRAC crRNA: (5′-TCAGGGTTCTGGATATCTGT-3′)</td><td><span class="dropBlock reference-citations"><a id="body-ref-optlJEeC1dY34" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="optlJEeC1dY34" aria-controls="optlJEeC1dY34">(Eyquem et&nbsp;al., 2017)</a><div class="dropBlock__holder" data-db-target-of="optlJEeC1dY34"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Eyquem, J. ∙ Mansilla-Soto, J. ∙ Giavridis, T. ...</div><div><strong>Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection</strong></div><div><em>Nature.</em> 2017; <strong>543</strong>:113-117</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature21405" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85014564234" target="_blank" aria-label="Open Scopus in new tab">Scopus (1254)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28225754/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature21405&amp;pmid=28225754" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; IDT</td><td>N/A</td></tr><tr><td>KLRB1 region#1 crRNA: (5′-AATTAAAGCCACTTACCCCG-3′)</td><td>This paper; IDT</td><td>N/A</td></tr><tr><td>KLRB1 region#2 crRNA: (5′-TTACCCCGAGGAAGAGATGA-3′)</td><td>This paper; IDT</td><td>N/A</td></tr><tr><td>NY-ESO-1 TCR HDR template</td><td>This paper; Genewiz</td><td>N/A</td></tr><tr><td>Primer: Human GAPDH Forward: (5′-GGAGCGAGATCCCTCCAAAAT-3′)</td><td>This paper</td><td>N/A</td></tr><tr><td>Primer: Human GAPDH Reverse: (5′-GGCTGTTGTCATACTTCTCATGG-3′)</td><td>This paper</td><td>N/A</td></tr><tr><td>Primer: Human CLEC2D Forward: (5′-CTGCCATCAAGAGCCATCAG-3′)</td><td>This paper</td><td>N/A</td></tr><tr><td>Primer: Human CLEC2D Reverse: (5′-TCAGCCCAATCCAGTGATCA-3′)</td><td>This paper</td><td>N/A</td></tr><tr><td>Primer: Oligo(dT) (5′–AAGCAGTGGTATCAACGCAGAGTACTT<br>TTTTTTTTTTTTTTTTTTTTTTTTTTTTVN-3′)</td><td>IDT</td><td>N/A</td></tr><tr><td>Primer: ISPCR (5′-AAGCAGTGGTATCAACGCAGAGT-3′)</td><td>IDT</td><td>N/A</td></tr><tr><td>Primer: HLA-A<sup>∗</sup>02 Forward: (5′-ACCGTCCAGAGGATGTATGG-3′)</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td>Primer: HLA-A<sup>∗</sup>02 Reverse: (5′-CCAGGTAGGCTCTCAACTGC-3′)</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Recombinant DNA</b></td></tr><tr><td>Plasmid: NY-ESO-1 Protein</td><td>This paper</td><td>N/A</td></tr><tr><td>Plasmid: NY-ESO-1 T&nbsp;cell receptor</td><td>This paper</td><td>N/A</td></tr><tr><td>Hs-CD3E</td><td>ACDbio</td><td>Cat# 553971-C2 RRID: N/A</td></tr><tr><td>Hs-KLRB1</td><td>ACDbio</td><td>Cat# 509031 RRID: N/A</td></tr><tr><td>Hs-PTPRC</td><td>ACDbio</td><td>Cat# 601991-C2 RRID: N/A</td></tr><tr><td>Hs-NPM1-X-CLEC2D</td><td>ACDbio</td><td>Cat# 419751 RRID: N/A</td></tr><tr><td>Hs-HSPA6-O1</td><td>ACDbio</td><td>Cat# 837201 RRID: N/A</td></tr><tr><td>Hs-HSPH1</td><td>ACDbio</td><td>Cat# 837191 RRID: N/A</td></tr><tr class="rowsep"><td>Hs-HSPA1A-O1</td><td>ACDbio</td><td>Cat# 837181 RRID: N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Software and algorithms</b></td></tr><tr><td>FlowJo version 10.7.1</td><td>BD</td><td><a id="intref0295" href="https://www.flowjo.com" target="_blank">https://www.flowjo.com</a></td></tr><tr><td>FACSDiva software version 8.0</td><td>BD Bioscience</td><td><a id="intref0300" href="https://www.bdbiosciences.com/en-us" target="_blank">https://www.bdbiosciences.com/en-us</a></td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2821%2900065-9" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Resource availability</h3><section id="sec-4-2-1"><h4>Lead contact</h4><div id="p0135" role="paragraph">Requests for further information should be directed to Kai Wucherpfennig (<a id="intref0305" href="mailto:Kai_Wucherpfennig@dfci.harvard.edu">Kai_Wucherpfennig@dfci.harvard.edu</a>).</div></section><section id="sec-4-2-2"><h4>Materials availability</h4><div id="p0140" role="paragraph">Requests for resources and reagents should be directed to and will be fulfilled by Kai Wucherpfennig (<a id="intref0310" href="mailto:Kai_Wucherpfennig@dfci.harvard.edu">Kai_Wucherpfennig@dfci.harvard.edu</a>).</div></section><section id="sec-4-2-3"><h4>Data and code availability</h4><div id="p0145" role="paragraph">Processed data generated for this study are available at the Gene Expression Omnibus (GEO: <a id="intref0315" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163108" target="_blank">GSE163108</a>; <a id="intref0320" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163108" target="_blank">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163108</a>). Raw scRNA-seq data are deposited in the controlled access respository Data Use Oversight System (DUOS) (<a id="intref0325" href="https://duos.broadinstitute.org/#/hom" target="_blank">https://duos.broadinstitute.org/#/hom</a>). Accession: DUOS000006 via the data catalog&nbsp;(<a id="PC_linkl4K4w5EVXV" href="https://duos.broadinstitute.org/dataset_catalog" target="_blank">https://duos.broadinstitute.org/dataset_catalog</a>). The code supporting the current study is available from M.L.S (<a id="intref0330" href="mailto:Suva.Mario@mgh.harvard.edu">Suva.Mario@mgh.harvard.edu</a>) on request.</div></section></section><section id="sec-4-3"><h3>Experimental model and subject details</h3><section id="sec-4-3-1"><h4>Procurement and processing of primary human glioma samples for scRNA-seq</h4><div id="p0150" role="paragraph">Surgically resected glioma specimens were provided on ice by the Brigham and Women’s Hospital (BWH) and the Massachusetts General Hospital (MGH) Pathology Tissue Banks within 30&nbsp;minutes of lesion excision. Prior to the procedure, all patients provided informed consent for the collection of glioma specimens. Samples were de-identified prior to receipt and acquired under a protocol approved by the Institutional Review Board (DF/HCC 10-417). Subjects included both females and males spanning a range of age from 25-77 years. Clinical characteristics and details of individual patients are provided in (<a id="crosref1450" href="#mmc1">Table S1</a>). To determine sample size estimation, FACS purified T&nbsp;cells were isolated and sequenced, following removal of cells that did not meet quality criteria (73 – 531 cells analyzed per patient for the SmartSeq2 method; 3,424-6,026 cells analyzed per patient for the 10X genomics method). T&nbsp;cells were profiled at scale sufficient to enable statistical power. Tumor specimens from each subject were allocated to experimental groups through the determination of IDH1/2 mutational status and assigned to IDH mutant (IDH-G; 15 cases) or IDH wild-type (GBM; 16 cases) cohorts.</div></section><section id="sec-4-3-2"><h4>Experimental mouse models</h4><div id="p0155" role="paragraph">Healthy, naive female NOD.Cg-Prkdc&nbsp;&lt; scid &gt; IL2rg&nbsp;&lt; tm1Wjl &gt; /SzJ (NSG) mice aged 6-8&nbsp;weeks were purchased from The Jackson Laboratory (Bar Harbor, ME). All mice were housed in specific pathogen free conditions in compliance with all guidelines of the Institutional Care and Use Committee (IACUC) and were subjected to procedures after approval of the Dana-Farber Cancer Institute (DFCI) Animal Care and Use Committee (Protocol: 08-049). Only treatment-naive mice (aged 10-12&nbsp;weeks) were used that had not been part of any previous experimental procedures. Mice were housed together in indicated groups and monitored daily for neurological symptoms indicative of brain tumors (altered gait, seizure, loss of weight, lethargy). Mice were immediately euthanized upon reaching pre-determined clinical endpoints and when recommend by veterinary staff of the DFCI animal unit. All mice were purchased (no mice were bred) for this study.</div></section><section id="sec-4-3-3"><h4>Patient-derived and cell line tumor models</h4><div id="p0160" role="paragraph">Patient derived glioblastoma neurosphere cells MGG123 (recurrent GBM) (<span class="dropBlock reference-citations"><a id="body-ref-sref38-2" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38-2" aria-controls="sref38-2">Nigim et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref38-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Nigim, F. ∙ Cavanaugh, J. ∙ Patel, A.P. ...</div><div><strong>Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment</strong></div><div><em>J.&nbsp;Neuropathol. Exp. Neurol.</em> 2015; <strong>74</strong>:710-722</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/NEN.0000000000000210" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84934343090" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26083570/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FNEN.0000000000000210&amp;pmid=26083570" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), MGG75 (newly diagnosed GBM) (<span class="dropBlock reference-citations"><a id="body-ref-sref20" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20" aria-controls="sref20">Higuchi et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Higuchi, F. ∙ Fink, A.L. ∙ Kiyokawa, J. ...</div><div><strong>PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide</strong></div><div><em>Mol. Cancer Ther.</em> 2018; <strong>17</strong>:2551-2563</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1535-7163.MCT-18-0177" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85057628319" target="_blank" aria-label="Open Scopus in new tab">Scopus (31)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30217967/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1535-7163.MCT-18-0177&amp;pmid=30217967" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), D270 (<span class="dropBlock reference-citations"><a id="body-ref-sref13" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13" aria-controls="sref13">Gedeon et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Gedeon, P.C. ∙ Schaller, T.H. ∙ Chitneni, S.K. ...</div><div><strong>A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma</strong></div><div><em>Clin. Cancer Res.</em> 2018; <strong>24</strong>:3611-3631</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-17-0126" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85051238877" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29703821/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-17-0126&amp;pmid=29703821" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and BT142 (IDH-G) were maintained in Neurobasal Medium (Thermo Fisher Scientific) supplemented with 0.5% N-2 and 2% B-27 (Thermo Fisher Scientific), 1% Penicillin/Streptomycin (Thermo Fisher Scientific), 1.5% Glutamax (Thermo Fisher Scientific), 20&nbsp;ng/mL of EGF and 20&nbsp;ng/mL of FGF-2 (Shenandoah Biotechnology) in ultra-low attachment T-25 or T-75 flasks (Corning; Corning, NY). D270 cells were obtained from the laboratory of John Sampson at Duke University (<span class="dropBlock reference-citations"><a id="body-ref-sref35" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35" aria-controls="sref35">Miao et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref35"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Miao, H. ∙ Choi, B.D. ∙ Suryadevara, C.M. ...</div><div><strong>EGFRvIII-specific chimeric antigen receptor T&nbsp;cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma</strong></div><div><em>PLoS ONE.</em> 2014; <strong>9</strong>:e94281</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0094281" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84899523433" target="_blank" aria-label="Open Scopus in new tab">Scopus (98)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24722266/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0094281&amp;pmid=24722266" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). BT142 cells and U-87 MG cells were procured from and authenticated by ATCC (Manassas, VA). All tumor lines were tested monthly for mycoplasma. U-87 MG cells were maintained <i>in&nbsp;vitro</i> with DMEM medium supplemented with 10% FBS, 2&nbsp;mM Glutamax, and 100 units/ml penicillin/streptomycin. All tumor cells were HLA typed to confirm the HLA-A<sup>∗</sup>02:01 genotype. Briefly, genomic DNA was extracted from MGG123, MGG75, BT142, and D270 using the Quick-DNA miniprep kit (Zymo Research; Tustin, CA) and subsequently PCR amplified using the forward primer: ACCGTCCAGAGGATGTATGG and reverse primer: CCAGGTAGGCTCTCAACTGC. The 202bp DNA band was extracted and gel purified using the MinElute gel extraction kit (QIAGEN). Sanger sequencing was performed using the above forward primer and aligned to the HLA-A<sup>∗</sup>02:01 sequence (GenBank: <a id="intref0335" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=GQ996941.1" target="_blank">GQ996941.1</a>). U-87 MG cells were HLA typed by the Tissue Typing Laboratory of Brigham and Women’s Hospital.</div></section></section><section id="sec-4-4"><h3>Method details</h3><section id="sec-4-4-1"><h4>Single-cell isolation from tumor tissue</h4><div id="p0165" role="paragraph">Tumor specimens were mechanically disrupted into small pieces with a disposable, sterile scalpel and further dissociated into single cell suspensions using the enzymatic brain dissociation kit (P) from Miltenyi Biotec (Bergisch Gladbach, Germany) following the manufacturer’s protocol. Fc receptor blocking was performed on the total cell suspension using Human TruStain FcX reagent (Biolegend; San Diego, CA). Cell suspensions were subsequently stained for flow cytometry using antibodies specific for CD45 [HI30]-BV605, CD3 [HIT3a]-BV510, PD-1 (CD279) [MIH4]-PE, CD161 [DX12]-BV421 from BD Bioscience (Franklin Lakes, NJ) (BWH specimens) and CD45 [REA747]-VioBlue, CD3 [BW264/56]-PE from Miltenyi Biotec (Bergisch Gladbach, Germany) (MGH specimens). The exclusion panel included the following APC-labeled mAbs: CD14 [63D3], CD64 [10.1], CD163 [GHI/61], CD15 [HI98] from Biolegend (San Diego, CA), and CD66b [G10F5] ThermoFisher Scientific (Waltham, MA). Tumor cell suspensions were next spiked with 0.5&nbsp;μM Calcein AM (ThermoFisher) to enable gating of live cells and incubated in the dark at room temperature for 10&nbsp;minutes. Live, single T&nbsp;cells (gating: Calcein, AM<sup>+</sup>, Exclusion<sup>-</sup>, CD45<sup>+</sup>, CD3<sup>+</sup>) from all IDHwt-GBM&nbsp;+ IDHmut-gliomas were sorted into individual wells of a 96-well twin.tec PCR plate (Eppendorf; Hamburg, Germany) that contained 10μL/well of RLT buffer (QIAGEN; Venlo, Netherlands), using a BD Biosciences Aria III fluorescence-activated cell sorter (FACS) with a 70μM nozzle. Plates were immediately centrifuged at 800 xg for 1&nbsp;minute at 4°C and frozen on dry ice. For scRNA-seq library construction using the 10X Genomics protocol, 15,000 live, single T&nbsp;cells (gating: Calcein AM<sup>+</sup>, Exclusion<sup>-</sup>, CD45<sup>+</sup>, CD3<sup>+</sup>) were sorted in a 15ml Falcon tube containing 8ml media (RPMI).</div></section><section id="sec-4-4-2"><h4>Preparation of scRNA-seq libraries</h4><div id="p0170" role="paragraph">Single cell cDNA and sequencing libraries were prepared using the SMART-seq2 protocol (<span class="dropBlock reference-citations"><a id="body-ref-sref39-2" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-2" aria-controls="sref39-2">Picelli et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref39-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Picelli, S. ∙ Faridani, O.R. ∙ Björklund, A.K. ...</div><div><strong>Full-length RNA-seq from single cells using Smart-seq2</strong></div><div><em>Nat. Protoc.</em> 2014; <strong>9</strong>:171-181</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nprot.2014.006" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84891677425" target="_blank" aria-label="Open Scopus in new tab">Scopus (2539)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24385147/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnprot.2014.006&amp;pmid=24385147" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) with several adaptations. Agencourt RNAClean beads were used to purify RNA prior to oligo (dT) hybridization. RNase inhibitor was added to the dT annealing step at 1U/μl. Trehalose (1M) was used instead of water to make up the reaction volume. For the reverse transcription step, Maxima RNaseH-minus RT (200&nbsp;U/μl) was used as the RT enzyme at 2U/μl. MgCl<sub>2</sub> was added at 0.01M and DTT was omitted from the reaction. Trehalose (1M) was used to stabilize the reaction rather than betaine. The RT step was performed at 50°C for 90&nbsp;minutes followed by 85°C for 5&nbsp;minutes. In the PCR pre-amplification step, an ISPCR primer was used at 0.2&nbsp;μM and PCR was performed for 21 cycles. PCR purification was performed using AMpure XP beads at 0.8X. Libraries were tagmented and enriched with dual indexes using Illumina Nextera XT Library Prep kits. Libraries from 384 or 768 cells with unique indexes were pooled together and sequenced at 2pM on an Illumina Nextseq 500 sequencer, yielding paired-end 38 base pair reads (<span class="dropBlock reference-citations"><a id="body-ref-sref53-1" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-1" aria-controls="sref53-1">Tirosh et&nbsp;al., 2016a</a><div class="dropBlock__holder" data-db-target-of="sref53-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Tirosh, I. ∙ Izar, B. ∙ Prakadan, S.M. ...</div><div><strong>Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq</strong></div><div><em>Science.</em> 2016; <strong>352</strong>:189-196</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad0501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84963614956" target="_blank" aria-label="Open Scopus in new tab">Scopus (2751)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27124452/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad0501&amp;pmid=27124452" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-3"><h4>Preparation and sequencing of scRNA-seq libraries using 10X Genomics Protocol</h4><div id="p0175" role="paragraph">Gene expression and TCR enriched libraries were prepared as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref32" href="#" role="doc-biblioref" data-xml-rid="bib32" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref32" aria-controls="sref32">Luoma et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Luoma, A.M. ∙ Suo, S. ∙ Williams, H.L. ...</div><div><strong>Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy</strong></div><div><em>Cell.</em> 2020; <strong>182</strong>:655-671.e22</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.06.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.06.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85087986491" target="_blank" aria-label="Open Scopus in new tab">Scopus (266)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32603654/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2020.06.001&amp;pmid=32603654" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, tumor samples were dissociated to generate single cell suspension and stained for FACS, as described above. 15,000 CD45<sup>+</sup>CD3<sup>+</sup> cells were sorted and washed with PBS containing 0.05% RNase-free BSA (ThermoFisher Scientific #AM2616). The isolated cells were loaded into separate channels of a Single Cell Chip A with reverse transcriptase reagent mixture and 5′gel beads according to the manufacturer’s protocol (10X Genomics; Pleasanton, CA). Chips were next loaded into the 10X Genomics Chromium Controller for single-cell partitioning, immediately followed by emulsion recovery from the chip and incubated in a deep-well block Thermocycler (Bio-Rad Laboratories) for the reverse transcription reaction.</div><div id="p0180" role="paragraph">cDNA isolation and library preparation were completed as per the manufacturer’s protocol. Isolated cDNA was amplified (13 cycles). Consecutively, cDNA was allocated for preparation of a gene expression library or TCR enrichment/library preparation with the Chromium Single Cell V(D)J TCR kit (10X Genomics). The quality of the cDNA and library was evaluated using the D5000 and D1000 high-sensitivity kits on a 2200 TapeStation system (Agilent; Santa Clara, CA). T&nbsp;cell gene expression libraries and TCR V(D)J libraries were sequenced on the Illumina HiSeq platform with 150&nbsp;bp paired-end read configuration. For gene expression libraries 20,000 reads per cell and for TCR enriched libraries 5,000 reads per cell were obtained, respectively.</div></section><section id="sec-4-4-4"><h4>RNA <i>in situ</i> hybridization</h4><div id="p0185" role="paragraph">Paraffin-embedded tissue sections from human tumors from Massachusetts General Hospital were obtained according to Institutional Review Board-approved protocols (DF/HCC 10-417). Sections were mounted on glass slides and stored at −80°C. Slides were stained using the RNAscope 2.5 HD Duplex Detection Kit (Advanced Cell Diagnostics, Cat. No. 322430). Slides were baked for 1&nbsp;h at 60°C, deparaffinized and dehydrated with xylene and ethanol. The tissue was pretreated with RNAscope Hydrogen Peroxide (Cat. No. 322335) for 10&nbsp;min at room temperature and RNAscope Target Retrieval Reagent (Cat. No. 322000) for 15&nbsp;min at 98°C. RNAscope Protease Plus (Cat. No. 322331) was then applied to the tissue for 30&nbsp;min at 40°C. Hybridization probes were prepared by diluting the C2 probe (red) 1:40 into the C1 probe (green). Advanced Cell Technologies RNAscope Target Probes used included Hs-CD3E (Cat. No. 553971-C2), Hs-KLRB1 (Cat. No. 509031), Hs- Hs-PTPRC (Cat. No. 601991-C2), Hs-NPM1-X-CLEC2D (Cat. No. 419751). Probes were added to the tissue and hybridized for 2&nbsp;h at 40°C. A series of 10 amplification steps were performed using instructions and reagents provided in the RNAscope 2.5 HD Duplex Detection Kit. Tissue was counterstained with Gill’s hematoxylin for 25&nbsp;s at room temperature followed by mounting with VectaMount media (Vector Laboratories).</div></section><section id="sec-4-4-5"><h4>Analysis of NK cell receptors on T&nbsp;cells from primary human GBM specimens</h4><div id="p0190" role="paragraph">GBM tissue was dissociated into a single cell suspension as described above. Next, Fc receptors were blocked with Human TruStain FcX (Biolegend), and cells were subsequently stained with CD45 [HI30]-PacificBlue, CD8ɑ [HIT8a]-AlexaFluor488, CD4 [OKT4]-AlexaFluor700,&nbsp;CD16 [3G8]-BV570, CD25 [BC96]-BV605, TIGIT [A15153G]-PE/Cy7, CD279 (PD-1) [EH12.2H7]-APC, Zombie NIR (obtained from biolegend), CD3 [HIT3a]-BV510, CD161 [DX12]-BV421 (obtained from BD), CD56 [CMSSB]-PerCP/eFluor710 (from Invitrogen), NKG2C [REA205]-PE from MiltenyiBiotec, and NKp80 [239127]-AlexaFluor750 from R&amp;D systems. All reagents were titrated and confirmed to stain PBMCs from healthy individuals. Samples were analyzed on a Sony SP6800 spectral analyzer which captured fluorescence emission spectra from 500&nbsp;nm to 800&nbsp;nm using a 32-channel photomultiplier tube (PMT). The signals from each fluorophore were unmixed mathematically by the spectral shape using an algorithm based upon the least-squares method. Cells were gated on live (ZombieNIR negative), CD45<sup>+</sup>, CD3<sup>+</sup> and CD8<sup>+</sup> or CD4<sup>+</sup> populations. Cell populations were then analyzed for labeling with CD161 as well as PD-1, TIGIT, CD56, NKG2C and NKp80 antibodies. To assess the NK-cell to T&nbsp;cell ratio in GBM samples, cells were gated on live (ZombieNIR negative) CD45<sup>+</sup> population. The total cell numbers of CD3<sup>+</sup> or CD3<sup>-</sup>CD56<sup>+</sup> cells reported were determined based on the total number of cells in the dissociated single cell tumor suspensions and the percentage of gated ZombieNIR negative CD45+ cells that were either CD3<sup>+</sup> or CD3<sup>-</sup>CD56<sup>+</sup>.</div></section><section id="sec-4-4-6"><h4>Analysis of murine dendritic cells in GL261 tumors</h4><div id="p0195" role="paragraph">The study was performed following approval by the Dana-Farber Animal Care and Use Committee (Protocol: 08-049). GL261-luc2 cells (1&nbsp;× 10<sup>5</sup>) were resuspended in PBS and injected stereotactically into the right striatum of anesthetized, 7-week-old female albino C57BL/6 mice (The Jackson Laboratory, ME) using a Hamilton syringe and stereotactic frame. Mice with increasing bioluminescence signal between days 7 and 14 after tumor implantation were randomized into IgG control and PD-1 mAb (clone 8H3) treatment cohorts (6 mice per cohort). The antibodies were administered via intraperitoneal injection beginning on day 14 (500&nbsp;μg/mouse) after tumor implantation with repeat injections every 3&nbsp;days (250&nbsp;μg/dose) for a total of three injections. Brain samples were collected on day 22 and analyzed as below.</div><div id="p0200" role="paragraph">Tumors were dissected from brain tissue under a stereo microscope. Tumors were minced thoroughly in Petri dishes, and single cell suspensions were generated using the Brain Tumor Dissociation Kit (Miltenyi Biotec) according to the manufacture’s protocol with some modifications. Briefly, after dissociation enzymes had been added, samples were shaken and incubated for 15&nbsp;min at 37°C, and then pipetted up and down (20 times). These incubation and pipetting steps were repeated once. The samples were passed through a 70&nbsp;μm cell strainer before staining for cell surface markers. Single cell suspensions were incubated with Fc blocker (purified anti-mouse CD16/32), and cells were subsequently stained with anti-CD3 [17A2]-PE/Cy7, anti-CD45 [30-F11]-AlexaFluor 700, anti-NK1.1 [PK136]-Brilliant Violet 510, anti-CD4 [GK1.5]-Brilliant Violet 650, and anti-CD8a [53-6.7]-Brilliant Violet 785 (2&nbsp;μg/ml). Cells were washed and incubated with phycoerythrin (PE)-conjugated streptavidin (Prozyme). CLEC2D positive cells were identified by staining with anti-I-A/I-E [M5/14.15.2]-AlexaFluor 647, anti-CD45 [30-F11]-AlexaFluor 700, anti-CD11c [N418]-Brilliant Violet 785 and anti-CLEC2D [166C1309]-AlexaFluor 488 (Novus biologicals), or AlexaFluor 488-conjugated isotype control. Cells were treated with Zombie UV (Biolegend) after surface marker staining, and analyzed using a LSR Fortessa (BD Biosciences). Data were analyzed using FlowJo software (Tree Star). Antibodies were purchased from Biolegend unless otherwise stated.</div></section><section id="sec-4-4-7"><h4>Engineering GBM and IDH-G cellular models</h4><div id="p0205" role="paragraph">The MGG123, MGG75, and D270 cells were transduced with a lentivirus to express a NY-ESO-1 cDNA that encoded the relevant NY-ESO-1 protein (NYEP) containing the NY-ESO-1 epitope SLLMWITQC that is recognized by the 1G4 TCR when presented by HLA-A<sup>∗</sup>02:01. This lentiviral vector also encoded the selection marker ZsGreen (for MGG123 and MGG75) or non-functional human nerve growth factor receptor (NGFR) (for D270 and BT142) to enable the detection and isolation of transduced cells. The BT142 cells were also transduced with a lentiviral construct that contained a cassette to induce the expression of HLA-A<sup>∗</sup>02:01 which was followed by the NGFR extracellular domain. Gliomaspheres positive for the indicated selection marker (ZsGreen MGG123 and MGG75; or NGFR for D270 and BT142 cells) were purified by FACS to &gt; 99% purity to select a population with uniform NY-ESO-1 expression. Gliomasphere tumor cells were utilized between 2 and 5 passages for all experiments, and the appropriate selection marker expression was periodically verified to be expressed by &gt; 99% of the cells.</div><div id="p0210" role="paragraph">U-87 MG cells were transduced with a lentivirus to express the NY-ESO-1 cDNA and the NGFR (nonfunctional) extracellular domain. U87-NGFR<sup>+</sup> cells were purified by FACS to &gt; 99% purity and were utilized between 2 and 5 passages for all experiments. The NGFR marker expression was periodically verified.</div></section><section id="sec-4-4-8"><h4>Plasmid cloning and lentiviral vectors</h4><div id="p0215" role="paragraph">To generate the NY-ESO-1<sup>+</sup> tumor lines, cDNAs encoding NY-ESO-1 (accession number: <a id="intref0340" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=NM_139250.2" target="_blank">NM_139250.2</a>) and luciferase were connected through a 2A ribosomal skip sequence and cloned into the pHAGE-MCS lentiviral vector under the control of the EF-1ɑ promoter (<a id="crosref1490" href="#figs5">Figure&nbsp;S5</a>I). The cDNA encoding Zsgreen (for constructs transduced into MGG123 and MGG75) or the extracellular domain of NGFR (for constructs transduced into D270, BT142, and U-87 MG) was synthesized and cloned downstream of an IRES to serve as a marker for transduced cells; NGFR was non-functional as it lacked a cytoplasmic signaling domain. Recipient cells of NGFR were verified to be NGFR-negative prior to transduction. Following the amplification of the insert, the PCR product was run on an electrophoresis gel and the band of expected size was excised and purified using the MinElute gel extraction kit (QIAGEN) following the manufacturer’s protocol. Next, the purified amplicon was ligated into the vector backbone using the NotI and ClaI restriction enzymes. Transformed bacteria were plated on agarose containing ampicillin (100&nbsp;μg/ml) and a single colony was sequenced (Quintarabio; South San Francisco, CA).</div><div id="p0220" role="paragraph">For the gliomasphere cells, VSV-pseudotyped third-generation lentiviruses were produced by Lipofectamine 2000 (Thermo Fisher Scientific)-based transfection of 293T cells with a transfer plasmid, packaging plasmids (GAG/POL, RSV-Rev), and an envelope plasmid (VSV-G). Briefly, 293T cells were plated at a density of 6&nbsp;× 10<sup>4</sup> viable cells/cm<sup>2</sup> on a poly-L-lysine (Sigma) treated 100&nbsp;mm dish. 24 hours after plating, a mixture of lentiviral plasmids (10&nbsp;μg of transfer plasmid, 6.5&nbsp;μg of GAG/POL, 2.5&nbsp;μg of RSV-Rev and 3.5&nbsp;μg of VSV-G) was transfected with Lipofectamine 2000, following the manufacturer’s protocol. After 12-15 hours incubation, the culture medium was changed, and the supernatant was collected 48 and 72 hours post-transfection. Lentiviruses were concentrated by ultracentrifugation or with Lentivirus Precipitation Solution (ALSTEM) and resuspended in PBS to remove serum that can cause irreversible differentiation of gliomasphere cells. Sphere-forming glioma cells were transferred to ultra-low attachment 6-well plates without disrupting the spheres and incubated with the lentiviruses in a serially diluted manner.</div><div id="p0225" role="paragraph">For the U-87 MG model, the plasmid was transfected with packaging plasmids pCMV-dR8.91 and pCMV-VSV-G (Addgene #8454) into HEK293FT cells. Transfection was performed using TransIT-293 (Mirus, MIR2700), following the manufacturer’s protocol. Viral supernatant was harvested at 24 hours and 48 hours post-transfection and concentrated using a Sorvall wX+ ultracentrifuge (ThermoFisher) at 25,000 x <i>g</i> for 1.5 hours at 4°C. Virus titer was determined after all viral aliquots were frozen on dry ice and stored at −80°C. Virus was applied to the indicated tumor cells in a serial dilution from 1:1 to 1:2048.</div><div id="p0230" role="paragraph">The transfected tumor cells were isolated by FACS to &gt; 99% purity based on the expression of the selection marker ZsGreen (MGG123 and MGG75) or by staining for the human NGFR self-antigen (D270, BT142, and U-87 MG).</div><div id="p0235" role="paragraph">To generate the lentiviral transduced NY-ESO-1 [1G4] T&nbsp;cell receptor cells used in the U-87 MG experiments, HA and PC epitope tags were placed at the N terminus of the mature TCR α and β chains, respectively (<a id="crosref1495" href="#figs5">Figure&nbsp;S5</a>H) of the NY-ESO-1 TCR cDNA (1G4 TCR) (<span class="dropBlock reference-citations"><a id="body-ref-optgcJ2uHzuOq" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="optgcJ2uHzuOq" aria-controls="optgcJ2uHzuOq">Robbins et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="optgcJ2uHzuOq"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Robbins, P. ∙ Li, Y. ∙ El-Gamil, M. ...</div><div><strong>Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions</strong></div><div><em>J. Immunol.</em> 2008; <strong>180</strong>:6116-6131</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.180.9.6116" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-44449128698" target="_blank" aria-label="Open Scopus in new tab">Scopus (283)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18424733/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.180.9.6116&amp;pmid=18424733" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). cDNA was gel purified (as described above) and inserted into the pHAGE-MCS lentiviral vector backbone under the control of the EF-1ɑ promoter using NheI and ClaI restriction enzymes. The DNA sequence of the construct was confirmed for a single bacterial colony. Lentivirus was prepared as described above and stored at −80°C. NY-ESO-1 TCR lentivirus titration was performed on Jurkat J.RT3-T3.5 cells (ATCC) that lack the β chain of the T&nbsp;cell receptor. Briefly, a non-tissue culture treated 24-well plate was coated with retronectin (Takara; Kusatsu, Japan) at a final concentration of 15&nbsp;μg/ml at 4°C overnight. The plate was then blocked with 2% bovine serum albumin (BSA) in phosphate buffered saline (PBS) for 15&nbsp;minutes at room temperature. Virus was applied to the plate in a serial dilution from 1:1 to 1:8,192 in a volume of 300&nbsp;μL tissue culture media per well. The virus was then attached to the plate in a prewarmed 32°C centrifuge at 2,000 x <i>g</i> for 2.5 hours. Next, the viral supernatant was decanted, and wells were gently washed with PBS. Jurkat J.RT3-T3.5 cells (0.5&nbsp;× 10<sup>6</sup>) were then transferred to each well in the presence of protamine sulfate (10&nbsp;μg/ml) in a total volume of 2&nbsp;ml. The cells were next cultured for 3&nbsp;days and subsequently stained with a primary antibody that detects the HA-tag [3F10] (SigmaAldrich; St. Louis, MO) on the transfected NY-ESO-1 TCRɑ chain and a secondary anti-rat-FITC conjugated antibody (Life Technologies; Carlsbad, CA). HA-positive cells were quantified by flow cytometry using a Fortessa X-20 (BD Bioscience) flow cytometer.</div><div id="p0240" role="paragraph">Virus titer (viral particles/μL) was calculated by the equation: (percentage of HA-tag positive cells x the number of cells infected / volume in well) x dilution factor. The multiplicity of infection (MOI) of 15 was subsequently calculated by the equation: (number of cells infected x 15) / virus titer.</div></section><section id="sec-4-4-9"><h4>Generation of bivalent CD161 and CLEC2D fusion proteins</h4><div id="p0245" role="paragraph">To generate bivalent CD161- and CLEC2D-fusion proteins, the cDNAs of <i>KLRB1</i> (Accession number: <a id="intref0345" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=NM_002258.3" target="_blank">NM_002258.3</a>) and <i>CLEC2D</i> (Accession number: <a id="intref0350" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;db=nucleotide&amp;doptcmdl=genbank&amp;term=NM_013269.6" target="_blank">NM_013269.6</a>) were synthesized as gBlocks (IDT). Both CD161 and CLEC2D are expressed on the cell surface as homodimers. To generate bivalent fusion proteins, two copies of each gene were connected by a flexible linker followed by a mutated human IgG1 Fc region (to prevent binding to activating Fc receptors). Constructs were expressed via transient transfection in Expi293F cells using the ExpiFectamine 293 Transfection Kit (GIBCO). Transfected cells were grown in Optimum Growth flasks (Thomson Instrument) for 4-6&nbsp;days at 37°C, 8% CO2, 125-150&nbsp;rpm. Supernatants were spun, filtered, and passed over a Protein G Sepharose 4 Fast Flow column (GE). Fusion proteins were eluted at pH 11.5, neutralized, and concentrated in Amicon Ultra spin concentrators (Millipore Sigma), then further purified by gel filtration using a Superose 6 HPLC column (GE). Final yields for bivalent CLEC2D-Ig and CD161-Ig fusion proteins were 13&nbsp;mg/L and 0.6&nbsp;mg/L, respectively.</div></section><section id="sec-4-4-10"><h4>Isolation of primary human T&nbsp;cells for co-culture experiments</h4><div id="p0250" role="paragraph">Primary human T&nbsp;cells were isolated from fresh leukophoresis blood collars provided by the Brigham and Women’s Hospital blood bank. Briefly, PBMCs were isolated by density gradient centrifugation using Premium Ficoll-Paque 1.078 g/ml (GE Healthcare). T&nbsp;cells were isolated using the Human T&nbsp;cell isolation kit (EasySep, cat#17951) following the manufacturer’s instructions. Human T&nbsp;cells were maintained <i>in&nbsp;vitro</i> in RPMI-1640 medium supplemented with 9% fetal bovine serum (FBS), 1% human serum, 50 units/ml penicillin/streptomycin (Pen/Strep), 5&nbsp;mM HEPES, 2&nbsp;mM Glutamax, 5&nbsp;mM non-essential amino acids, 5&nbsp;mM sodium pyruvate, 50&nbsp;μM β-mercaptoethanol, and 30 units/ml of recombinant human IL-2 (Peprotech; Rocky Hill, NJ). CD161+Vα7.2- T&nbsp;cells were next purified by FACS after blocking of Fc receptors with Human TruStain FCX (Biolegend) followed by staining of cells with pre-conjugated flow cytometry antibodies specific for CD3 [HIT3a]-APC, CD161 [HP-3G10]-PerCP_Cy5.5, Vα7.2 [3C10]-BV786. Following sorting using an Aria III (BD Biosciences), and where indicated, polyclonal CD161+Vα7.2- T&nbsp;cells were expanded using ɑCD3/ɑCD28 coated human Dynabeads (Thermo Fisher Scientific; Waltham, MA) at a bead to cell ratio of 1:1 in the presence of recombinant human IL-2 (30 IU/ml) (Peprotech; Rocky Hill, NJ) for three days, followed by electroporation with RNPs containing gRNAs targeting <i>TRAC</i> and either <i>KLRB1</i> or control. T&nbsp;cells used in U-87 MG experiments were next expanded using fresh Dynabeads and IL-2 for an additional 3&nbsp;days followed by transduction with the NY-ESO-1 TCR lentivirus. Transduced T&nbsp;cells were labeled using anti-HA [3F10] primary antibody (SigmaAldrich) and a secondary anti-rat FITC antibody (Invitrogen) to enable isolation of NY-ESO-1 TCR<sup>+</sup> T&nbsp;cells (HA positive) using an Aria III flow cytometer.</div></section><section id="sec-4-4-11"><h4>Gene editing of primary human T&nbsp;cells</h4><div id="p0255" role="paragraph">Guide RNA (gRNA) sequences were designed using the ChopChop Harvard software suite to identify five sequences that specifically targeted each gene (<span class="dropBlock reference-citations"><a id="body-ref-sref26" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26" aria-controls="sref26">Labun et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref26"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Labun, K. ∙ Montague, T.G. ∙ Gagnon, J.A. ...</div><div><strong>CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering</strong></div><div><em>Nucleic Acids Res.</em> 2016; <strong>44</strong>:W272-6</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkw398" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85011312299" target="_blank" aria-label="Open Scopus in new tab">Scopus (444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27185894/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkw398&amp;pmid=27185894" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, crisprRNAs (crRNA) targeting the human <i>CD4</i>, <i>CD2</i>, <i>KLRB1</i> or <i>TRAC</i> genes as well as two “non-targeting” control crRNAs (targeting <i>LacZ</i> or an intergenic region) were synthesized by Integrated DNA Technologies (IDT; Coralville, IA). Guide RNAs (gRNAs) were generated by incubating equimolar concentrations of crRNAs targeting <i>KLRB1</i> region#1 (AATTAAAGCCACTTACCCCG), <i>KLRB1</i> region#2 (TTACCCCGAGGAAGAGATGA), <i>TRAC</i> (TCAGGGTTCTGGATATCTGT), <i>CD4</i> (GGCAAGGCCACAATGAACCG) or controls with tracrRNA (IDT) in nuclease free buffer (IDT), according to the manufacturer’s instructions, by incubation at 95°C for 5&nbsp;minutes; this yielded gRNAs at a final concentration of 60&nbsp;μM. Reactions were cooled to room temperature, followed by addition of an equal volume of Cas9 protein (20&nbsp;μM) modified to carry two nuclear localization signals (Cas9-NLS provided by QB3 Macrolab of the University of California Berkeley; Berkeley, CA). The Cas9 protein and gRNA mixture was next incubated at 37°C for 15&nbsp;minutes to form ribonucleoprotein complexes (RNP). To edit target genes, freshly isolated human T&nbsp;cells were stimulated with human ɑCD3/ɑCD28 Dynabeads with hIL-2 (30&nbsp;U/mL) for one to three days, as indicated. The expanded T&nbsp;cells were collected and resuspended in P3 buffer (Lonza; Basel, Switzerland) according to the manufacturer’s protocol. Next, 1&nbsp;×&nbsp;10<sup>6</sup> T&nbsp;cells (in 20&nbsp;μL P3 buffer) were electroporated with 3&nbsp;μL RNP per well of a nucleocuvette strip using an Amaxa 4D nucleofector with program EH-100. The final concentration of Cas9 in each nucleocuvette well was 10&nbsp;μM. Electroporated T&nbsp;cells were then transferred to individual wells of a 48 well recovery plate containing human αCD3/αCD28 Dynabeads and hIL-2 (30&nbsp;U/ml) in fully supplemented RPMI-1640 media (as described above). Dual gene editing was achieved by resuspending 1&nbsp;× 10<sup>6</sup> primary human T&nbsp;cells in 17&nbsp;μL of P3 buffer and electroporation with 3 uL each of the two gRNAs, as indicated.</div></section><section id="sec-4-4-12"><h4>Generation of NY-ESO-1 TCR T&nbsp;cells</h4><div id="p0260" role="paragraph">For experiments with the gliomasphere tumor cells, the NY-ESO-1 (1G4) TCR was induced using a single stranded DNA homology directed repair template (HDR) with an RNP (<i>TRAC</i> gRNA&nbsp;+ Cas9 protein) directed against the human <i>TRAC</i> locus. The HDR template was designed as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref47" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47" aria-controls="sref47">Roth et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref47"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Roth, T.L. ∙ Puig-Saus, C. ∙ Yu, R. ...</div><div><strong>Reprogramming human T&nbsp;cell function and specificity with non-viral genome targeting</strong></div><div><em>Nature.</em> 2018; <strong>559</strong>:405-409</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0326-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85050234806" target="_blank" aria-label="Open Scopus in new tab">Scopus (552)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29995861/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0326-5&amp;pmid=29995861" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) with several modifications. Briefly, a T2A self-cleaving peptide was placed upstream of a PC tag, which was immediately followed by the NY-ESO-1 β-variable region, the β-constant region, and a P2A peptide. These regions were followed with an HA tag, the NY-ESO-1 ⍺-variable region, and a partial (45 nt) ⍺-constant region that resulted in the <i>TRAC</i> gRNA binding site to be inactivated thus preventing multiple rounds of editing. Upon incorporation of the HDR template, the partial ⍺-constant region of the template inserted in-line with the remaining endogenous ⍺-constant region resulting in a functional ⍺-chain upon protein translation (<a id="crosref1510" href="#figs5">Figure&nbsp;S5</a>G). The 5′ and 3′ ends of the described template are surrounded by ∼300nt homology arms.</div><div id="p0265" role="paragraph">Purified (described above) CD161+Vα7.2- T&nbsp;cells (1&nbsp;× 10<sup>6</sup> per well) were electroporated with 3&nbsp;μL of <i>TRAC</i> RNP&nbsp;+ 4&nbsp;μg of single stranded HDR template in 16&nbsp;μL of fully supplemented P3 buffer. Following electroporation, 80&nbsp;μL of prewarmed RPMI supplemented media was added to each well, and the T&nbsp;cells were incubated in the nucleovette strips for 10&nbsp;mins at 37°C. T&nbsp;cells were transferred to pre-acclimated recovery plates containing IL-2 (30&nbsp;U/ml) and a 1:1 ratio of CD3/CD28 dynabeads (Invitrogen) and expanded for 10&nbsp;days.</div><div id="p0270" role="paragraph">The experiments for the U-87 MG model utilized CD161+Vα7.2- T&nbsp;cells that were transduced with lentivirus by spin infection (as&nbsp;described above) to introduce the NY-ESO-1 TCR. Briefly, a non-tissue culture treated 24 well plate was coated with 0.8&nbsp;mL of 15&nbsp;μg/ml Retronectin (Takara; Kyoto, Japan) overnight at 4°C. Wells were blocked with sterile 2% BSA for 15&nbsp;minutes at room temperature and gently washed once with PBS. Next, lentivirus was added to wells of the retronectin-coated plate at a multiplicity of&nbsp;infection (MOI) of 15, and plates were spun for 2.5 hours at 2,000 x <i>g</i> at 32°C. The supernatant in the wells was then carefully decanted, and wells were gently washed with 0.5&nbsp;mL of PBS. 0.5&nbsp;× 10<sup>6</sup> control or <i>KLRB1</i> edited T&nbsp;cells were transferred to wells&nbsp;containing 10&nbsp;μg/ml protamine sulfate (SigmaAldrich) in RPMI-1640 media containing 30&nbsp;U/ml IL-2 and cultured for three days. NY-ESO-1<sup>+</sup> T&nbsp;cells were isolated to &gt; 90% purity by FACS and immediately expanded with Dynabeads and IL-2 (30&nbsp;U/ml) for 5&nbsp;days.</div></section><section id="sec-4-4-13"><h4>Co-culture of edited human T&nbsp;cells with GBM cells</h4><div id="p0275" role="paragraph">Patient-derived human gliomasphere cells (MGG123, MGG75, or BT142) were dissociated with Accutase (Millipore Sigma) for 3&nbsp;minutes, filtered with a 100&nbsp;μM cell strainer to generate a single cell suspension, and seeded into ultra-low attachment 96-well plates at a density of 2.5&nbsp;× 10<sup>4</sup> cells per well. The tumor cells were allowed to reform neurospheres for 4 hours prior to the addition of T&nbsp;cells. U87-NYEP<sup>+</sup> tumor cells were seeded into 96-well plates at a density of 3&nbsp;× 10<sup>4</sup> cells per well and allowed to attach to the plate for 8 hours. NY-ESO-1 TCR<sup>+</sup> T&nbsp;cells, that had been edited with <i>KLRB1</i> (or control) gRNAs as well as a <i>TRAC</i> gRNA, were seeded into wells in triplicate at the indicated effector T&nbsp;cell to tumor cell ratios (E:T). For co-culture experiments with CD161 blocking mAb, NY-ESO-1 TCR<sup>+</sup> T&nbsp;cells that expressed wild-type <i>KLRB1</i> (but that had the endogenous TCR inactivated by editing the <i>TRAC</i> locus) were incubated with indicated target tumor cells in the presence of 10&nbsp;μg/ml of either CD161 [HP-3G10] mAb or mouse IgGκ isotype control Ab. Co-cultures were incubated for 24 or 72 hours. The supernatants from the cocultures that contained <i>KLRB1</i> or control edited T&nbsp;cells or CD161 mAb were collected for detection of IL-2 and IFNγ by enzyme linked immunosorbent assays (ELISA) according to the manufacturer’s instructions (Biolegend). ELISAs were performed in triplicate in DELFIA high-binding 96-well assay plates (Perkin-Elmer; Waltham, MA). Each well was coated with capture antibody (based on lot specific antibody concentration) that was diluted in carbonate buffer with pH of 9.5 and incubated overnight at 4°C. Plates were washed with PBS&nbsp;+ 0.05% Tween-20 and subsequently blocked with 1% BSA in PBS at room temperature for 1 hour. Following a two hour incubation with experimental cell culture supernatants and the manufacturer provided standard, plates were washed and incubated with the manufacturer’s biotinylated detection antibody for 1 hour at room temperature. The secondary antibody was next detected with streptavidin-Europium (Perkin-Elmer; Waltham, MA) and DELFIA Enhancement Solution (Perkin-Elmer). The Europium fluorescence was analyzed using an EnVision multimode plate reader (Perkin-Elmer).</div><div id="p0280" role="paragraph">Gliomasphere co-culture experiments that were analyzed by flow cytometry were collected at the indicated time points and stained with the viability dye Zombie UV (Biolegend) in PBS followed by monoclonal antibodies specific for extracellular markers dependent upon the assay. The eight hour cytotoxicity killing experiments were stained with: CD3 [HIT3a]-APC and CD45 [HI30]-APC/Cy7. The co-cultures examining T&nbsp;cell activation were stained with: CD3 [HIT3a]-BV510, CD8 [RPA-T8]-BV650, CD69 [FN50]-BV421, CD25 [BC96]- BV785, CD107a [H4A3]-PE, PD-1 [EH12.2H7]-PE/Dazzle594, and CD161 [HP-3G10]-PerCP/Cy5.5 in 2% FBS in PBS. The cells were next fixed (Cytofix/Cytoperm, BD bioscience) for analysis.</div><div id="p0285" role="paragraph">For U-87MG co-culture assays analyzed by flow cytometry, cells were co-cultured in the presence of protein transport inhibitor cocktail (ThermoFisher) for the final six hours of culture in the absence of PMA/ionomycin; cells were then stained with Zombie UV (viability) in PBS and then the following monoclonal antibodies specific for the extracellular markers CD3 [HIT3a]-BV510, CD8 [RPA-T8]-BV650, CD4 [OKT4]-APC/Cy7, CD69 [FN50]-BV421, CD161 [HP-3G10]-PerCP/Cy5.5 in 2% FBS in PBS. The cells were fixed (Cytofix/Cytoperm, BD bioscience), permeabilized (Permeabilization buffer, Thermofisher), and stained for the intracellular markers Perforin [B-D48]-PE, GranzymeB [GB11]-AlexaFluor647, IL-2 [MQ1-17H12]-FITC, IFNγ [4S.B3]-BV711, TNFɑ [MAb11]-PE/Cy7. To further examine exhaustion markers, a separate overlapping panel was used that contained monoclonal antibodies that detected CD3 [HIT3a]-BV510, CD8 [RPA-T8]-BV650, CD4 [OKT4]-APC/Cy7, LAG-3 [11C3C65]-FITC, CTLA-4 [L3D10]-PE/Cy7, TIM-3 [F38-2E2]-BV785, TIGIT [A15153G]-PE, PD-1 [EH12.2H7]-PE/Dazzle594.</div><div id="p0290" role="paragraph">Flow cytometry acquisition was performed using an LSR Fortessa X-20 (BD Bioscience). Flow cytometry files were analyzed using FlowJo v10.7.1 (BD; Franklin Lakes, NJ). The CD3 [HIT3a]-BV510 was purchased from BD Bioscience, CD161 [HP-3G10]-PerCP/Cy5.5 from eBioscience, and all other flow cytometry antibodies were purchased from Biolegend.</div></section><section id="sec-4-4-14"><h4>Humanized mouse model to evaluate impact of KLRB1 gene on T&nbsp;cell function</h4><div id="p0295" role="paragraph">The following procedures were performed following approval by the Dana-Farber Animal Care and Use Committee (Protocol: 08-049). Tumor implantation into the left striatum of the mouse cortex and the subsequent administration of T&nbsp;cells into the right lateral ventricle were achieved by stereotactic surgical injections. NOD.Cg-Prkdc&nbsp;&lt; scid &gt; IL2rg&nbsp;&lt; tm1Wjl &gt; /SzJ (NSG) mice were shaved on the crown of the head from midbrow to ears, weighed, and tagged one day prior to surgery. On the day of surgery, anesthesia was induced using a precision isoflurane vaporizer (VetEquip; Livermore, CA) at an input air flow rate of 3.0 l/min and isoflurane of 4% for 3&nbsp;minutes. The anesthetized mouse was next transferred into a small animal stereotactic instrument (Kopf Instruments; Tujunga, CA) that was equipped with continuous adjustable flow of isoflurane to maintain anesthesia with input air flow of 1.5 l/min and between 0.75% and 1.5% isoflurane. The eyes of the animal were protected with Puralube ophthalmic ointment (Dechra Veterinary; Overland Park, KS) and the crown was disinfected with povidone-iodine (PDI Healthcare; Woodcliff Lake, NJ). A 1&nbsp;cm midline incision was made above the sagittal suture allowing the underlying fascia to be retracted by blunt dissection. The calvaria was next cleaned with sterile gauze. The skull was adjusted to a level plane by ensuring that the dorsal/ventral coordinates of bregma and lambda were within ± 50&nbsp;μm. Using Bregma as coordinate zero for all mice, the needle was adjusted to the following coordinates: medial/lateral:&nbsp;+0.2&nbsp;mm; anterior/posterior:&nbsp;+0.1&nbsp;mm; dorsal/ventral: −0.3&nbsp;mm. A burr hole was drilled and the needle inserted for 3&nbsp;minutes to form a void for the injected cells to aggregate. The needle was then partially withdrawn to the final injection depth of −0.25&nbsp;mm. Next, 5&nbsp;× 10<sup>4</sup> MGG123 or 1.5&nbsp;× 10<sup>4</sup> U87 MG tumor cells that expressed the NY-ESO-1 protein were injected in a volume of 2&nbsp;μL at a&nbsp;rate of 0.5&nbsp;μL/min using a programmable Pump 11 Elite Nanomite micro-syringe pump (Harvard Apparatus; Holliston, MA). The needle was fully withdrawn three minutes following completion of the cell infusion and the trepanation was sealed with bone wax (Medline; Northfield, IL). The midline incision was closed using 9mm wound clips (MikRon Precision; Gardena, CA) and 4-0 Ethilon sutures (Ethicon; Somerville, NJ), followed by the application of triple antibiotic ointment to the incision daily for 2&nbsp;days. All animals were administered buprenorphine 75&nbsp;mg/kg subcutaneously immediately following surgery and twice daily thereafter for 2&nbsp;days, as needed if animal exhibited signs of distress.</div><div id="p0300" role="paragraph">The T&nbsp;cells were administered into the contralateral ventricle seven or eight days following tumor implantation in a second stereotactic surgery using the methods described above, at the following coordinates: medial/lateral:&nbsp;+0.03&nbsp;mm; anterior/posterior: −0.1&nbsp;mm; and dorsal/ventral: −0.285mm. <i>KLRB1</i> or control edited NY-ESO-1 TCR<sup>+</sup> T&nbsp;cells were injected in a volume of 7.5&nbsp;μL at a rate of 1.5&nbsp;μL/min. The MGG123 gliomasphere model received two injections of 0.8 x10<sup>6</sup> NY-ESO-1 TCR<sup>+</sup> T&nbsp;cells for survival experiments and flow cytometry analysis. The U-87 MG model received a single injection of 0.4&nbsp;× 10<sup>6</sup> T&nbsp;cells for survival experiments or 2&nbsp;× 10<sup>6</sup> T&nbsp;cells for flow cytometry analysis. The needle was removed 2&nbsp;minutes after cell infusion was completed and closing was performed as described above. Buprenorphine was given for analgesia at the same dose and administration schedule used following tumor implantation. All instruments were sterilized between each mouse using a dry bead sterilizer (CellPoint Scientific; Gaithersburg, MD) at 350°C for three minutes.</div></section><section id="sec-4-4-15"><h4>Bioluminescence imaging of tumor bearing mice</h4><div id="p0305" role="paragraph">Following tumor implantation, mice where analyzed by bioluminescence imaging (BLI) starting on day −1, relative to T&nbsp;cell administration via the lateral ventricle. Briefly, mice were anesthetized using a precision isoflurane vaporizer (VetEquip; Livermore, CA) at an input air flow rate of 3.0 l/min and isoflurane of 4% for 5&nbsp;minutes followed by the intraperitoneal administration of luciferin (150&nbsp;mg/kg). Eight minutes after the luciferin injection, the mice were imaged using a Xenogen Imaging System (PerkinElmer) with an automatic exposure time. BLI was performed twice weekly, as indicated, and analyzed using living image software package (PerkinElmer) to quantify signal flux (photons / second).</div></section><section id="sec-4-4-16"><h4>Histological analysis of intracranial MGG123 growth</h4><div id="p0310" role="paragraph">MGG123-bearing mouse was euthanized at survival endpoint and perfused via the left cardiac ventricle with 10&nbsp;mL of PBS, followed by 10&nbsp;mL of buffered formalin (MilliporeSigma). The intact brain was removed from the cranium, and three gross sections were made: the first containing the frontal lobe anterior to bregma, the second encompassing the region intermediate of bregma and lambda, the third posterior of lambda. The gross sections were placed into a conical tube containing 50&nbsp;mL of buffered formalin for 36 hours. The sections were then dehydrated in 70% ethanol for at least 24 hours prior to embedding in paraffin. 6&nbsp;μM paraffin-embedded sections were stained with H&amp;E by the Rodent Histopathology Core of Dana-Farber/Harvard Cancer Center and scanned using an Aperio VERSA 200 (Leica Biosystems; Wetzlar, Germany). Images were captured with Aperio Image Scope software v.12.4.0.5043 (Leica).</div></section><section id="sec-4-4-17"><h4><i>Ex&nbsp;vivo</i> analysis</h4><div id="p0315" role="paragraph">Upon reaching the protocol endpoint (moribund), MGG123 gliomasphere-bearing mice were euthanized, and the intact brain was extracted from the cranium. The whole brain was grossly sectioned into three regions (as described above) and the tumor was carefully isolated from the surrounding parenchyma. The lesion was dissociated, filtered into a single cell suspension, and total cells were counted. The cells were then incubated with the viability dye Zombie UV per the manufacturer instructions in PBS and next stained in 2% FBS in PBS with monoclonal antibodies to detect the extracellular markers: CD3 [HIT3a]-BV510, CD8 [RPA-T8]-BV650, CD4 [OKT4]-APC/Cy7, TIM3 [F38-2E2]-BV421, PD-1 [EH12.2H7]-PE/Dazzle594, and CD161 [HP-3G10]-PerCP/Cy5.5. The cells were fixed (BD bioscience), permeabilized (Thermofisher), and stained for the intracellular marker GranzymeB [GB11]-AlexaFluor647.</div><div id="p0320" role="paragraph">The mice in the U-87 MG model were euthanized on day 8 following T&nbsp;cell administration and the whole brain was removed from the cranium. The brain was grossly dissected, the tumor mass was removed, dissociated into a single cell suspension, total cells were counted, and incubated with Zombie UV viability dye. The cells were then stained in 2% FBS in PBS with monoclonal antibodies to detect: CD3 [HIT3a]-BV510, CD8 [RPA-T8]-BV650, CD4 [OKT4]-APC/Cy7, TIGIT [A15153G]-PE, PD-1 [EH12.2H7]-PE/Dazzle594, and CD161 [HP-3G10]-PerCP/Cy5.5. The cells were then fixed, permeabilized, and stained for GranzymeB [GB11]-AlexaFluor647, IL-2 [MQ1-17H12]-FITC, IFNγ [4S.B3]-BV711, TNFɑ [MAb11]-PE/Cy7.</div><div id="p0325" role="paragraph">Flow cytometry acquisition for all <i>ex&nbsp;vivo</i> experiments was performed using an LSR Fortessa X-20 (BD Bioscience) and analyzed using FlowJo v10.7.1 (BD; Franklin Lakes, NJ).</div></section><section id="sec-4-4-18"><h4>qPCR analysis of CLEC2D mRNA</h4><div id="p0330" role="paragraph">mRNA was isolated from the indicated cell lines using a RNeasy kit according to the manufacturer’s instructions (QIAGEN, Venlo, the Netherlands). mRNA (1&nbsp;μg) was used to synthesize cDNA using SuperScript VILO (Invitrogen; Carlsbad, CA). The following qPCR primers were designed for the detection of the following human cDNAs: GAPDH-Forward: GGAGCGAGATCCCTCCAAAAT, GAPDH-Reverse: GGCTGTTGTCATACTTCTCATGG; CLEC2D-Forward: CTGCCATCAAGAGCCATCAG, CLEC2D-Reverse: TCAGCCCAATCCAGTGATCA. Power SYBR Green master mix (Thermo Fisher) was used following the manufacturer’s instructions. All primers were verified for the production of a single specific PCR product with a melting curve program.</div></section></section><section id="sec-4-5"><h3>Quantification and statistical analysis</h3><div id="p0335" role="paragraph">All computational analyses were performed in R (v4.0.0).</div><section id="sec-4-5-1"><h4>scRNA-seq data processing (SMART-Seq2)</h4><div id="p0340" role="paragraph">We processed sequencing data from raw reads to gene expression matrices as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref53-2" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-2" aria-controls="sref53-2">Tirosh et&nbsp;al., 2016a</a><div class="dropBlock__holder" data-db-target-of="sref53-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Tirosh, I. ∙ Izar, B. ∙ Prakadan, S.M. ...</div><div><strong>Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq</strong></div><div><em>Science.</em> 2016; <strong>352</strong>:189-196</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad0501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84963614956" target="_blank" aria-label="Open Scopus in new tab">Scopus (2751)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27124452/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad0501&amp;pmid=27124452" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, we used bcl2fastq to generate demultiplexed FASTQ files, and aligned the resulting paired-end scRNA-seq reads to the human transcriptome (hg19) using Bowtie (v0.12.7) (<span class="dropBlock reference-citations"><a id="body-ref-sref28" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28" aria-controls="sref28">Langmead et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Langmead, B. ∙ Trapnell, C. ∙ Pop, M. ...</div><div><strong>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</strong></div><div><em>Genome Biol.</em> 2009; <strong>10</strong>:R25</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/gb-2009-10-3-r25" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-62349130698" target="_blank" aria-label="Open Scopus in new tab">Scopus (16504)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19261174/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fgb-2009-10-3-r25&amp;pmid=19261174" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We quantified gene expression levels from these alignments as transcripts-per-million (TPM) values by running RSEM (v1.2.19) in paired-end mode (<span class="dropBlock reference-citations"><a id="body-ref-sref30" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30" aria-controls="sref30">Li and Dewey, 2011</a><div class="dropBlock__holder" data-db-target-of="sref30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Li, B. ∙ Dewey, C.N.</div><div><strong>RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome</strong></div><div><em>BMC Bioinformatics.</em> 2011; <strong>12</strong>:323</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1471-2105-12-323" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-79961123152" target="_blank" aria-label="Open Scopus in new tab">Scopus (13966)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21816040/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1471-2105-12-323&amp;pmid=21816040" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We normalized the total transcripts per cell to one-hundred thousand (TP100K), as this is our estimated complexity of single-cell libraries prepared by SMART-Seq2 (<span class="dropBlock reference-citations"><a id="body-ref-sref53-3" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-3" aria-controls="sref53-3">Tirosh et&nbsp;al., 2016a</a><div class="dropBlock__holder" data-db-target-of="sref53-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Tirosh, I. ∙ Izar, B. ∙ Prakadan, S.M. ...</div><div><strong>Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq</strong></div><div><em>Science.</em> 2016; <strong>352</strong>:189-196</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad0501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84963614956" target="_blank" aria-label="Open Scopus in new tab">Scopus (2751)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27124452/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad0501&amp;pmid=27124452" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and then log-transformed these values to report gene expression as E&nbsp;= ln(TP100K+1).</div></section><section id="sec-4-5-2"><h4>Quality control of scRNA-seq (SMART-Seq2)</h4><div id="p0345" role="paragraph">For each cell, we considered a gene to be detected if its TP100K &gt; 0. We excluded all cells with either&nbsp;&lt; 500 or &gt; 7,500 unique genes detected, or with fewer than 20 housekeeping genes detected based on a previously curated gene set (<span class="dropBlock reference-citations"><a id="body-ref-sref53-4" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-4" aria-controls="sref53-4">Tirosh et&nbsp;al., 2016a</a><div class="dropBlock__holder" data-db-target-of="sref53-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Tirosh, I. ∙ Izar, B. ∙ Prakadan, S.M. ...</div><div><strong>Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq</strong></div><div><em>Science.</em> 2016; <strong>352</strong>:189-196</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad0501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84963614956" target="_blank" aria-label="Open Scopus in new tab">Scopus (2751)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27124452/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad0501&amp;pmid=27124452" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Three patient samples (E88, E119, and MGH142), where the majority of T&nbsp;cells failed to meet these criteria, were completely omitted from further analysis.</div><div id="p0350" role="paragraph">To ensure our studied cell population consisted only of T&nbsp;cells, we carried out an initial round of graph-based clustering (<span class="dropBlock reference-citations"><a id="body-ref-sref2" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2" aria-controls="sref2">Blondel et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Blondel, V.D. ∙ Guillaume, J.-L. ∙ Lambiotte, R. ...</div><div><strong>Fast unfolding of communities in large networks</strong></div><div><em>J.&nbsp;Stat. Mech.</em> 2008;</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1088/1742-5468/2008/10/P10008" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-56349094785" target="_blank" aria-label="Open Scopus in new tab">Scopus (13959)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1088%2F1742-5468%2F2008%2F10%2FP10008" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), described below, to identify cell types that might have been flow-sorted with the T&nbsp;cells. We first identified and removed B cells, myeloid cells, and astrocytes. We next identified NK cells and cell doublets by carrying out clustering using non-negative matrix factorization (NMF) with the Brunet&nbsp;algorithm and 7 factors in the factorization. This was implemented in the R package NMF (v0.21.0) (<span class="dropBlock reference-citations"><a id="body-ref-sref12" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12" aria-controls="sref12">Gaujoux and Seoighe, 2010</a><div class="dropBlock__holder" data-db-target-of="sref12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Gaujoux, R. ∙ Seoighe, C.</div><div><strong>A flexible R package for nonnegative matrix factorization</strong></div><div><em>BMC Bioinformatics.</em> 2010; <strong>11</strong>:367</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1471-2105-11-367" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-77954069195" target="_blank" aria-label="Open Scopus in new tab">Scopus (899)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20598126/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1471-2105-11-367&amp;pmid=20598126" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We identified doublets as a distinct cluster of cells expressing both T&nbsp;cell markers (<i>CD3D</i>, <i>CD3E</i>, <i>CD3G</i>) and either astrocyte markers (<i>GFAP</i>) or myeloid markers (<i>C1QB</i>, <i>C1QC</i>). We searched for potential NK cells by examining the cluster of CD8 T&nbsp;cells, as NK cells and CD8 T&nbsp;cells share transcriptional programs. We identified a small cell population (127 cells) within the cluster of CD8 T&nbsp;cells with low mean expression (ln(TP100K+1)&nbsp;&lt; 1) of T&nbsp;cell markers (<i>CD3D</i>, <i>CD3E</i>, <i>CD3G</i>, <i>CD247</i>). We identified differentially expressed genes, as described below, between this cell population and the remaining CD8 T&nbsp;cells and found that this population had lower expression of other T&nbsp;cell markers (<i>CD5</i>, <i>IL7R</i>, <i>CD8A</i>, <i>CD8B</i>) and higher expression of NK markers (<i>KIR2DL1</i>, <i>KIR2DL3</i>, <i>KIR2DS4</i>). To ensure our results were not confounded by NK cells, we removed this population. The above filtering steps removed 8% of the cells. Finally, we also excluded a small percentage of cells (2%) that were either cycling T&nbsp;cells that expressed both CD4 and CD8, cycling T&nbsp;cells that lacked expression of CD4 and CD8, or T<sub>regs</sub> that expressed CD8. Positive gene expression was defined as ln(TP100K+1) &gt; 1 and lack of gene expression was defined as ln(TP100K+1)&nbsp;&lt; 1. After these quality control steps, overall we retained 8,252 T&nbsp;cells from 27 glioma samples (from 26 patients), with a total of 22,448 genes detected in at least one cell. These T&nbsp;cells are used in all analyses reported in this work (clustering, cell type and cell state identification, clonal expansion, pan-cancer metaanalysis).</div></section><section id="sec-4-5-3"><h4>Cell type and cell state identification (SMART-Seq2)</h4><div id="p0355" role="paragraph">We carried out analyses of all T&nbsp;cells to identify cell types, states, and their corresponding gene signatures using the R package Seurat (v2.3.4) (<a id="intref0355" href="https://github.com/satijalab/seurat" target="_blank">https://github.com/satijalab/seurat</a>) (<span class="dropBlock reference-citations"><a id="body-ref-opt7Nc15lWMeS" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="opt7Nc15lWMeS" aria-controls="opt7Nc15lWMeS">Butler et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="opt7Nc15lWMeS"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Butler, A. ∙ Hoffman, P. ∙ Smibert, P. ...</div><div><strong>Integrating single-cell transcriptomic data across different conditions, technologies, and species</strong></div><div><em>Nature Biotechnology.</em> 2018; <strong>36</strong>:411-420</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.4096" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85046298440" target="_blank" aria-label="Open Scopus in new tab">Scopus (6218)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29608179/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.4096&amp;pmid=29608179" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We chose highly variable genes for clustering analyses using <i>FindVariableGenes</i>, which controls for the inherent relationship between the mean and the variance of gene expression. We used the following thresholds for the mean expression (x) and the variance to mean ratio (y): x.low.cutoff&nbsp;= 0.1, x.high.cutoff&nbsp;= 7, y.cutoff&nbsp;= 0.5. We identified variable genes within each patient sample and selected the 1,500 variable genes that were most commonly shared across all patient samples. Next, we centered the expression of each gene to have a mean of zero using <i>ScaleData</i> and performed Principal Components Analysis (PCA) with <i>RunPCA</i>. We performed graph-based Louvain clustering on the top 20 principal components using <i>FindClusters</i>, with the resolution parameter set to 0.7 and k for the k-nearest neighbor algorithm set to 30. We identified differentially expressed genes for each cluster of cells using the t test implemented in <i>FindMarkers</i> while adjusting p values for multiple hypothesis testing with the Bonferroni correction. Finally, we visualized gene expression and clustering results on a Uniform Manifold Approximation and Projection embedding (UMAP) of the top twenty PCs using <i>RunUMAP</i> with the following settings: min_dist&nbsp;= 0.5, number of neighbors&nbsp;= 30, and distance metric&nbsp;= Euclidean.</div><div id="p0360" role="paragraph">To sub-cluster CD4 T&nbsp;cells (4,369 cells) or CD8 T&nbsp;cells (3,883 cells), we carried out clustering using NMF (<a id="crosref1550" href="#fig1">Figure&nbsp;1</a>E). When clustering CD4 T&nbsp;cells and CD8 T&nbsp;cells, we used 6 factors in the factorization, and when clustering all glioma T&nbsp;cells found in clonotypes, we used 4 factors. As an alternative to NMF clustering, we also carried out graph-based Louvain clustering using resolution parameters of 0.5 and 0.7 for CD4 and CD8 T&nbsp;cells respectively. We calculated UMAP visualizations for the CD4 T&nbsp;cells and CD8 T&nbsp;cells using the top twenty PCs as input features, and the same settings as above.</div><div id="p0365" role="paragraph">We annotated the cell type or state represented by each cluster by considering the cluster’s differentially expressed genes together with the known cell type markers <i>CD3D</i>, <i>CD3E</i>, <i>CD3G</i>, <i>CD4</i>, <i>CD8A</i>, <i>CD8B</i>, and <i>FOXP3</i>. To identify a cell’s state in the cell cycle, we used <i>CellCycleScoring</i>, which scores the levels of programs for S phase and G2/M phase using previously defined gene sets for DNA replication and mitosis (<span class="dropBlock reference-citations"><a id="body-ref-sref53-5" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-5" aria-controls="sref53-5">Tirosh et&nbsp;al., 2016a</a><div class="dropBlock__holder" data-db-target-of="sref53-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Tirosh, I. ∙ Izar, B. ∙ Prakadan, S.M. ...</div><div><strong>Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq</strong></div><div><em>Science.</em> 2016; <strong>352</strong>:189-196</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad0501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84963614956" target="_blank" aria-label="Open Scopus in new tab">Scopus (2751)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27124452/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad0501&amp;pmid=27124452" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0370" role="paragraph">To examine gene expression signatures within single cells, we scored the levels of specific signatures using <i>AddModuleScore</i>, which calculates the average expression levels of the genes in a signature and then subtracts off the average expression levels of control gene sets (<span class="dropBlock reference-citations"><a id="body-ref-sref53-6" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-6" aria-controls="sref53-6">Tirosh et&nbsp;al., 2016a</a><div class="dropBlock__holder" data-db-target-of="sref53-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Tirosh, I. ∙ Izar, B. ∙ Prakadan, S.M. ...</div><div><strong>Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq</strong></div><div><em>Science.</em> 2016; <strong>352</strong>:189-196</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad0501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84963614956" target="_blank" aria-label="Open Scopus in new tab">Scopus (2751)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27124452/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad0501&amp;pmid=27124452" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Control gene sets were chosen to have similar expression values to the genes in the signature. All genes were binned into 25 bins based on their average expression across all cells, and for each gene in a signature, a random set of 20 genes was chosen from the same average expression bin as that gene. This procedure controls a signature’s expression level for the differences in cell quality and library complexity across single cells. We defined cytotoxicity, NK, and inhibitory signature scores based on established marker genes. For the cytotoxicity signature, we included the genes <i>PRF1</i>, <i>GZMB</i>, <i>GZMA</i>, <i>GZMH</i>, <i>NKG7</i>, and <i>GNLY</i>, for the NK signature, we included the genes <i>KLRD1</i>, <i>FGFBP2</i>, <i>FCGR3A</i>, <i>S1PR5</i>, <i>KLRC1</i>, <i>KLRC3</i>, <i>KLRB1</i>, and <i>KLRC2</i>, and for the inhibitory signature, we included the genes <i>PDCD1</i>, <i>CTLA4</i>, <i>HAVCR2</i>, <i>LAG3</i>, and <i>TIGIT</i>. We defined a CD8 T&nbsp;cell as having a high NK signature score if it had an NK signature score &gt; 0.5; otherwise we defined the cell as having a low NK signature score (<a id="crosref1565" href="#fig2">Figure&nbsp;2</a>C). We then identified the differentially expressed genes between the high NK and low NK signature score CD8 T&nbsp;cells using <i>FindMarkers</i> as described above. We confirmed that the top differentially expressed genes were not sensitive to the threshold used to define cells as having a high NK versus a low NK signature score by repeating the analyses with thresholds of 0 and of 1.</div><div id="p0375" role="paragraph">We identified significant changes in cell type proportions under different treatment regimes (prior corticosteroids or immune checkpoint inhibitors) or in different glioma classes (GBM or IDH-G) using a Dirichlet-multinomial regression model (<span class="dropBlock reference-citations"><a id="body-ref-sref50" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50" aria-controls="sref50">Smillie et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref50"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Smillie, C.S. ∙ Biton, M. ∙ Ordovas-Montanes, J. ...</div><div><strong>Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis</strong></div><div><em>Cell.</em> 2019; <strong>178</strong>:714-730.e22</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2019.06.029&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2019.06.029&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85069176109" target="_blank" aria-label="Open Scopus in new tab">Scopus (666)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31348891/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.06.029&amp;pmid=31348891" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-5-4"><h4>Differential gene expression in IDH-G and GBM T&nbsp;cells (SMART-Seq2)</h4><div id="p0380" role="paragraph">To look for variability between the expression profiles of CD4 and CD8 T&nbsp;cells isolated from IDH-G and GBM, we used the <i>FindMarkers</i> function to identify differentially expressed genes between cells of the two tumor classes of a given subset. For three subsets, Interferon, Cytotoxicity, and Stress, we calculated the signature scores for the list of DE genes using <i>AddModuleScore</i> and compared the signature scores between the two classes by a two-sample Komolgorov-Smirnov test.</div></section><section id="sec-4-5-5"><h4>KLRB1 and tissue resident memory T&nbsp;cell signature comparison (SMART-Seq2 and 5′ end scRNA-Seq)</h4><div id="p0385" role="paragraph">In order to determine if any of the subsets of T&nbsp;cells we identified were Tissue Resident Memory T Cells (Trms), we first calculated a signature score using <i>AddModuleScore</i> for a Trm signature (<i>CA10</i>, <i>ITGA1</i>, <i>ITGAE</i>, <i>IL2</i>, <i>IL10</i>, <i>CXCR6</i>, <i>CXCL13</i>, <i>KCNK5</i>, <i>RGS1</i>, <i>CRTAM</i>, <i>DUSP6</i>, <i>PDCD1</i>) and the expression of <i>KLRB1</i>. We then calculated the Pearson correlation coefficients between the Trm signature and <i>KLRB1</i> expression in all CD4 T&nbsp;cells, all CD8 T&nbsp;cells, and their respective subsets of cells.</div></section><section id="sec-4-5-6"><h4>Reconstructing TCR chain sequences (SMART-Seq2)</h4><div id="p0390" role="paragraph">For each single T&nbsp;cell, we computationally reconstructed its TCR α and β chain sequences from the corresponding scRNA-seq data using TraCeR (v0.6.0, <a id="intref0360" href="https://github.com/Teichlab/tracer" target="_blank">https://github.com/Teichlab/tracer</a>) (<span class="dropBlock reference-citations"><a id="body-ref-sref52-2" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52-2" aria-controls="sref52-2">Stubbington et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref52-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Stubbington, M.J.T. ∙ Lönnberg, T. ∙ Proserpio, V. ...</div><div><strong>T cell fate and clonality inference from single-cell transcriptomes</strong></div><div><em>Nat. Methods.</em> 2016; <strong>13</strong>:329-332</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.3800" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84960194523" target="_blank" aria-label="Open Scopus in new tab">Scopus (320)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26950746/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.3800&amp;pmid=26950746" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We ran TraCeR assembly with the following Trinity (<span class="dropBlock reference-citations"><a id="body-ref-sref16" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16" aria-controls="sref16">Grabherr et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Grabherr, M.G. ∙ Haas, B.J. ∙ Yassour, M. ...</div><div><strong>Full-length transcriptome assembly from RNA-Seq data without a reference genome</strong></div><div><em>Nat. Biotechnol.</em> 2011; <strong>29</strong>:644-652</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.1883" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-79960264362" target="_blank" aria-label="Open Scopus in new tab">Scopus (14980)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21572440/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.1883&amp;pmid=21572440" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) settings in our configuration file: inchworm_only&nbsp;= True and trinity_kmer_length&nbsp;= 15. We classified a T&nbsp;cell as having a reconstructed TCR if we could reconstruct productive sequences for α and/or β chains. We defined clonotypes based on grouping T&nbsp;cells sharing an identical α and/or β chain, and we reported the size of the clonotype as the number of cells in this grouping. We defined a T&nbsp;cell as a singleton if it had a reconstructed TCR that did not share an identical α and/or β chain with any other T&nbsp;cell from that same tumor.</div></section><section id="sec-4-5-7"><h4>Differential gene expression in clonal cells (SMART-Seq2)</h4><div id="p0395" role="paragraph">To compare expression levels between clonal and non-clonal T&nbsp;cells, we first calculated the mean expression of each gene in these respective populations. These populations differ in cell composition and cell quality across different patient tumors. To control for this, we matched every clonotype in each patient tumor with ten sets of non-clonal T&nbsp;cells randomly drawn from that same patient tumor. Each randomly selected set of non-clonal T&nbsp;cells had the same number of cells as the corresponding clonotype, and each selected T&nbsp;cell was a singleton. For each gene, we calculated its mean expression value across all cells in clonotypes from all tumors, and across all random sets of non-clonal cells from all tumors, and subtracted its mean expression in all non-clonal cells from its mean expression in clonal cells. Because we take the mean expression value across all cells from all clonotypes, this gives greater weight to clonotypes with greater size.</div><div id="p0400" role="paragraph">To compare expression variability between clonal and non-clonal T&nbsp;cells we followed a similar approach. To quantify variability of each gene for clonal cells, we calculated the <i>L</i><sub>1</sub> distance between the expression of a gene in cell <i>x</i> and in cell <i>y</i> in the same clonotype. (We used <i>L</i><sub>1</sub> and not <i>L</i><sub>2</sub>, because squaring the expression difference will emphasize larger differences, which are often driven by technical noise in scRNA-seq.) For each clonotype from each patient tumor, we calculated the <i>L</i><sub>1</sub> distances for every possible pair of cells within the clonotype, and then calculated the mean distance across all these distances. We divided this mean <i>L</i><sub>1</sub> distance by the gene’s mean expression across all cells from all clonotypes (as above), to get a coefficient of variation (CV). To quantify variability of each gene for non-clonal cells, we use the same approach but instead calculated <i>L</i><sub>1</sub> distances within the random sets of non-clonal cells, with non-clonal cells defined as above. We finally calculated the difference in CV values between clonal and non-clonal cells. We excluded genes with low mean expression in both the clonal and nonclonal cells (ln(TP100K+1)&nbsp;&lt; 0.1) as these genes would have greatly inflated CV values and not be reliably quantified.</div><div id="p0405" role="paragraph">To test for each gene whether the differences in mean expression or CV are significantly different between clonal and non-clonal cells, we empirically generated a background distribution. We shuffled the expression values between clonal and non-clonal cells for each gene and calculated the differences in mean expression and CV for this shuffled expression data. We repeated this 100 times for each gene and then calculated a z-score of the observed difference relative to this empirical null distribution. If the magnitude of the z-score was greater than 3, the observed difference in the actual data was more extreme than any of the values in the empirical null distribution.</div></section><section id="sec-4-5-8"><h4>scRNA-seq data processing (5′ end scRNA-seq)</h4><div id="p0410" role="paragraph">We processed raw sequencing reads from both library types (gene expression and V(D)J) to generate gene expression matrices and to reconstruct TCR alpha and beta chain sequences. For both library types, we demultiplexed FASTQ files from the raw sequencing reads using Cell Ranger mkfastq (v3.1) (10x Genomics). For the gene expression libraries, we then aligned these reads to the human GRCh38 genome (refdata-cellranger-GRCh38-3.0.0) using Cell Ranger count (v3.1) (10x Genomics). We normalized the total number of unique molecular identifiers (UMIs) per cell to ten thousand (TP10K) and then log-transformed these values to report gene expression as E&nbsp;= ln(TP10K+1). For the V(D)J libraries, we assembled the sequencing reads into contigs and annotated the segments and CDR3 regions using Cell Ranger vdj (v3.1) (10x Genomics) and a V(D)J reference (refdata-cellranger-vdj-GRCh38-alts-ensembl-3.1.0). We used the clonotype groups as determined by Cell Ranger vdj, where cells in a clonotype share the same productive CDR3 nucleotide sequence.</div></section><section id="sec-4-5-9"><h4>Quality control of scRNA-seq (5′ end scRNA-seq)</h4><div id="p0415" role="paragraph">For each cell, we considered a gene to be detected if its TP10K &gt; 0. We excluded all cells with&nbsp;&lt; 400&nbsp;UMIs detected, either&nbsp;&lt; 200 or&nbsp;&gt;&nbsp;5,000 unique genes detected, or with &gt; 10% of UMIs coming from mitochondrial genes. As with our SMART-Seq2 analysis, we carried out an initial round of clustering, described below, to identify and remove cells that were not T&nbsp;cells or droplets that contained cell doublets. We first identified and removed myeloid cells and astrocytes. We then identified and removed two types of cell doublets: T&nbsp;cells expressing <i>CD4</i>, <i>CD8A</i>, and <i>CD8B</i>, and a cluster of Tregs expressing <i>CD8</i>. After these quality control steps, overall we retained 25,256 T&nbsp;cells from 5 glioma samples (from 5 patients). These T&nbsp;cells are used in all analyses reported in this work.</div></section><section id="sec-4-5-10"><h4>Cell type and cell state identification (5′ end scRNA-seq)</h4><div id="p0420" role="paragraph">To identify the cell states present in CD4 T&nbsp;cells (3,665 cells) and CD8 T&nbsp;cells (21,502 cell), we used Seurat (v3.2.0). In order to perform batch correction and identify highly variable genes in the two populations of T&nbsp;cells, we split the data by sample, used <i>NormalizeData</i> to normalize gene expression, and identified variable genes using <i>FindVariableFeatures.</i> In order to integrate the samples, we used <i>FindIntegrationAnchors</i> to identify shared variable genes across samples and used <i>SelectIntegrationFeatures</i> to integrate the datasets. We then centered mean gene expression across all samples to zero using <i>ScaleData</i> and performed Principle Components Analysis (PCA) using <i>RunPCA</i>. We then used Louvain clustering on the top 20 principal components (PCs) using <i>FindNeighbors</i>, with the k-nearest neighbor algorithm set to 20, and <i>FindClusters</i>, with the resolution parameter set to 1. For two-dimensional visualization, we employed Uniform Manifold Approximation and Projection embedding (UMAP) using <i>RunUMAP</i> (min.dist&nbsp;= 0.5, number of neighbors&nbsp;= 15, and distance metric&nbsp;= Euclidean). Lastly, to identify differentially expressed genes we implemented <i>FindAllMarkers.</i></div><div id="p0425" role="paragraph">In order to identify the different cell states in the CD4 T&nbsp;cells and CD8 T&nbsp;cells, we clustered these subpopulations using NMF. For clustering of the CD4 T&nbsp;cells, we used 8 factors; when clustering the CD8 T&nbsp;cells we used 9 factors. We then generated UMAP visualizations of the CD4 T&nbsp;cells and CD8 T&nbsp;cells using the top 20 PCs as described above. We used the differentially expressed genes and known cell type markers to annotate the cell type or cell state of each cluster identified using NMF.</div></section><section id="sec-4-5-11"><h4>Differential gene expression in clonal cells (5′ end scRNA-seq)</h4><div id="p0430" role="paragraph">To compare expression levels in clonally expanded CD4 and CD8 T&nbsp;cells, we first binned cells by expression of <i>KLRB1</i>, those cells with <i>KLRB1</i> expression greater than zero were deemed KLRB1-positive and those with expression less than or equal to zero were deemed KLRB1-negative. We then used <i>FindMarkers</i> to identify differentially expressed genes between the KLRB1-positive and KLRB1-negative populations.</div></section><section id="sec-4-5-12"><h4>Analysis of gene expression in additional scRNA-seq glioma datasets</h4><div id="p0435" role="paragraph">To examine gene expression from malignant cells, myeloid cells and glial cells in diffuse gliomas, we analyzed our published, quality-controlled, scRNA-seq datasets for IDH mutant oligodendroglioma, IDH mutant astrocytoma, and IDH-wild-type GBM. Gene expression was given in units of ln(TP100K+1), and malignant cells, myeloid cells, and oligodendrocytes were identified based on the cell-type annotations provided in our published studies.</div></section><section id="sec-4-5-13"><h4>Analysis of gene expression by tumor-infiltrating T&nbsp;cells in additional scRNA-seq cancer datasets</h4><div id="p0440" role="paragraph">We collected processed scRNA-seq datasets for the following human cancers: melanoma (<span class="dropBlock reference-citations"><a id="body-ref-sref21-3" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21-3" aria-controls="sref21-3">Jerby-Arnon et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref21-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Jerby-Arnon, L. ∙ Shah, P. ∙ Cuoco, M.S. ...</div><div><strong>A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade</strong></div><div><em>Cell.</em> 2018; <strong>175</strong>:984-997.e24</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.09.006&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.09.006&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85055549585" target="_blank" aria-label="Open Scopus in new tab">Scopus (793)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30388455/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.09.006&amp;pmid=30388455" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref48-2" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48-2" aria-controls="sref48-2">Sade-Feldman et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref48-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Sade-Feldman, M. ∙ Yizhak, K. ∙ Bjorgaard, S.L. ...</div><div><strong>Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma</strong></div><div><em>Cell.</em> 2018; <strong>175</strong>:998-1013.e20</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.10.038&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.10.038&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85055560004" target="_blank" aria-label="Open Scopus in new tab">Scopus (1075)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30388456/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.10.038&amp;pmid=30388456" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), colorectal cancer (<span class="dropBlock reference-citations"><a id="body-ref-sref59-3" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-3" aria-controls="sref59-3">Zhang et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref59-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Zhang, L. ∙ Yu, X. ∙ Zheng, L. ...</div><div><strong>Lineage tracking reveals dynamic relationships of T&nbsp;cells in colorectal cancer</strong></div><div><em>Nature.</em> 2018; <strong>564</strong>:268-272</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0694-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85058518221" target="_blank" aria-label="Open Scopus in new tab">Scopus (694)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30479382/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0694-x&amp;pmid=30479382" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (<a id="intref0365" href="http://crc.cancer-pku.cn/" target="_blank">http://crc.cancer-pku.cn/</a>), non-small cell lung cancer (<span class="dropBlock reference-citations"><a id="body-ref-sref27" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27" aria-controls="sref27">Lambrechts et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Lambrechts, D. ∙ Wauters, E. ∙ Boeckx, B. ...</div><div><strong>Phenotype molding of stromal cells in the lung tumor microenvironment</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1277-1289</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0096-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85049650563" target="_blank" aria-label="Open Scopus in new tab">Scopus (1017)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29988129/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0096-5&amp;pmid=29988129" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (<a id="intref0370" href="https://scope.aertslab.org" target="_blank">https://scope.aertslab.org</a>), and liver cancer (<span class="dropBlock reference-citations"><a id="body-ref-sref61-3" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61-3" aria-controls="sref61-3">Zheng et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref61-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Zheng, C. ∙ Zheng, L. ∙ Yoo, J.K. ...</div><div><strong>Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:1342-1356.e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2017.05.035&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2017.05.035&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85020894317" target="_blank" aria-label="Open Scopus in new tab">Scopus (1381)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28622514/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.05.035&amp;pmid=28622514" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (<a id="intref0375" href="http://hcc.cancer-pku.cn/" target="_blank">http://hcc.cancer-pku.cn/</a>). In some studies, samples were collected from both malignant tissue and normal, adjacent tissues. We used the sample and cell-type annotations provided by the authors to select only T&nbsp;cells from the malignant tissue samples. In liver cancer and colorectal cancer, 4% and 1% of the T&nbsp;cells, respectively, were MAIT cells (as defined by the dataset authors). For melanoma, colorectal cancer, and liver cancer, we constructed t-distributed stochastic neighbor embedding (t-SNE) visualizations using <i>RunTSNE</i> with perplexity&nbsp;= 30. For lung cancer, we used the t-SNE visualization provided by the authors.</div></section><section id="sec-4-5-14"><h4>Pan-cancer metanalysis of KLRB1 transcriptional programs</h4><div id="p0445" role="paragraph">We identified <i>KLRB1</i> programs by comparing between cells in which <i>KLRB1</i> was detected (KLRB1<sup>+</sup>) and cells in which <i>KLRB1</i> was not detected (KLRB1<sup>-</sup>). Each <i>KLRB1</i> program consisted of the genes whose expression was significantly greater in KLRB1<sup>+</sup> T&nbsp;cells relative to KLRB1<sup>-</sup> T&nbsp;cells, and as above, differential expression analysis was performed using a t test on the log-transformed TPM100K values. We identified the <i>KLRB1</i> programs separately in CD4 and CD8 T&nbsp;cells, using the glioma IDH-G&nbsp;+ GBM cohort. We then repeated this analysis in the five other scRNA-Seq T&nbsp;cell datasets listed above. We evaluated the significance of overlap in genes between the programs that were identified in each T&nbsp;cell cohort with a hypergeometric test (<a id="crosref1610" href="#fig7">Figure&nbsp;7</a>C). For each pair of programs we also report the observed versus expected ratio (<a id="crosref1615" href="#fig7">Figure&nbsp;7</a>D), that is, the number of genes in the overlap between the two programs, divided by the number of genes that are expected to be in the overlap if the programs were randomly sampled. Lastly, to integrate the results that were obtained across the six cohorts in this metanalysis and derive the final pan-cancer program, we used Fisher’s combined probability test and corrected the resulting p values for multiple hypotheses testing using the Benjamini-Hochberg correction. The different programs and the final pan-cancer p values are provided in <a id="crosref1620" href="#mmc5">Table S5</a>. To define the pan-cancer <i>KLRB1</i> programs in CD4 T&nbsp;cells and in CD8 T&nbsp;cells (<a id="crosref1625" href="#fig7">Figure&nbsp;7</a>E), we used those significant genes that appeared in at least 3 of 6 of the <i>KLRB1</i> programs from the six cancer cohorts, including the glioma IDH-G&nbsp;+ GBM cohort.</div></section><section id="sec-4-5-15"><h4>T cell differences between IDH-G and GBM in bulk RNA-seq profiles from TCGA</h4><div id="p0450" role="paragraph">To evaluate the differences in T&nbsp;cell expression in a larger dataset, we leveraged the GBM and IDH-G bulk RNA-seq expression profiles from the TCGA. First, we combined the scRNA-seq data with our previously published glioblastoma scRNA-seq data, which were generated using the same protocol, to compare the average expression of each gene across different cell types and identify genes that were at least 8-fold higher expressed in T&nbsp;cells than in any other cell-type. Next, we found the log-transformed expression of each of these T&nbsp;cell specific genes in the bulk RNA seq dataset. Next, we calculated the total T&nbsp;cell signal for each tumor, defined by the average expression of the genes CD2, CD3D, CD3E, and CD3G. Since the state of T&nbsp;cells cannot be properly evaluated if the total T&nbsp;cell signal is low, we restricted further analysis to 129 out of 148 tumors from GBM dataset and 161 out of 428 tumors for the IDH-G dataset that had a total T&nbsp;cell signal above 2. Next, to normalize each gene’s expression in the bulk RNA-seq to its total T&nbsp;cell expression, we generated a relative expression profile for each T&nbsp;cell specific gene, by subtracting from its expression the median expression of all T&nbsp;cell specific genes. Next, to visualize the difference in expression between the GBM and IDH-G tumors, we performed a Student’s t test comparison between the normalized expression (as well as the non-normalized log2-transformed expression) of each T&nbsp;cell specific gene in GBM tumors compared to the IDH-G tumors and plotted the -log10(p value) from this comparison against the log2(fold change) value in a volcano plot.</div></section></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0455" role="paragraph">We thank Ania Hupalowska for help with graphics and Dr. John Sampson (Duke University) for generously providing cells from the D270 PDX model. This work was supported by a grant from the Ben and Catherine Ivy Foundation (to D.A.R., M.L.S., and K.W.W.) and the Bridge Project, a partnership between the Koch Institute for Integrative Cancer Research at MIT and the Dana-Farber/Harvard Cancer Center (to K.W.W., M.L.S., and A.R.R.). The work was supported by the NIH (R01 CA238039 to K.W.W., P01 CA236749 to K.W.W., M.L.S., D.A.R., and E.A.C., R01 CA234018 to K.W.W. and X.S.L., and R37CA245523 to M.L.S.), a gift from the Ambrose Monell Foundation (to K.W.W.), the MGH Research Scholars (to M.L.S.), the Sontag Foundation (to M.L.S.), the Zuckerman STEM Leadership Program (to I.T.), the Human Frontier Science Program (to I.T.), the Mexican Friends New Generation (to I.T.), and the Benoziyo Endowment Fund for the Advancement of Science (to I.T.). K.W.W. is a member of the Parker Institute for Cancer Immunotherapy (PICI). N.D.M. was supported by a postdoctoral fellowship from the American Cancer Society (PF-17-042-01-LIB) and the NIH education loan repayment program funded by the NCI (L30 CA231679-01). S.M. was supported by a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (DFG, MA-8489/1-1). A.M. is an investigator at the Chan Zuckerberg Biohub, holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund and the Cancer Research Institute (CRI) Lloyd J. Old STAR award, has received funding from the Innovative Genomics Institute (IGI), and is a member of the Parker Institute for Cancer Immunotherapy (PICI). A.R. was supported by funds from the Howard Hughes Medical Institute, the Klarman Cell Observatory, NCI (1U24CA180922 and R33CA202820), by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute, and the Ludwig Center at MIT. E.M.P. is supported by the National Science Foundation Graduate Research Fellowship (DGE1745303). S.G. was supported by a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (DFG, GR 5252/1-1). L.J.-A. is a Chan Zuckerberg Biohub investigator and holds a Career Award at the Scientific Interface from Burroughs Wellcome Fund (BWF). L.J.-A. was a fellow of the Eric and Wendy Schmidt postdoctoral program and a CRI Irvington Fellow supported by the CRI. L.N.G.C. was supported by a K12 award (CA090354). D.P.C. was supported by NIH (R01CA227821 and P50CA165962), the Tawingo Fund, and Loglio Foundation. T.H. was supported by Grant-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science, SENSHIN Medical Research Foundation, and Kanae Foundation for the Promotion of Medical Science.</div><section id="sec-5"><h3>Author contributions</h3><div id="p0460" role="paragraph">N.D.M., O.A., I.T., S.G., E.M.P., D.A.R., A.R., M.L.S., and K.W.W. conceived the project, designed the study, and interpreted results. N.D.M., S.G., M.D., H.L.C., and S.M. collected T&nbsp;cells from human gliomas for scRNA-seq. A.R.R., M.E.S., C.M.H., L.N.G., and S.G. generated scRNA-seq data using the Smart-seq2 method. S.M. generated scRNA-seq data with the 10X Genomics method. O.A., I.T., E.M.P., R.C.-M., L.J.-A., W.Z., and X.S.L. performed computational analyses. N.D.M. and S.M. performed flow cytometry analyses. A.R.R., M.E.S., and S.G. performed ISH experiments. N.D.M., M.F., and O.O. performed CRISPR KO and functional assays. N.D.M. and S.M. performed <i>in&nbsp;vivo</i> surgical injections in humanized mouse models. M.J.P. performed GL261 surgical injections. H.W. and T.H. generated gliomaspheres models. N.D.M., Y.I., P.C.G., and M.J.P. analyzed murine GBM models. J.P. generated protein reagents. K.S. and A.M. provided protocols for editing of human T&nbsp;cells. A.E.C., L.N.G., B.S., P.S.J., D.P.C., P.K.B., K.L.L., D.N.L., M.P.F., and D.A.R. consented patients and provided clinico-pathological guidance to the study. O.R.-R. provided experimental support. K.W.W., N.D.M., O.A., I.T., A.R., and M.L.S. wrote the manuscript with feedback from all authors.</div></section><section id="sec-6"><h3>Declaration of interests</h3><div id="p0465" role="paragraph">N.D.M., O.A., I.T., A.R., M.L.S., and K.W.W. are co-inventors of a patent application on the CLEC2D-CD161 pathway for the treatment of cancer. K.W.W., M.L.S., and A.R. are co-founders of Immunitas Therapeutics. K.W.W., M.L.S., and I.T. are advisory board members of Immunitas Therapeutics. K.W.W. serves on the scientific advisory board of TCR2 Therapeutics, T-Scan Therapeutics, SQZ Biotech, and Nextechinvest and received sponsored research funding from Bristol-Myers Squibb and Novartis. A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics, and until August 31, 2020, was an SAB member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov, and Thermo Fisher Scientific. From August 1, 2020, A.R. is an employee of Genentech. N.D.M. serves as a scientific advisor to Immunitas Therapeutics. A.M. is cofounder, member of the Boards of Directors, and member of Scientific Advisory Boards of Spotlight Therapeutics and Arsenal Biosciences. A.M. has served as an advisor to Juno Therapeutics, was a member of the scientific advisory board at PACT Pharma, and an advisor to Trizell. A.M. has received an honorarium from Merck and a consulting fee from AlphaSights and is an investor in and informal advisor to Offline Ventures. A.M. owns stock in Arsenal Biosciences, Spotlight Therapeutics, and PACT Pharma. The Marson lab has received research support from Juno Therapeutics, Epinomics, Sanofi, GlaxoSmithKline, Gilead, and Anthem. E.A.C. is currently an advisor to Advantagene Inc., Alcyone Biosciences, Insightec, Inc., Sigilon Therepeutics, and DNAtrix Inc. and has equity interest in DNAtrix; A.M. has advised Oncorus, Merck, Tocagen, Ziopharm, Stemgen, NanoTx., Ziopharm Oncology, Cerebral Therapeutics, Genenta, Merck, Janssen, Karcinolysis, and Shanaghai Biotech and has received research support from Advantagene, NewLink Genetics, and Amgen. A.M. is a named inventor on patents related to oncolytic HSV1. D.A.R. has received research support from Acerta Phamaceuticals, Agenus, Celldex, EMD Serono, Incyte, Inovio, Midatech, Omniox, and Tragara, and he has served as paid consultant for Abbvie, Advantagene, Agenus, Amgen, Bayer, Bristol-Myers Squibb, Celldex, DelMar, EMD Serono, Genentech/Roche, Inovio, Merck, Merck KGaA, Monteris, Novocure, Oncorus, Oxigene, Regeneron, Stemline, and Taiho Oncology, Inc. P.K.B., outside the scope of this work, has consulted for Angiochem, Genentech-Roche, Lilly, Tesaro, ElevateBio, Pfizer (Array), SK Life Sciences, and Dantari and is supported by the Breast Cancer Research Foundation, Damon Runyon Cancer Research Foundation, Ben and Catherine Ivy Foundation, and the National Cancer Institute (5R01CA244975-02, 5R21CA220253-02, and 5R01CA227156-03), BMS, Lilly, and honoraria from Merck, Genentech-Roche, and Lilly. D.P.C. has consulted for Lilly and Boston Pharmaceuticals and has received honoraria and travel reimbursement from Merck. O.R.-R. is an employee of Genentech since October 2020. O.R.-R. is a co-inventor on patent applications filed by the Broad Institute for inventions relating to work in single-cell genomics, such as in PCT/US2018/060860 and US provisional application 62/745,259. E.A.C. is currently an advisor to Advantagene Inc., Alcyone Biosciences, Insightec Inc., DNAtrix, Immunomic Therapeutics, Sangamo Therapeutics, and Seneca Therapeutics, has equity interest in DNAtrix, Immunomic Therapeutics, and Seneca Therapeutics, and has also advised Oncorus, Merck, Tocagen, Ziopharm, Stemgen, NanoTx., Ziopharm Oncology, Cerebral Therapeutics, Genenta. Merck, Janssen, Karcinolysis, and Shanghai Biotech. E.A.C. has received research support from NIH, US Department of Defense, American Brain Tumor Association, National Brain Tumor Society, Alliance for Cancer Gene Therapy, Neurosurgical Research Education Foundation, Advantagene, NewLink Genetics, and Amgen and also is a named inventor on patents related to oncolytic HSV1 and noncoding RNAs. X.S.L. is a cofounder, board member, and consultant of GV20 Oncotherapy and its subsidiaries, SAB of 3DMedCare, a consultant for Genentech, a stockholder of Bristol Myers Squibb (BMY), Thermo Fisher Scientific (TMO), Walgreens Boots Alliance (WBA), Abbott Laboratories (ABT), AbbVie Inc. (ABBV), and Johnson &amp; Johnson (JNJ), and receives research funding from Takeda and Sanofi.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental information (6)</h2><div id="p0475" role="paragraph"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div id="mmc1" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.01.022/attachment/80d498fb-d238-4cf6-bf09-5df9618e8834/mmc1.xlsx" download="mmc1.xlsx" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">Spreadsheet (13.21 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Table S1. Clinical cohort, related to Figures 1, 2, 3, 4, S1, S2, S3, and S4</div></div></div><div id="mmc2" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.01.022/attachment/6e619314-3851-4ae7-a79b-d3cddace3fd2/mmc2.xlsx" download="mmc2.xlsx" aria-labelledby="mmc2-heading mmc2-link"><span id="mmc2-link">Spreadsheet (153.64 KB)</span></a></div><div class="core-description"><div id="mmc2-heading" class="heading">Table S2. Gene expression data for SMART-seq2 dataset, related to Figures 1, 2, and S3</div><div id="espara0015" role="paragraph">Sheet 1. Marker genes in GBM and IDH-G CD8 T&nbsp;cells (Figure&nbsp;1F_CD8_DE_genes) All differentially expressed genes in IDHwt-GBM and IDHmut-glioma CD8 T&nbsp;cells are listed. This corresponds to the left heatmap in Figure&nbsp;1F. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed (following the cluster numbering in Figure&nbsp;1E), the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base e) in expression between the gene in the listed cluster and all other clusters. Sheet 2. Marker genes in GBM and IDH-G CD4 T&nbsp;cells (Figure&nbsp;1F_CD4_DE_genes) All differentially expressed genes in GBM and IDH-glioma CD4 T&nbsp;cells are listed. This corresponds to the right heatmap in Figure&nbsp;1F. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed (following the cluster numbering in Figure&nbsp;1E), the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base e) in expression between the gene in the listed cluster and all other clusters. Sheet 3. Marker genes in GBM and IDH-G CD8 T&nbsp;cells with high versus low NK signature scores (Figure&nbsp;2D_HighNK_CD8_DE_genes) All differentially expressed genes between CD8 T&nbsp;cells with high NK signature scores compared to low NK signature scores are listed. The CD8 T&nbsp;cells are from GBM and IDH-G. This corresponds to Figure&nbsp;2D. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed (high NK signature or low NK signature), the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base e) in expression between the gene in the listed cluster and all other clusters. Sheet 4. Marker genes in clonally expanded GBM and IDH-G T&nbsp;cells (Figure&nbsp;S3E_ClonalCells_DE_genes) All differentially expressed genes in clonally expanded IDHwt-GBM and IDHmut-glioma T&nbsp;cells are listed. This corresponds to Figure&nbsp;S3E. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed (following the cluster annotations in Figure&nbsp;S3D), the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base <i>e</i>) in expression between the gene in the listed cluster and all other clusters.</div></div></div><div id="mmc3" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.01.022/attachment/99b8e280-8951-4282-b960-0b00b5a7e4bc/mmc3.xlsx" download="mmc3.xlsx" aria-labelledby="mmc3-heading mmc3-link"><span id="mmc3-link">Spreadsheet (125.90 KB)</span></a></div><div class="core-description"><div id="mmc3-heading" class="heading">Table S3. Gene expression data for 10X Genomics dataset, related to Figures 3 and S2</div><div id="espara0020" role="paragraph">Sheet 1. Marker genes in GBM CD8 T&nbsp;cells (Figure&nbsp;S2C_CD8_DE_genes) All differentially expressed genes in GBM CD8 T&nbsp;cells profiled using the 10X Genomics platform are listed. This corresponds to the left heatmap in Figure&nbsp;S2C. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed, the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base e) in expression between the gene in the listed cluster and all other clusters. Sheet 2. Marker genes in IDH-G CD4 T&nbsp;cells (Figure&nbsp;S2C_CD4_DE_genes) All differentially expressed genes in GBM CD4 T&nbsp;cells profiled using the 10X Genomics platform are listed. This corresponds to the right heatmap in Figure&nbsp;S2C. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed, the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base e) in expression between the gene in the listed cluster and all other clusters. Sheet 3. Marker genes in clonally expanded KLRB1+ versus KLRB1- cells in GBM CD8 T&nbsp;cells (Figure&nbsp;3F_DEgenes_CD8_KLRB1+_KLRB1-) All differentially expressed genes in GBM KLRB1+ versus KLRB1- CD8 T&nbsp;cells profiled using the 10X Genomics platform are listed. This corresponds to the columns labeled CD8+ in the heatmap in Figure&nbsp;3F. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed, the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base e) in expression between the gene in the listed cluster and all other clusters. Sheet 4. Marker genes in clonally expanded KLRB1+ versus KLRB1- cells in GBM CD4 T&nbsp;cells (Figure&nbsp;3F_DEgenes_CD4_KLRB1+_KLRB1-) All differentially expressed genes in GBM KLRB1+ versus KLRB1- CD4 T&nbsp;cells profiled using the 10X Genomics platform are listed. This corresponds to the columns labeled CD4+ in the heatmap in Figure&nbsp;3F. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed, the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base e) in expression between the gene in the listed cluster and all other clusters.</div></div></div><div id="mmc4" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.01.022/attachment/15981cf4-c7ce-4b39-90ae-f4fd7137fb97/mmc4.xlsx" download="mmc4.xlsx" aria-labelledby="mmc4-heading mmc4-link"><span id="mmc4-link">Spreadsheet (56.85 KB)</span></a></div><div class="core-description"><div id="mmc4-heading" class="heading">Table S4. Marker genes in cellular signatures from the SMART-seq2 dataset, related to Figure&nbsp;2</div><div id="espara0025" role="paragraph">Sheet 1. Marker genes between Cytotoxicity-NK cells CD8&nbsp;T between GBM and IDH-G (Figure&nbsp;2A_CD8_Cyto-NK_topDEgenes) All differentially expressed genes between Cytotoxicity-NK CD8 T&nbsp;cells between GBM and IDH-G. This corresponds to the left panel of Figure&nbsp;2A. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed (high NK signature or low NK signature), the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base e) in expression between the gene in the listed cluster and all other clusters. Sheet 2. Marker genes between Interferon CD8 T&nbsp;cells between GBM and IDH-G (Figure&nbsp;2A_CD8_Interferon_topDEgenes) All differentially expressed genes between interferon CD8 T&nbsp;cells between GBM and IDH-G. This corresponds to the center panel of Figure&nbsp;2A. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed (high NK signature or low NK signature), the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base e) in expression between the gene in the listed cluster and all other clusters. Sheet 3. Marker genes between Stress CD8 T&nbsp;cells between GBM and IDH-G (Figure&nbsp;2A_CD8_Stress_topDEgenes) All differentially expressed genes between stress CD8 T&nbsp;cells between GBM and IDH-G. This corresponds to the right panel of Figure&nbsp;2A. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed (high NK signature or low NK signature), the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base e) in expression between the gene in the listed cluster and all other clusters. Sheet 4. Marker genes between Cytotoxicity-Chemokine CD4 T&nbsp;cells between GBM and IDH-G (Figure&nbsp;2B_CD4_Cyto_Chemo_topDEgenes) All differentially expressed genes between cytotoxicity-chemokine CD4 T&nbsp;cells between GBM and IDH-G. This corresponds to the left panel of Figure&nbsp;2B. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed (high NK signature or low NK signature), the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base e) in expression between the gene in the listed cluster and all other clusters. Sheet 5. Marker genes between Interferon CD4 T&nbsp;cells between GBM and IDH-G (Figure&nbsp;2B_CD4_Interferon_topDEgenes) All differentially expressed genes between interferon CD4 T&nbsp;cells between GBM and IDH-G. This corresponds to the center panel of Figure&nbsp;2B. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed (high NK signature or low NK signature), the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base e) in expression between the gene in the listed cluster and all other clusters. Sheet 6. Marker genes between Stress CD4 T&nbsp;cells between GBM and IDH-G (Figure&nbsp;2B_CD4_Stress_topDEgenes) All differentially expressed genes between stress CD4 T&nbsp;cells between IDHwt-GBM and IDHmut gliomas. This corresponds to the right panel of Figure&nbsp;2B. For each gene we list: its p value from the t test and its Bonferroni-adjusted p value (p_val_adj), the cluster in which the gene appears as differentially expressed (high NK signature or low NK signature), the frequency at which the gene is detected in the listed cluster (pct.1) and in all other clusters (pct.2), and the average log-fold change (avg_lnFC, base <i>e</i>) in expression between the gene in the listed cluster and all other clusters.</div></div></div><div id="mmc5" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.01.022/attachment/59c2050c-0858-4ca7-bd88-eaef0a45bdc8/mmc5.xlsx" download="mmc5.xlsx" aria-labelledby="mmc5-heading mmc5-link"><span id="mmc5-link">Spreadsheet (119.45 KB)</span></a></div><div class="core-description"><div id="mmc5-heading" class="heading">Table S5. Pan-cancer <i>KLRB1</i> program, related to Figure&nbsp;7</div><div id="espara0030" role="paragraph">Sheet 1. Pan-cancer KLRB1 program for GBM and IDH-G CD8 T&nbsp;cells (Figure&nbsp;7E_CD8_KLRB1program) Each row lists a gene identified in a KLRB1 transcriptional program in CD8 T&nbsp;cells from at least one of the analyzed cancer datasets (glioma, lung, melanoma, colon, liver). There are two melanoma datasets: Melanoma1 and Melanoma2 (Jerby-Arnon et&nbsp;al., 2018, Sade-Feldman et&nbsp;al., 2018). The columns indicate for each cancer dataset whether the gene is detected (1) or not detected (0) in the KLRB1 program for that cancer. The genes are sorted based on the number of cancer datasets that support their association with KLRB1 (N). The p value is calculated using Fisher’s combined probability test with Benjamini-Hochberg correction. From these genes, we derive the pan-cancer KLRB1 program for CD8 T&nbsp;cells shown in the left heatmap of Figure&nbsp;7E (STAR methods). Sheet 2. Pan-cancer KLRB1 program for GBM and IDH-G CD4 T&nbsp;cells (Figure&nbsp;7E_CD4_KLRB1program) Each row lists a gene identified in a KLRB1 transcriptional program in CD4 T&nbsp;cells from at least one of the analyzed cancer datasets (glioma, lung, melanoma, colon, liver). There are two melanoma datasets: Melanoma1 and Melanoma2 (Jerby-Arnon et&nbsp;al., 2018, Sade-Feldman et&nbsp;al., 2018). The columns indicate for each datasets dataset whether the gene is detected (1) or not detected (0) in the KLRB1 program for that cancer. The genes are sorted based on the number of cancer datasets that support their association with KLRB1 (N). The p value is calculated using Fisher’s combined probability test with Benjamini-Hochberg correction. From these genes, we derive the pan-cancer KLRB1 program for CD4 T&nbsp;cells shown in the right heatmap of Figure&nbsp;7E (STAR methods).</div></div></div><div id="mmc6" class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.01.022/attachment/6ce5c77c-c239-4027-8b79-381202b292db/mmc6.xlsx" download="mmc6.xlsx" aria-labelledby="mmc6-heading mmc6-link"><span id="mmc6-link">Spreadsheet (11.13 KB)</span></a></div><div class="core-description"><div id="mmc6-heading" class="heading">Table S6. Correlation of <i>KLRB1</i> expression with Trm signature, related to Figure&nbsp;7</div><div id="espara0035" role="paragraph">Sheet 1. Correlation between <i>KLRB1</i> expression and Trm signature in each subset of CD8 and CD4 T&nbsp;cells (KLRB1_Trm_Correlation) Correlation between expression of <i>KLRB1</i> and the Trm gene signature for each subset of CD8 and CD4 T&nbsp;cells from both data sets (SMART-seq2 and 10x Genomics). For each subset, we list the Pearson correlation coefficient and p value.</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref1" title="View in article">1.</a></div><div>Aldemir, H. ∙ Prod’homme, V. ∙ Dumaurier, M.J. ...</div><div><strong>Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor</strong></div><div><em>J.&nbsp;Immunol.</em> 2005; <strong>175</strong>:7791-7795</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.175.12.7791" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-29144438027" target="_blank" aria-label="Open Scopus in new tab">Scopus (227)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16339512/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.175.12.7791&amp;pmid=16339512" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref2" title="View in article">2.</a></div><div>Blondel, V.D. ∙ Guillaume, J.-L. ∙ Lambiotte, R. ...</div><div><strong>Fast unfolding of communities in large networks</strong></div><div><em>J.&nbsp;Stat. Mech.</em> 2008;</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1088/1742-5468/2008/10/P10008" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-56349094785" target="_blank" aria-label="Open Scopus in new tab">Scopus (13959)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1088%2F1742-5468%2F2008%2F10%2FP10008" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref3" title="View in article">3.</a></div><div>Brown, C.E. ∙ Alizadeh, D. ∙ Starr, R. ...</div><div><strong>Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2016; <strong>375</strong>:2561-2569</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1610497" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85007288271" target="_blank" aria-label="Open Scopus in new tab">Scopus (1297)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28029927/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1610497&amp;pmid=28029927" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref4-1" title="View in article">4.</a></div><div>Bunse, L. ∙ Pusch, S. ∙ Bunse, T. ...</div><div><strong>Suppression of antitumor T&nbsp;cell immunity by the oncometabolite (R)-2-hydroxyglutarate</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1192-1203</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0095-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85049652256" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29988124/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0095-6&amp;pmid=29988124" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="opt7Nc15lWMeS" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-opt7Nc15lWMeS" title="View in article">5.</a></div><div>Butler, A. ∙ Hoffman, P. ∙ Smibert, P. ...</div><div><strong>Integrating single-cell transcriptomic data across different conditions, technologies, and species</strong></div><div><em>Nature Biotechnology.</em> 2018; <strong>36</strong>:411-420</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.4096" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85046298440" target="_blank" aria-label="Open Scopus in new tab">Scopus (6218)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29608179/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.4096&amp;pmid=29608179" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref5" title="View in article">6.</a></div><div>Chan, C.J. ∙ Martinet, L. ∙ Gilfillan, S. ...</div><div><strong>The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions</strong></div><div><em>Nat. Immunol.</em> 2014; <strong>15</strong>:431-438</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ni.2850" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84899099175" target="_blank" aria-label="Open Scopus in new tab">Scopus (374)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24658051/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fni.2850&amp;pmid=24658051" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref6" title="View in article">7.</a></div><div>Chongsathidkiet, P. ∙ Jackson, C. ∙ Koyama, S. ...</div><div><strong>Sequestration of T&nbsp;cells in bone marrow in the setting of glioblastoma and other intracranial tumors</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1459-1468</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0135-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85052329798" target="_blank" aria-label="Open Scopus in new tab">Scopus (427)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30104766/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0135-2&amp;pmid=30104766" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref7-1" title="View in article">8.</a></div><div>Fergusson, J.R. ∙ Smith, K.E. ∙ Fleming, V.M. ...</div><div><strong>CD161 defines a transcriptional and functional phenotype across distinct human T&nbsp;cell lineages</strong></div><div><em>Cell Rep.</em> 2014; <strong>9</strong>:1075-1088</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.celrep.2014.09.045&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.celrep.2014.09.045&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84919777275" target="_blank" aria-label="Open Scopus in new tab">Scopus (215)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25437561/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2014.09.045&amp;pmid=25437561" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="optlJEeC1dY34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-optlJEeC1dY34" title="View in article">9.</a></div><div>Eyquem, J. ∙ Mansilla-Soto, J. ∙ Giavridis, T. ...</div><div><strong>Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection</strong></div><div><em>Nature.</em> 2017; <strong>543</strong>:113-117</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature21405" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85014564234" target="_blank" aria-label="Open Scopus in new tab">Scopus (1254)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28225754/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature21405&amp;pmid=28225754" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref8" title="View in article">10.</a></div><div>Fergusson, J.R. ∙ Hühn, M.H. ∙ Swadling, L. ...</div><div><strong>CD161(int)CD8+ T&nbsp;cells: a novel population of highly functional, memory CD8+ T&nbsp;cells enriched within the gut</strong></div><div><em>Mucosal Immunol.</em> 2016; <strong>9</strong>:401-413</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/mi.2015.69" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84961794382" target="_blank" aria-label="Open Scopus in new tab">Scopus (90)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26220166/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fmi.2015.69&amp;pmid=26220166" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref9" title="View in article">11.</a></div><div>Filley, A.C. ∙ Henriquez, M. ∙ Dey, M.</div><div><strong>Recurrent glioma clinical trial, CheckMate-143: the game is not over yet</strong></div><div><em>Oncotarget.</em> 2017; <strong>8</strong>:91779-91794</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.18632/oncotarget.21586" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85032635307" target="_blank" aria-label="Open Scopus in new tab">Scopus (267)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29207684/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.18632%2Foncotarget.21586&amp;pmid=29207684" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref10" title="View in article">12.</a></div><div>Friebel, E. ∙ Kapolou, K. ∙ Unger, S. ...</div><div><strong>Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes</strong></div><div><em>Cell.</em> 2020; <strong>181</strong>:1626-1642</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.04.055&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.04.055&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85086403846" target="_blank" aria-label="Open Scopus in new tab">Scopus (366)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32470397/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2020.04.055&amp;pmid=32470397" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref11" title="View in article">13.</a></div><div>Gao, J. ∙ Zheng, Q. ∙ Xin, N. ...</div><div><strong>CD155, an onco-immunologic molecule in human tumors</strong></div><div><em>Cancer Sci.</em> 2017; <strong>108</strong>:1934-1938</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cas.13324" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85027534666" target="_blank" aria-label="Open Scopus in new tab">Scopus (135)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28730595/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcas.13324&amp;pmid=28730595" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref12" title="View in article">14.</a></div><div>Gaujoux, R. ∙ Seoighe, C.</div><div><strong>A flexible R package for nonnegative matrix factorization</strong></div><div><em>BMC Bioinformatics.</em> 2010; <strong>11</strong>:367</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1471-2105-11-367" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-77954069195" target="_blank" aria-label="Open Scopus in new tab">Scopus (899)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20598126/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1471-2105-11-367&amp;pmid=20598126" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref13" title="View in article">15.</a></div><div>Gedeon, P.C. ∙ Schaller, T.H. ∙ Chitneni, S.K. ...</div><div><strong>A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma</strong></div><div><em>Clin. Cancer Res.</em> 2018; <strong>24</strong>:3611-3631</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-17-0126" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85051238877" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29703821/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-17-0126&amp;pmid=29703821" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref14" title="View in article">16.</a></div><div>Germain, C. ∙ Meier, A. ∙ Jensen, T. ...</div><div><strong>Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2011; <strong>286</strong>:37964-37975</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1074%2Fjbc.M111.285312&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1074%2Fjbc.M111.285312&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-80055065444" target="_blank" aria-label="Open Scopus in new tab">Scopus (100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21930700/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M111.285312&amp;pmid=21930700" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref15" title="View in article">17.</a></div><div>Germain, C. ∙ Guillaudeux, T. ∙ Galsgaard, E.D. ...</div><div><strong>Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin’s lymphomas dampening natural killer cell functions</strong></div><div><em>OncoImmunology.</em> 2015; <strong>4</strong>:e1026503</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/2162402X.2015.1026503" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84940488391" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26405582/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F2162402X.2015.1026503&amp;pmid=26405582" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref16" title="View in article">18.</a></div><div>Grabherr, M.G. ∙ Haas, B.J. ∙ Yassour, M. ...</div><div><strong>Full-length transcriptome assembly from RNA-Seq data without a reference genome</strong></div><div><em>Nat. Biotechnol.</em> 2011; <strong>29</strong>:644-652</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.1883" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-79960264362" target="_blank" aria-label="Open Scopus in new tab">Scopus (14980)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21572440/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.1883&amp;pmid=21572440" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref17" title="View in article">19.</a></div><div>Grossman, S.A. ∙ Ye, X. ∙ Lesser, G. ..., NABTT CNS Consortium</div><div><strong>Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide</strong></div><div><em>Clin. Cancer Res.</em> 2011; <strong>17</strong>:5473-5480</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-11-0774" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-80051693219" target="_blank" aria-label="Open Scopus in new tab">Scopus (422)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21737504/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-11-0774&amp;pmid=21737504" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref18" title="View in article">20.</a></div><div>Guo, X. ∙ Zhang, Y. ∙ Zheng, L. ...</div><div><strong>Global characterization of T&nbsp;cells in non-small-cell lung cancer by single-cell sequencing</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:978-985</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0045-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85049041084" target="_blank" aria-label="Open Scopus in new tab">Scopus (967)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29942094/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0045-3&amp;pmid=29942094" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref19-1" title="View in article">21.</a></div><div>Gustafson, M.P. ∙ Lin, Y. ∙ New, K.C. ...</div><div><strong>Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone</strong></div><div><em>Neuro-oncol.</em> 2010; <strong>12</strong>:631-644</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/neuonc/noq001" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-78349293679" target="_blank" aria-label="Open Scopus in new tab">Scopus (191)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20179016/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fneuonc%2Fnoq001&amp;pmid=20179016" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref20" title="View in article">22.</a></div><div>Higuchi, F. ∙ Fink, A.L. ∙ Kiyokawa, J. ...</div><div><strong>PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide</strong></div><div><em>Mol. Cancer Ther.</em> 2018; <strong>17</strong>:2551-2563</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1535-7163.MCT-18-0177" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85057628319" target="_blank" aria-label="Open Scopus in new tab">Scopus (31)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30217967/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1535-7163.MCT-18-0177&amp;pmid=30217967" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref21-1" title="View in article">23.</a></div><div>Jerby-Arnon, L. ∙ Shah, P. ∙ Cuoco, M.S. ...</div><div><strong>A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade</strong></div><div><em>Cell.</em> 2018; <strong>175</strong>:984-997.e24</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.09.006&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.09.006&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85055549585" target="_blank" aria-label="Open Scopus in new tab">Scopus (793)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30388455/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.09.006&amp;pmid=30388455" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib62" class="citations"><div id="opt0OZ8fupRej" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-opt0OZ8fupRej" title="View in article">24.</a></div><div>Kaplanski, G.</div><div><strong>Interleukin-18: Biological properties and role in disease pathogenesis</strong></div><div><em>Immunol. Rev.</em> 2018; <strong>281</strong>:138-153</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/imr.12616" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85037980848" target="_blank" aria-label="Open Scopus in new tab">Scopus (385)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29247988/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fimr.12616&amp;pmid=29247988" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib22" class="citations"><div id="sref22" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref22" title="View in article">25.</a></div><div>Keller, A.N. ∙ Corbett, A.J. ∙ Wubben, J.M. ...</div><div><strong>MAIT cells and MR1-antigen recognition</strong></div><div><em>Curr. Opin. Immunol.</em> 2017; <strong>46</strong>:66-74</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.coi.2017.04.002" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85018411759" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28494326/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.coi.2017.04.002&amp;pmid=28494326" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref23" title="View in article">26.</a></div><div>Keskin, D.B. ∙ Anandappa, A.J. ∙ Sun, J. ...</div><div><strong>Neoantigen vaccine generates intratumoral T&nbsp;cell responses in phase Ib glioblastoma trial</strong></div><div><em>Nature.</em> 2019; <strong>565</strong>:234-239</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0792-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85059785792" target="_blank" aria-label="Open Scopus in new tab">Scopus (938)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30568305/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0792-9&amp;pmid=30568305" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref24-1" title="View in article">27.</a></div><div>Klemm, F. ∙ Maas, R.R. ∙ Bowman, R.L. ...</div><div><strong>Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells</strong></div><div><em>Cell.</em> 2020; <strong>181</strong>:1643-1660</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.05.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.05.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85086386623" target="_blank" aria-label="Open Scopus in new tab">Scopus (533)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32470396/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2020.05.007&amp;pmid=32470396" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref25" title="View in article">28.</a></div><div>Kumar, B.V. ∙ Ma, W. ∙ Miron, M. ...</div><div><strong>Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites</strong></div><div><em>Cell Rep.</em> 2017; <strong>20</strong>:2921-2934</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.celrep.2017.08.078&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.celrep.2017.08.078&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85029578875" target="_blank" aria-label="Open Scopus in new tab">Scopus (674)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28930685/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2017.08.078&amp;pmid=28930685" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref26" title="View in article">29.</a></div><div>Labun, K. ∙ Montague, T.G. ∙ Gagnon, J.A. ...</div><div><strong>CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering</strong></div><div><em>Nucleic Acids Res.</em> 2016; <strong>44</strong>:W272-6</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gkw398" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85011312299" target="_blank" aria-label="Open Scopus in new tab">Scopus (444)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27185894/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgkw398&amp;pmid=27185894" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref27" title="View in article">30.</a></div><div>Lambrechts, D. ∙ Wauters, E. ∙ Boeckx, B. ...</div><div><strong>Phenotype molding of stromal cells in the lung tumor microenvironment</strong></div><div><em>Nat. Med.</em> 2018; <strong>24</strong>:1277-1289</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41591-018-0096-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85049650563" target="_blank" aria-label="Open Scopus in new tab">Scopus (1017)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29988129/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41591-018-0096-5&amp;pmid=29988129" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28" title="View in article">31.</a></div><div>Langmead, B. ∙ Trapnell, C. ∙ Pop, M. ...</div><div><strong>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</strong></div><div><em>Genome Biol.</em> 2009; <strong>10</strong>:R25</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/gb-2009-10-3-r25" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-62349130698" target="_blank" aria-label="Open Scopus in new tab">Scopus (16504)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19261174/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fgb-2009-10-3-r25&amp;pmid=19261174" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref29" title="View in article">32.</a></div><div>Le Bourhis, L. ∙ Dusseaux, M. ∙ Bohineust, A. ...</div><div><strong>MAIT cells detect and efficiently lyse bacterially-infected epithelial cells</strong></div><div><em>PLoS Pathog.</em> 2013; <strong>9</strong>:e1003681</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.ppat.1003681" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84887281193" target="_blank" aria-label="Open Scopus in new tab">Scopus (300)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24130485/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.ppat.1003681&amp;pmid=24130485" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref30" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref30" title="View in article">33.</a></div><div>Li, B. ∙ Dewey, C.N.</div><div><strong>RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome</strong></div><div><em>BMC Bioinformatics.</em> 2011; <strong>12</strong>:323</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/1471-2105-12-323" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-79961123152" target="_blank" aria-label="Open Scopus in new tab">Scopus (13966)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21816040/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2F1471-2105-12-323&amp;pmid=21816040" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref31" title="View in article">34.</a></div><div>Llibre, A. ∙ López-Macías, C. ∙ Marafioti, T. ...</div><div><strong>LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation</strong></div><div><em>J.&nbsp;Immunol.</em> 2016; <strong>196</strong>:2085-2094</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.1502462" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84962010443" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26829983/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.1502462&amp;pmid=26829983" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref32" title="View in article">35.</a></div><div>Luoma, A.M. ∙ Suo, S. ∙ Williams, H.L. ...</div><div><strong>Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy</strong></div><div><em>Cell.</em> 2020; <strong>182</strong>:655-671.e22</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.06.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2020.06.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85087986491" target="_blank" aria-label="Open Scopus in new tab">Scopus (266)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32603654/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2020.06.001&amp;pmid=32603654" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref33" title="View in article">36.</a></div><div>McLane, L.M. ∙ Abdel-Hakeem, M.S. ∙ Wherry, E.J.</div><div><strong>CD8&nbsp;T Cell Exhaustion During Chronic Viral Infection and Cancer</strong></div><div><em>Annu. Rev. Immunol.</em> 2019; <strong>37</strong>:457-495</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1146/annurev-immunol-041015-055318" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85065028922" target="_blank" aria-label="Open Scopus in new tab">Scopus (1112)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30676822/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1146%2Fannurev-immunol-041015-055318&amp;pmid=30676822" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref34" title="View in article">37.</a></div><div>Meresse, B. ∙ Curran, S.A. ∙ Ciszewski, C. ...</div><div><strong>Reprogramming of CTLs into natural killer-like cells in celiac disease</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2006; <strong>203</strong>:1343-1355</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20060028" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-33646675580" target="_blank" aria-label="Open Scopus in new tab">Scopus (244)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16682498/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20060028&amp;pmid=16682498" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref35" title="View in article">38.</a></div><div>Miao, H. ∙ Choi, B.D. ∙ Suryadevara, C.M. ...</div><div><strong>EGFRvIII-specific chimeric antigen receptor T&nbsp;cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma</strong></div><div><em>PLoS ONE.</em> 2014; <strong>9</strong>:e94281</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0094281" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84899523433" target="_blank" aria-label="Open Scopus in new tab">Scopus (98)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24722266/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0094281&amp;pmid=24722266" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref36" title="View in article">39.</a></div><div>Mori, L. ∙ Lepore, M. ∙ De Libero, G.</div><div><strong>The Immunology of CD1- and MR1-Restricted T Cells</strong></div><div><em>Annu. Rev. Immunol.</em> 2016; <strong>34</strong>:479-510</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1146/annurev-immunol-032414-112008" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84969752983" target="_blank" aria-label="Open Scopus in new tab">Scopus (130)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26927205/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1146%2Fannurev-immunol-032414-112008&amp;pmid=26927205" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#figs2" title="View in article">40.</a></div><div>Neftel, C. ∙ Laffy, J. ∙ Filbin, M.G. ...</div><div><strong>An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma</strong></div><div><em>Cell.</em> 2019; <strong>178</strong>:835-849.e21</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2019.06.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2019.06.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85071345728" target="_blank" aria-label="Open Scopus in new tab">Scopus (1252)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31327527/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.06.024&amp;pmid=31327527" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref38-1" title="View in article">41.</a></div><div>Nigim, F. ∙ Cavanaugh, J. ∙ Patel, A.P. ...</div><div><strong>Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment</strong></div><div><em>J.&nbsp;Neuropathol. Exp. Neurol.</em> 2015; <strong>74</strong>:710-722</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/NEN.0000000000000210" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84934343090" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26083570/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FNEN.0000000000000210&amp;pmid=26083570" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39-1" title="View in article">42.</a></div><div>Picelli, S. ∙ Faridani, O.R. ∙ Björklund, A.K. ...</div><div><strong>Full-length RNA-seq from single cells using Smart-seq2</strong></div><div><em>Nat. Protoc.</em> 2014; <strong>9</strong>:171-181</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nprot.2014.006" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84891677425" target="_blank" aria-label="Open Scopus in new tab">Scopus (2539)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24385147/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnprot.2014.006&amp;pmid=24385147" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40" title="View in article">43.</a></div><div>Rapoport, A.P. ∙ Stadtmauer, E.A. ∙ Binder-Scholl, G.K. ...</div><div><strong>NY-ESO-1-specific TCR-engineered T&nbsp;cells mediate sustained antigen-specific antitumor effects in myeloma</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:914-921</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.3910" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84938963928" target="_blank" aria-label="Open Scopus in new tab">Scopus (694)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26193344/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.3910&amp;pmid=26193344" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref41" title="View in article">44.</a></div><div>Reardon, D.A. ∙ Omuro, A. ∙ Brandes, A. ...</div><div><strong>Randomized phase 3 study evaluating the efficacy and safety of nivolumab versus bevacizumab in patients with recurrent glioblastoma: Checkmate 143</strong></div><div><em>Neuro-Oncol.</em> 2019; <strong>19</strong>:iii21</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=D.A.ReardonA.OmuroA.BrandesJ.RiegerA.WickJ.SepulvedaS.PhuphanichP.de+SouzaM.S.AhluwaliaM.LimRandomized+phase+3+study+evaluating+the+efficacy+and+safety+of+nivolumab+versus+bevacizumab+in+patients+with+recurrent+glioblastoma%3A+Checkmate+143Neuro-Oncol.19Suppl+32019iii21" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42" title="View in article">45.</a></div><div>Reardon, D.A. ∙ Brandes, A.A. ∙ Omuro, A. ...</div><div><strong>Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial</strong></div><div><em>JAMA Oncol.</em> 2020; <strong>6</strong>:1003-1010</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/jamaoncol.2020.1024" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85085281407" target="_blank" aria-label="Open Scopus in new tab">Scopus (818)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32437507/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1001%2Fjamaoncol.2020.1024&amp;pmid=32437507" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="optgcJ2uHzuOq" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-optgcJ2uHzuOq" title="View in article">46.</a></div><div>Robbins, P. ∙ Li, Y. ∙ El-Gamil, M. ...</div><div><strong>Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions</strong></div><div><em>J. Immunol.</em> 2008; <strong>180</strong>:6116-6131</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.180.9.6116" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-44449128698" target="_blank" aria-label="Open Scopus in new tab">Scopus (283)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18424733/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.180.9.6116&amp;pmid=18424733" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref43" title="View in article">47.</a></div><div>Robbins, P.F. ∙ Morgan, R.A. ∙ Feldman, S.A. ...</div><div><strong>Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2011; <strong>29</strong>:917-924</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2010.32.2537" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-79952304769" target="_blank" aria-label="Open Scopus in new tab">Scopus (1352)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21282551/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1200%2FJCO.2010.32.2537&amp;pmid=21282551" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44" title="View in article">48.</a></div><div>Rosen, D.B. ∙ Bettadapura, J. ∙ Alsharifi, M. ...</div><div><strong>Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor</strong></div><div><em>J.&nbsp;Immunol.</em> 2005; <strong>175</strong>:7796-7799</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.175.12.7796" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-29144444611" target="_blank" aria-label="Open Scopus in new tab">Scopus (222)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16339513/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.175.12.7796&amp;pmid=16339513" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref45" title="View in article">49.</a></div><div>Rosen, D.B. ∙ Cao, W. ∙ Avery, D.T. ...</div><div><strong>Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells</strong></div><div><em>J.&nbsp;Immunol.</em> 2008; <strong>180</strong>:6508-6517</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.180.10.6508" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-45549100768" target="_blank" aria-label="Open Scopus in new tab">Scopus (140)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18453569/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.180.10.6508&amp;pmid=18453569" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46" title="View in article">50.</a></div><div>Roth, P. ∙ Mittelbronn, M. ∙ Wick, W. ...</div><div><strong>Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1</strong></div><div><em>Cancer Res.</em> 2007; <strong>67</strong>:3540-3544</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-06-4783" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-34248529706" target="_blank" aria-label="Open Scopus in new tab">Scopus (84)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17440061/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-06-4783&amp;pmid=17440061" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref47" title="View in article">51.</a></div><div>Roth, T.L. ∙ Puig-Saus, C. ∙ Yu, R. ...</div><div><strong>Reprogramming human T&nbsp;cell function and specificity with non-viral genome targeting</strong></div><div><em>Nature.</em> 2018; <strong>559</strong>:405-409</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0326-5" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85050234806" target="_blank" aria-label="Open Scopus in new tab">Scopus (552)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29995861/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0326-5&amp;pmid=29995861" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#fig7" title="View in article">52.</a></div><div>Sade-Feldman, M. ∙ Yizhak, K. ∙ Bjorgaard, S.L. ...</div><div><strong>Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma</strong></div><div><em>Cell.</em> 2018; <strong>175</strong>:998-1013.e20</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.10.038&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2018.10.038&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85055560004" target="_blank" aria-label="Open Scopus in new tab">Scopus (1075)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30388456/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.10.038&amp;pmid=30388456" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref49" title="View in article">53.</a></div><div>Schirmer, L. ∙ Rothhammer, V. ∙ Hemmer, B. ...</div><div><strong>Enriched CD161high CCR6+ γδ T&nbsp;cells in the cerebrospinal fluid of patients with multiple sclerosis</strong></div><div><em>JAMA Neurol.</em> 2013; <strong>70</strong>:345-351</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/2013.jamaneurol.409" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84874864228" target="_blank" aria-label="Open Scopus in new tab">Scopus (63)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23599932/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1001%2F2013.jamaneurol.409&amp;pmid=23599932" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref50" title="View in article">54.</a></div><div>Smillie, C.S. ∙ Biton, M. ∙ Ordovas-Montanes, J. ...</div><div><strong>Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis</strong></div><div><em>Cell.</em> 2019; <strong>178</strong>:714-730.e22</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2019.06.029&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2019.06.029&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85069176109" target="_blank" aria-label="Open Scopus in new tab">Scopus (666)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31348891/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2019.06.029&amp;pmid=31348891" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref51" title="View in article">55.</a></div><div>Smolders, J. ∙ Heutinck, K.M. ∙ Fransen, N.L. ...</div><div><strong>Tissue-resident memory T&nbsp;cells populate the human brain</strong></div><div><em>Nat. Commun.</em> 2018; <strong>9</strong>:4593</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-018-07053-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85055966401" target="_blank" aria-label="Open Scopus in new tab">Scopus (233)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30389931/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41467-018-07053-9&amp;pmid=30389931" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref52-1" title="View in article">56.</a></div><div>Stubbington, M.J.T. ∙ Lönnberg, T. ∙ Proserpio, V. ...</div><div><strong>T cell fate and clonality inference from single-cell transcriptomes</strong></div><div><em>Nat. Methods.</em> 2016; <strong>13</strong>:329-332</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nmeth.3800" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84960194523" target="_blank" aria-label="Open Scopus in new tab">Scopus (320)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26950746/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnmeth.3800&amp;pmid=26950746" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref53-1" title="View in article">57.</a></div><div>Tirosh, I. ∙ Izar, B. ∙ Prakadan, S.M. ...</div><div><strong>Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq</strong></div><div><em>Science.</em> 2016; <strong>352</strong>:189-196</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aad0501" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84963614956" target="_blank" aria-label="Open Scopus in new tab">Scopus (2751)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27124452/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aad0501&amp;pmid=27124452" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54" title="View in article">58.</a></div><div>Tirosh, I. ∙ Venteicher, A.S. ∙ Hebert, C. ...</div><div><strong>Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma</strong></div><div><em>Nature.</em> 2016; <strong>539</strong>:309-313</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature20123" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85016091925" target="_blank" aria-label="Open Scopus in new tab">Scopus (721)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27806376/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature20123&amp;pmid=27806376" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib55" class="citations"><div id="sref55" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55" title="View in article">59.</a></div><div>Venteicher, A.S. ∙ Tirosh, I. ∙ Hebert, C. ...</div><div><strong>Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq</strong></div><div><em>Science.</em> 2017; <strong>355</strong>:eaai8478</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.aai8478" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85016574289" target="_blank" aria-label="Open Scopus in new tab">Scopus (612)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28360267/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.aai8478&amp;pmid=28360267" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref56" title="View in article">60.</a></div><div>Woroniecka, K. ∙ Chongsathidkiet, P. ∙ Rhodin, K. ...</div><div><strong>T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma</strong></div><div><em>Clin. Cancer Res.</em> 2018; <strong>24</strong>:4175-4186</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-17-1846" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85050928290" target="_blank" aria-label="Open Scopus in new tab">Scopus (394)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29437767/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-17-1846&amp;pmid=29437767" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref57" title="View in article">61.</a></div><div>Zhang, Q. ∙ Rahim, M.M. ∙ Allan, D.S. ...</div><div><strong>Mouse Nkrp1-Clr gene cluster sequence and expression analyses reveal conservation of tissue-specific MHC-independent immunosurveillance</strong></div><div><em>PLoS ONE.</em> 2012; <strong>7</strong>:e50561</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0050561" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-84870727260" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23226525/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0050561&amp;pmid=23226525" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58" title="View in article">62.</a></div><div>Zhang, L. ∙ Sorensen, M.D. ∙ Kristensen, B.W. ...</div><div><strong>D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells</strong></div><div><em>Clin. Cancer Res.</em> 2018; <strong>24</strong>:5381-5391</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-17-3855" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85055912662" target="_blank" aria-label="Open Scopus in new tab">Scopus (63)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30006485/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-17-3855&amp;pmid=30006485" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref59-1" title="View in article">63.</a></div><div>Zhang, L. ∙ Yu, X. ∙ Zheng, L. ...</div><div><strong>Lineage tracking reveals dynamic relationships of T&nbsp;cells in colorectal cancer</strong></div><div><em>Nature.</em> 2018; <strong>564</strong>:268-272</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-018-0694-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85058518221" target="_blank" aria-label="Open Scopus in new tab">Scopus (694)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30479382/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-018-0694-x&amp;pmid=30479382" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60" title="View in article">64.</a></div><div>Zhao, Y. ∙ Zheng, Z. ∙ Robbins, P.F. ...</div><div><strong>Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines</strong></div><div><em>J.&nbsp;Immunol.</em> 2005; <strong>174</strong>:4415-4423</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.174.7.4415" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-15444371764" target="_blank" aria-label="Open Scopus in new tab">Scopus (175)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15778407/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.174.7.4415&amp;pmid=15778407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61-1" title="View in article">65.</a></div><div>Zheng, C. ∙ Zheng, L. ∙ Yoo, J.K. ...</div><div><strong>Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing</strong></div><div><em>Cell.</em> 2017; <strong>169</strong>:1342-1356.e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2017.05.035&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=10.1016%2Fj.cell.2017.05.035&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.01.022&amp;key=2-s2.0-85020894317" target="_blank" aria-label="Open Scopus in new tab">Scopus (1381)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28622514/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.05.035&amp;pmid=28622514" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none linkback-ad widget-" id="684c6365-474d-4ce7-932a-ddffa4f64d88">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <h2>CHORUS Manuscript</h2>
<p style="margin-bottom:5px;">
<a target="_blank" href="/action/clickThrough?id=2959&amp;url=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fam%2Fpii%2FS0092867421000659&amp;loc=%2Fcell%2Ffulltext%2FS0092-8674%2821%2900065-9&amp;pubId=59497943&amp;placeholderId=1346&amp;productId=1822"> View Open Manuscript</a>
</p>
        </div></div>
                </div>
                </div>

        
</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (14)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/60d9467a-adad-4456-9f2d-72a21c0e5c0e/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/980b33ad-3a02-4a01-a80d-6c7856e7e0de/main.assets/figs1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/d0f9d8bf-dbef-4ac7-80c6-ba5ad2c7a6f5/main.assets/figs2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/ed402f3d-e78b-4d93-8f57-fad45799ef94/main.assets/gr2.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/e8f199c2-6a54-4700-8c4b-27b67b4eb90c/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/48a76bbc-e340-4c1e-aebb-345a698bc51b/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/84680bfa-fb67-44b5-a7d9-81ba29ce7928/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/69a120cc-44fe-4c9d-9604-069130672905/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/b7317d76-78ec-4327-bd23-c345b9fb4d0d/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/1cda8c3d-9625-4b23-b916-374011c99ada/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/f42814ff-4eb8-4780-8899-e8e64afb311c/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/bbc3f616-4946-4a0b-9373-c43e0cf334d1/main.assets/gr6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig7" aria-label="Go to Figure&amp;nbsp;7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/98a5620c-9176-42ea-b863-ee510bc01a88/main.assets/gr7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs7" aria-label="Go to Figure&amp;nbsp;S7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/asset/4b3058fb-8413-46da-89cb-1761a6acb1b0/main.assets/figs7.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel js--loaded" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bissue%3Aissue%3Apii%5C%3AS0092867420X00067%3Bwebsite%3Awebsite%3Acell-site%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3Apii%5C%3AS0092867421000659%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Bpage%3Astring%3AShow+Full+Text%3BrequestedJournal%3Ajournal%3Acell%3Bwgroup%3Astring%3ADefault+Website+Group%3BsubPage%3Astring%3AFull+Text" data-pb-mode-enabled="false">
                <li class="publication-list__box publication-list__box-axel">
                    <ul class="rlist axel-list__box">
                        
                        
            <li class="plum-x-wrapper">
                <div class="plum-x plum-x--axel">
                    <div class="plum-x__items">
                        
                    <div class="plum-x__item plum-x-citation">
                        <div class="plum-x__item-num">274</div>
                        <div class="plum-x__item-title">Citations</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-capture">
                        <div class="plum-x__item-num">450</div>
                        <div class="plum-x__item-title">Captures</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-mention">
                        <div class="plum-x__item-num">14</div>
                        <div class="plum-x__item-title">Mentions</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-socialMedia">
                        <div class="plum-x__item-num">127</div>
                        <div class="plum-x__item-title">Social Media</div>
                    </div>    
                
                    </div>
                    <div class="plum-x__details">
                        <div class="plum-x__logo">
                            <img src="/products/marlin/releasedAssets/images/plumx-logo.png" alt="Plum X logo">
                        </div>
                        <a class="plum-x__view-details" href="https://plu.mx/plum/a/?doi=10.1016/j.cell.2021.01.022&amp;theme=plum-jbs-theme&amp;hideUsage=true" target="_blank">
                            <span>View details</span>
                            <span class="sr-only">opens in a new tab</span>
                            <i class="icon-external-arrow" aria-hidden="true"></i>
                        </a>
                    </div>
                </div>  
            </li>
        
                    </ul>
                </li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (6)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/attachment/80d498fb-d238-4cf6-bf09-5df9618e8834/mmc1.xlsx" download="mmc1.xlsx"><span id="mmc1-link">Spreadsheet (13.21 KB)</span></a><div class="core-description">Table S1. Clinical cohort, related to Figures 1, 2, 3, 4, S1, S2, S3, and S4</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/attachment/6e619314-3851-4ae7-a79b-d3cddace3fd2/mmc2.xlsx" download="mmc2.xlsx"><span id="mmc2-link">Spreadsheet (153.64 KB)</span></a><div class="core-description">Table S2. Gene expression data for SMART-seq2 dataset, related to Figures 1, 2, and S3</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/attachment/99b8e280-8951-4282-b960-0b00b5a7e4bc/mmc3.xlsx" download="mmc3.xlsx"><span id="mmc3-link">Spreadsheet (125.90 KB)</span></a><div class="core-description">Table S3. Gene expression data for 10X Genomics dataset, related to Figures 3 and S2</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/attachment/15981cf4-c7ce-4b39-90ae-f4fd7137fb97/mmc4.xlsx" download="mmc4.xlsx"><span id="mmc4-link">Spreadsheet (56.85 KB)</span></a><div class="core-description">Table S4. Marker genes in cellular signatures from the SMART-seq2 dataset, related to Figure&nbsp;2</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/attachment/59c2050c-0858-4ca7-bd88-eaef0a45bdc8/mmc5.xlsx" download="mmc5.xlsx"><span id="mmc5-link">Spreadsheet (119.45 KB)</span></a><div class="core-description">Table S5. Pan-cancer <i>KLRB1</i> program, related to Figure&nbsp;7</div></div></div><div id="collapsible-supplementary" data-expandable="item"><div class="content" style="display:none;" role="region" id="collapsible-supplementary_content"><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.01.022/attachment/6ce5c77c-c239-4027-8b79-381202b292db/mmc6.xlsx" download="mmc6.xlsx"><span id="mmc6-link">Spreadsheet (11.13 KB)</span></a><div class="core-description">Table S6. Correlation of <i>KLRB1</i> expression with Trm signature, related to Figure&nbsp;7</div></div></div></div><button class="trigger" aria-controls="collapsible-supplementary_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show more</span><span class="collapse">Show less</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related Articles</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S0092867421000659" class="ux3DeferredOnScrollWidget axel-related-articles__body ux3DeferredLoaded" data-show-more="true">We haven't found any related articles.</div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2021.01.022","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">Inhibitory CD161 receptor identified in glioma-infiltrating T&nbsp;cells by single-cell analysis</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.01.022/asset/60d9467a-adad-4456-9f2d-72a21c0e5c0e/main.assets/gr1.jpg" height="952" width="723" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/cf027cc7-232f-4a8f-9206-4df06d2423aa/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.01.022/asset/980b33ad-3a02-4a01-a80d-6c7856e7e0de/main.assets/figs1.jpg" height="894" width="727" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/5f4fc166-35f2-4db6-9b33-2b8b926a09b2/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.01.022/asset/d0f9d8bf-dbef-4ac7-80c6-ba5ad2c7a6f5/main.assets/figs2.jpg" height="949" width="711" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/372e1f12-4afb-481d-ab2b-a083891ed3de/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.01.022/asset/ed402f3d-e78b-4d93-8f57-fad45799ef94/main.assets/gr2.jpg" height="892" width="759" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/461ae7ae-cc38-42ae-88f8-b7eb9687e685/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.01.022/asset/e8f199c2-6a54-4700-8c4b-27b67b4eb90c/main.assets/gr3.jpg" height="949" width="747" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/aaf1ffeb-8b46-4a57-bbf4-1fae8a36fe7e/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.01.022/asset/48a76bbc-e340-4c1e-aebb-345a698bc51b/main.assets/figs3.jpg" height="773" width="759" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/0f85a9a4-c06f-4d2b-a02c-6328e20b636a/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.01.022/asset/84680bfa-fb67-44b5-a7d9-81ba29ce7928/main.assets/gr4.jpg" height="948" width="747" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/a3c53b18-1d0b-4e28-b3f9-98061d97df6b/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.01.022/asset/69a120cc-44fe-4c9d-9604-069130672905/main.assets/figs4.jpg" height="766" width="759" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/4fcddd1f-1609-4772-bce6-18d906cfe0b2/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.01.022/asset/b7317d76-78ec-4327-bd23-c345b9fb4d0d/main.assets/gr5.jpg" height="913" width="761" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/370b14aa-87a8-4974-a667-f4b0f5ff5705/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.01.022/asset/1cda8c3d-9625-4b23-b916-374011c99ada/main.assets/figs5.jpg" height="949" width="726" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/acab84a5-5444-4c96-a1f3-68763cdeb90c/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.01.022/asset/f42814ff-4eb8-4780-8899-e8e64afb311c/main.assets/figs6.jpg" height="951" width="759" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/12725f93-aa62-41ee-a8ea-dc52a0a6e516/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.01.022/asset/bbc3f616-4946-4a0b-9373-c43e0cf334d1/main.assets/gr6.jpg" height="949" width="737" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/df9aadb2-34ea-4619-9d3c-f75214c5586e/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2021.01.022/asset/98a5620c-9176-42ea-b863-ee510bc01a88/main.assets/gr7.jpg" height="934" width="759" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/230aa888-d306-4307-829c-e2f9221bb84b/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.01.022/asset/4b3058fb-8413-46da-89cb-1761a6acb1b0/main.assets/figs7.jpg" height="949" width="743" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/c030e331-814f-4cf8-9405-058233c5a6a3/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.01.022/asset/60d9467a-adad-4456-9f2d-72a21c0e5c0e/main.assets/gr1.jpg" height="952" width="723" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/cf027cc7-232f-4a8f-9206-4df06d2423aa/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.01.022/asset/980b33ad-3a02-4a01-a80d-6c7856e7e0de/main.assets/figs1.jpg" height="894" width="727" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/5f4fc166-35f2-4db6-9b33-2b8b926a09b2/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.01.022/asset/d0f9d8bf-dbef-4ac7-80c6-ba5ad2c7a6f5/main.assets/figs2.jpg" height="949" width="711" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/372e1f12-4afb-481d-ab2b-a083891ed3de/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.01.022/asset/ed402f3d-e78b-4d93-8f57-fad45799ef94/main.assets/gr2.jpg" height="892" width="759" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/461ae7ae-cc38-42ae-88f8-b7eb9687e685/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.01.022/asset/e8f199c2-6a54-4700-8c4b-27b67b4eb90c/main.assets/gr3.jpg" height="949" width="747" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/aaf1ffeb-8b46-4a57-bbf4-1fae8a36fe7e/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.01.022/asset/48a76bbc-e340-4c1e-aebb-345a698bc51b/main.assets/figs3.jpg" height="773" width="759" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/0f85a9a4-c06f-4d2b-a02c-6328e20b636a/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.01.022/asset/84680bfa-fb67-44b5-a7d9-81ba29ce7928/main.assets/gr4.jpg" height="948" width="747" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/a3c53b18-1d0b-4e28-b3f9-98061d97df6b/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.01.022/asset/69a120cc-44fe-4c9d-9604-069130672905/main.assets/figs4.jpg" height="766" width="759" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/4fcddd1f-1609-4772-bce6-18d906cfe0b2/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.01.022/asset/b7317d76-78ec-4327-bd23-c345b9fb4d0d/main.assets/gr5.jpg" height="913" width="761" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/370b14aa-87a8-4974-a667-f4b0f5ff5705/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.01.022/asset/1cda8c3d-9625-4b23-b916-374011c99ada/main.assets/figs5.jpg" height="949" width="726" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/acab84a5-5444-4c96-a1f3-68763cdeb90c/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.01.022/asset/f42814ff-4eb8-4780-8899-e8e64afb311c/main.assets/figs6.jpg" height="951" width="759" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/12725f93-aa62-41ee-a8ea-dc52a0a6e516/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.01.022/asset/bbc3f616-4946-4a0b-9373-c43e0cf334d1/main.assets/gr6.jpg" height="949" width="737" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/df9aadb2-34ea-4619-9d3c-f75214c5586e/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;7</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2021.01.022/asset/98a5620c-9176-42ea-b863-ee510bc01a88/main.assets/gr7.jpg" height="934" width="759" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/230aa888-d306-4307-829c-e2f9221bb84b/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S7</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.01.022/asset/4b3058fb-8413-46da-89cb-1761a6acb1b0/main.assets/figs7.jpg" height="949" width="743" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.01.022/asset/c030e331-814f-4cf8-9405-058233c5a6a3/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)00065-9';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)00065-9';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749589455633","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openarchive","volumeNumber":"184","issueNumber":"5","viewState":"fulltext","format":"MIME-HTML","id":"pii:S0092867421000659","coverDate":"202103","type":"XOCS-JOURNAL:SCOPE-FULL","title":"Inhibitory CD161 receptor identified in gliomainfiltrating Txa0cells by singlecell analysis","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94dbd1e88b6927fa',t:'MTc0OTU4OTQ1NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94dbd1e88b6927fa&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2021.01.022&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div></body></html>